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ABSTRACT 
Boswellia dalzielii (Burseraceae) has ethnopharmacological importance and is claimed 
to have anti-infection and immunomodulatory effects. In the Northern part of Nigeria, 
a region with a tropical dry climate, an aqueous infusion of this plant is used in the 
treatment of infections and tumours.  
The traditional formulation method was mimicked under laboratory conditions, and the 
effect of temperature and the impact of endophytic microbes present in aqueous 
infusion of B. dalzielii was also investigated. Activity-guided fractionation against 
Staphylococcus aureus and its methicillin-resistant strain resulted in the identification of 
two antibacterial compounds namely gallic acid and pyrogallol. The Minimum Inhibitory 
Concentration for pyrogallol and gallic acid against S. aureus growth are 508 and 753 
µM, while against MRSA growth are 254 and 2032 µM, respectively. A growth Inhibition 
assay showed the activity of gallic acid as bacteriostatic, and pyrogallol as bacteriocidal 
against tested microorganisms. Interestingly, the bacteriocidal compound was found to 
arise by conversion of gallic acid by the endophyte Enterobacter cloacae. In addition, 
Pantoea spp was also isolated from the bark of B. Dalzielii. The sequences of both E. 
cloacae and Pantoea spp are deposited in the GenBank nucleotide database under the 
accession number MH764584 and MH764583, respectively.  
Similarly, activity-guided fractionation of B. Dalzielii bark against breast cancer cell line 
(MCF7) using MTT cytotoxicity assay resulted in the identification of a cytotoxic 
compound, catechol, and the half maximal effective concentration (EC50) observed was 
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86µM. The growth inhibition effect of catechol was observed to be time- and 
concentration- dependent. Endophytic Klebsiella pneumonia species (strain A and B) 
were shown to be responsible for bioconversion of protocatechuic acid to catechol. In 
addition, Pantoea agglomerans was also isolated from the bark of B. dalzielii. The 
sequences of Klebsiella pneumonia A,  Klebsiella pneumonia B and Pantoea agglomerans 
are deposited in the GenBank nucleotide database under the accession number 
MH762022, MH762023 and MH762024, respectively. All isolated compounds were 
identified using HPLC, TLC, NMR, FTIR and HRMS.  
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1  
INTRODUCTION 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Herbs and plants are medical jewels gracing the woods, fields and 
lanes which few eyes see, and few minds understand. Through this 
want of observation and knowledge the world suffers immense loss” 
- Linnaeus 1707-1778 
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 SYNOPSIS  
The work described in this thesis is performed at Natural Product Research Laboratory, 
School of Pharmacy, Health and Life Sciences, De Montfort University since April 2015 
as part of a research program. Presently, research on the use of combined drug therapy 
is consistently growing most especially in the fight against infection. Research effort in 
this era is to find solutions to life-threatening diseases and disorder and to achieve this, 
new theories, procedures and technologies are developed.  The primary goal of this 
work is to obtain promising compounds from ethno-pharmaceutical plant and testing 
them alone and in synergy thus determining their bio-activity against micro-organisms 
and cancer cells. 
 BACKGROUND 
In rural communities of the Northern part of Nigeria, traditional medicine is highly 
regarded primarily for its easy accessibility and affordability. The author grew up in a 
community where the Boswellia plants bark, Boswellia odorata and Boswellia dalzielii, 
were used as supplements for maintaining normal function of the body and the 
extraction is conducted via maceration and decoction. The theoretical point of view is 
that this plant helps the body in getting rid of nascent cells as well as promoting 
homeostasis. Growing up with this theoretical knowledge, the author wants to produce 
scientific results backing this ethno-pharmacological claims. B. dalzielii is also used alone 
or/and in combination with other plants for the treatment and management of cancer, 
commonly known as daji in Hausa language, a language commonly spoken in the 
Northern part of Nigeria. Example of such combination used for the treatment of cancer 
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that has boils as one of the symptoms include the use of the stem bark of Spondias 
mombin (Common name: Tsada), Boswellia dalzielii (Common name: Arrarabi), 
Detarium microcarpum (Common name: Taura), Sclerocarya birrea (Common name: 
Danya) and Vitellaria paradoxa (Common name: Kade). Two teaspoons of each of the 
plant are used measured and mixed. The combination is ingested three times a day using 
milk or water. Where water is used as a solvent, plant extraction is conducted either via 
maceration and decoction. This mixture is claimed to be used for the treatment of ulcer, 
liver cirrhosis, kidney disease and irregular menstrual period.  
The purpose of this thesis is to provide scientific proof to some of the 
ethnopharmacological claims attributed to Boswellia dalzielii. 
 ETHNOPHARMACOLOGY 
The appreciation of herbal medicines is associated with ethnicity, culture, geographical 
location and economic pressures (WHO, 2013). Currently, we can see a global spread of 
traditional health care systems and medicine through publications  (Heinrich et al., 1998; 
der Veen and Morales, 2015; Heinrich and Jäger, 2015). Available resources on the 
internet on the use of traditional medicines have also contributed to their globalisation 
(Sud and Sud, 2013).  Also, immigration could impact and transform traditional medicine 
and evolve this knowledge, whereas urbanization could diminish the original value of 
such knowledge (Pirker et al., 2012). Ethnopharmacology could be a stepping stone in 
validating ethnobotanical claims on the use of traditional medicines, where data 
collected via this route could be used for several bioassays to prove these claims.  
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The term Ethnopharmacology first appeared in 1967, in a symposium 
(Ethnopharmacologic search of psychoactive drugs) aimed at sharing and recording 
information on psychoactive plants used in indigenous societies (Efron, Holmstedt and 
Kline, 1967). The symposium led to the release of a document on psychoactive plants 
with abundant details on the plants` botany, extraction methods, pharmacological 
studies and efficacy obtained. This is very similar to the present bioactivity guided 
fractionation employed in present drug discovery (Weller, 2012).  In this field, data are 
collected and studied (field studies) from different indigenous societies. These data are 
mostly historic, therefore it is paramount to put into account empirical underpinning to 
which these plants are evaluated at that time (de Montellano, 1975; Lardos, 2015).  
Series of in-vitro test for activity is designed on the basis of the biochemistry and/or 
molecular biology of the disease to test extracts obtained from plant, resulting in the 
term Bioassay/Activity Guided Fractionation, as seen in the studies of (Phillipson et al., 
2002; Oldoni et al., 2016; Erenler et al., 2017). However, the bioassay designed for to 
verify the ethno-pharmacological claims might display an entirely different activity 
which could lead to an interesting finding. This was seen in the discovery of vinca 
alkaloids anticancer agents (vinblastine and vincristine) from Catharanthus roseus, a 
plant initially investigated for its reported use in Jamaica for the treatment of diabetes 
(reported in Gragg and Newman, 2010). In order to achieve a successful extraction of 
compounds from a plant, chemical examination (chemotaxonomic consideration) of the 
bioassay is encouraged.  This would provide a possibility to the nature of active 
compounds present in the extract. Example, anti-inflammatory activity noted in a 
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member of Asteraceae, could be ascribed to the presence of sesquiterpene lactones 
present in many members of the family (Ivanescu, Miron and Corciova, 2015). These 
bioactive compounds can then be further subjected to isolation and structural 
elucidation using appropriate techniques (Cid and Bravo, 2015). 
 PLANT AS MEDICINE 
For millennia, the plant kingdom has served as a vast reservoir of material used in the 
prevention and treatment of diseases (Grabley and Thiericke, 1999). Plants as a source 
of herbal medicine are used across the world and referred to as traditional medicine 
(TM) or complementary/alternative medicine in some countries (WHO, 2013). The term 
traditional medicine (TM) has been defined by the World Health Organization (WHO) as 
“the sum total of the knowledge, skills, and practices based on the theories, beliefs, and 
experiences indigenous to different cultures, whether explicable or not, used in the 
maintenance of health as well as in the prevention, diagnosis, improvement or 
treatment of physical and mental illness”. Whilst, Herbal medicines (HMs) were 
described to “include herbs, herbal materials, herbal preparations and finished herbal 
products, that contain as active ingredients parts of plants, or other plant materials, or 
combinations” (WHO, 2013). In 1985, WHO reported that about 80% of the world 
population relied on traditional medicine as the primary source of healthcare, especially 
in the rural communities. This dependence on traditional medicine is said to be mostly 
due to the easy accessibility and affordability of these medicines.To-date this percentile 
is regurgitated in the literature (Ramawat and Merillon, 2008; Salim, Chin and Kinghorn, 
2008; Abdullahi, 2011; Mahomoodally and Fawzi, 2013).   
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The 19th century witnessed the birth of the reductionist approach to the treatment of 
ailments, where medicine is reduced to simple models of one drug-one target approach 
by extraction of active compounds from natural products. One of the famous discoveries 
is the isolation of morphine from opium of Papaver Somniferum in 1817 by Friedrich 
Sertürner (Krishnamurti and Rao, 2016). Another example of a famous compound from 
plants is quinine, a compound isolated from cinchona (quina-quina) tree by Pierre 
Joseph Pelletier and Joseph Caventou in 1820 (Achan et al., 2011). In the 20th century, 
quinine was used as a template for the synthesis of other antimalarial drugs such as 
chloroquine and mefloquine (Jones, Panda and Hall, 2015). However by the end of the 
20th century, the world witnessed the resistance of Plasmodium falciparum to quinine 
based drugs (Achan et al., 2011), this necessitated the development of artemisinin from 
Artemisia annua, as a novel scaffold for drug discovery. Artemisinin also serves as a lead 
compound used in deriving other semi-synthetic anti-malaria drugs such as 
dihydroartemisinin, artesunate and arteether (Balunas and Kinghorn, 2005; Cragg and 
Newman, 2013; Jones, Panda and Hall, 2015; MC, 2015).  Artemisinin and its semi-
synthetic derivatives such as artemether and artesunate are now used in combination 
therapy with drugs such as lumefantrine, mefloquine and amodiaquin having different 
modes of action against Plasmodium parasite, the causative agent of malaria (de Ridder, 
van der Kooy and Verpoorte, 2008). With this approach, the chance of development of 
resistance is believed to be greatly reduced (WHO, 2015).  
Unlike the reductionist approach, the holistic approach to treating ailments is a 
multidimensional one, which was the initial form of most medicine and relates to the 
whole system rather than a specific part of the system. It puts into consideration the 
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physical, psychological, social and spiritual aspect of an individual. Here, an ailment is a 
consequence of patients` differential susceptibility in relation to the interaction 
between an individual and environmental factors. To achieve complete treatment of 
ailments, combined therapeutic approaches are used (Lyng, 1990; Bodeker, Kronenberg 
and Burford, 2008). This approach is seen in Ayurveda, Traditional Chinese medicines, 
traditional Europe and Middle American medicine, which are collections of natural 
remedies documented from centuries of experience, highly regarded and evolving in 
their own right (Mao and Wang, 2013). More so, both the Arabian and African heritage 
in folk medicine are in agreement with the eastern holistic approach toward disease 
treatment; whereas the Arabian folk medicine was believed to have developed for 
centuries due to commercial trading and networking, which led to the exchange of 
information and transferable skills. African traditional medicine has been orally 
transferred from generation to generation (WHO, 2013), where some herbal 
practitioners are self-taught while others inherited such knowledge and practice (which 
could be) through apprenticeship or family trade (Katoto, 2009; ACCD, 2012; eNCA, 
2014; Health24, 2014; Saharatv, 2014). The lack of written/printed resources may 
explain the relatively minor role played by African herbal knowledge on a global scale 
when compared to Ayurveda and Traditional Chinese medicine. However, the first 
attempt to make an inventory on the use of African traditional medicine has been 
published, titled `Plant Resources of Tropical Africa 11` (Schmelzer et al., 2008; 
Schmelzer, Gurib-Fakim and Arroo, 2013).  
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We currently have a dichotomy in health care approaches. On the one hand, we have 
evidence-based medicine, where carefully dosed active pharmaceutical ingredients 
(API) act on specific well-defined molecular targets.  On the other hand, we have 
complementary and alternative medicine - where the efficacy of treatment or 
intervention is determined by the overall increase in wellbeing. Practitioners of 
evidence-based medicine may dismiss traditional medicine as ‘old-fashioned’, whereas 
practitioners of complementary and alternative medicine may refer to evidence-based 
health care as ‘allopathic medicine’ that is the treatment of symptoms but rarely ever 
the cause of any disease. However, complementary and alternative medicine is not 
without consequences.  
The emphasis on using single compounds as active pharmaceutical ingredients (API) is 
due to the fact that the stability, dosing, mechanism of action, therapeutic efficacy and 
toxicity have been studied to a certain extent and is constantly updated (Siddiqui, 
AlOthman and Rahman, 2017). However, the use of herbs or mixture of herbs as drugs 
comes with numerous challenges, some of which include the methods of extraction: 
different extraction method result in different rate of extracting the active ingredients 
and in some circumstances result in production of artificial products thus changing the 
initial bioactivity or improving it (Albuquerque et al., 2017; Belwal et al., 2018; Zhang, 
Lin and Ye, 2018). Another challenge is toxicity and adverse effects: in most countries, 
there are no safety evaluation policies to regulate quality standard, proper prescription 
and potential hazards (Bandaranayake, 2006). Examples of plants reported for their 
adverse reactions are those belonging to the genus Aristolochia which are reported to 
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contain aristolochic acid and shown to have both nephrotoxic and genotoxic properties 
(Hwang et al., 2012; Sidorenko et al., 2012; Zhou et al., 2013; Koyama et al., 2016; 
Baudoux et al., 2018; Prinsloo, Nogemane and Street, 2018; Rietjens, 2018). More so, 
some medicinal herbs are associated with hepatotoxicity which could result to liver 
transplant or death, example include Ephedra sinica, Actaea racemose, Aconitum 
carmichaelii and Piper methysticum (Zheng and Navarro, 2016; de Boer and Sherker, 
2017; Andrade et al., 2018). In addition, assessing safety and efficacy of herbal product 
(s) is quite a challenge, since a single medicinal plant is expected to contain numerous 
amount of constituents, thus a mixture of medicinal herbal products might have several 
times that amount of constituents. Therefore, it will require tremendous resources and 
time to evaluate the safety of each active constituent present in a single medicinal plant, 
in this regard evaluating those present in a mixture of medicinal plants could be 
impossible (WHO, 2005). Despite these challenges, there are few plant mixtures 
approved as medicine and some are in different stages of clinical trials. 
 CLINICAL APPLICATIONS OF HERBAL MIXTURES 
In ethnobotany, plant combinations and mixtures of phytochemicals derived from 
different plants are regularly reported, but none such mixtures have received FDA 
approval (Mukherjee and Houghton, 2009; Butassi et al., 2015). The reason may be due 
to the fact that, if one drug could have multiple targets and one plant has numerous 
compounds, then the plant-target interaction and pharmacology will be too complex to 
elucidate, however not impossible.   
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Sativex, a mixture of delta-9-tetrahydrocannabinol and cannabidiol, extracts of Cannabis 
sativa has been approved in Canada for neuropathic pain relief in multiple sclerosis and 
may be used as an adjunctive analgesic in patients with advanced cancer (Bayer, 2007; 
Nurmikko et al., 2007; Mishra and Tiwari, 2011). In addition, some of the herbal mixtures 
are now in various stages of clinical trials, examples include the completed trial on the 
use of Ginkgo biloba extract in the treatment of Alzheimer`s disease and Viscum album 
extract for cancer treatment (NIH, 2008, 2013). The double-blind randomised controlled 
trial on the effect of essential oil extract of three Cretan aromatic plants (Coridothymus 
capitatus L., Origanum dictamnus L. and Salvia fruticosa Mill.) on upper respiratory tract 
infection was reported to be statistically insignificant, however descriptive differences 
were reported among virus positive participants (Duijker et al., 2015). The ethanol 
extract of Solidago chilensis was reported to alleviate pain and improve recovery in the 
external treatment of tendinitis of flexor and extensor tendons of the wrist and hand, in 
a placebo-controlled double-blind clinical study (Silva et al., 2015). Another significant 
study is seen in the randomised phase III trial of Viscum album extract, where an 
increased effect on overall survival in patients with locally advanced or metastatic 
pancreatic cancer was reported (Tröger et al., 2013).  
 PERCEIVED DRAWBACKS 
Newman and Cragg (2016) revealed a varying percentile in the increase and decrease of 
approved drugs from natural product where the highest percentile was ˃45% in 1985, 
with an extreme decrease of ˃ 10% in 1997 (See Figure 1.1). Although, the percentile has 
increased to about ˃20% in 2014 (Newman and Cragg, 2016). This decline may have 
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resulted from phytochemical redundancy observed in plants especially among plants 
belonging to the same genus. Further contributing factors include inadequate 
documentation, lack of scientific data to back ethnobotanical claims and difficulties 
associated with securing authentic plant identity. In addition, extraction, purification, 
isolation and identification are considered time-consuming processes (Newman and 
Cragg, 2012). Also, variation in the availability of sufficient quantities of plant material 
for commercial purposes, due to seasonal and environmental factors, attributed to the 
decline in FDA approved drugs of plant origin. Furthermore, most natural product drug 
discovery is through phenotypic screens and activity guided fractionation, the properties 
of isolated compounds may not comply with Lipinski`s rule of fives (Table 1.1). However, 
Lipinski himself has stated that his rules do not seem to apply to natural products 
(Owens, 2003) which was suggested to be due to structural parameters including 
structural diversity, chiral centres and atomic composition (Keller, Pichota and Yin, 2006; 
Newman and Cragg, 2012; Barber and Rostron, 2013).  Then, there is a lack of 
conventional criteria for evaluating quality, efficacy and safety combined with a 
reluctance to base decisions on ethnobotanical empiricism (Balunas and Kinghorn, 2005; 
McChesney, Venkataraman and Henri, 2007; Mukherjee and Houghton, 2009; Carmona 
and Pereira, 2013). 
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Figure 1. 1: Percentage of approved drugs from natural product from 1981 – 2014. 
 
Lipinski`s rule of five 
This empirical rule is used to distinguish between a drug like and 
non-drug like molecules, and it states that “poor absorption is more 
likely when:  
• The molecular weight is over 500 Dalton 
• Less lipophilicity (the logP is over 5) 
• There are more than five hydrogen bond donors (expressed 
as the sum of OHs and NHs) 
• There are more than ten hydrogen bond acceptors 
(expressed as the sum of Ns and Os).” 
Table 1. 1: The Lipinski`s rule of five (Barber and Rostron, 2013) 
New interdisciplinary technologies in the field of biotechnology, bioinformatics, medical 
chemistry and phytochemistry, have provided renewed interest in traditional remedies 
and a greater understanding of their effects at a molecular level (Balunas and Kinghorn, 
2005; Verpoorte, Alfermann and Johnson, 2007; Cordell, 2011, 2014). These include: 
DNA barcoding for verification of plant genus and species (Cordell, 2014), the use of 
metabolomics for characterization of metabolite profiles rather than individual 
compounds in plants (Yan et al., 2015), and biological evaluations aimed to address the 
potential risk in respect to dose specificity and side effects associated to the use of 
medicinal plants (Cordell, 2011; Cragg and Newman, 2013). Increased sensitivity of 
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spectroscopic methods and advances in information technology and computing power 
have eased the steps involved in product identification (Weckwerth and Fiehn, 2002; 
Dixon and Strack, 2003). In addition, genomic information from microbial source and 
their interaction with plant pave way to the discovery of known and unknown 
metabolites (Wilson et al., 2014; Li et al., 2015). These, combined with the techniques 
used in understanding systems biology such as the circulatory system via computational 
and mathematical modelling, allows the re-evaluation of traditional medical knowledge 
in the light of new insights into the signalling pathways that regulate cell physiology, and 
possibly to narrow the gap between the holistic and reductionist approach to health 
care. 
 Boswellia dalzielii 
B. dalzielii Hutchinson (Bursearceae) is a tree species abundant in the West African 
regions of Ivory Coast, Northern Nigeria and Cameroon.  It is a woodland savannah tree 
with a pale (peeling and ragged) papery bark, which forms leaves only after the flowering 
process. The blossoms are small white flowers on a leafless tree (Dalziel, 1910). The 
leaves are ovate-lanceolate (lowest) and elongated-lanceolate (higher) 5 – 9 cm long, 1 
– 2 cm wide, acutely serrate, membranous and glabrous, the apices of the branches are 
about 1cm in diameter and the bark is described as thin and deciduous (Dalziel, 1910).  
 
In northern Nigeria, Boswellia dalzielii is locally known as  Ararabi or Hararabi, and the 
common name is frankincense tree (Dalziel, 1910; Kankara et al., 2015). To the best of 
the author`s knowledge, the bark is most commonly used in the treatment of infections 
and tumours in Kaduna state in northern Nigeria, thus the bark is used in the present 
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study. Moreover, literature showed that the stem and leaves are used in maternal health 
care, especially in postpartum wound healing in Katsina state in northern Nigeria  
(Kankara et al., 2015), and  in the treatment of diarrhoea, piles, heat rashes and umbilical 
cord complications in Kano state in northern Nigeria (Abubakar et al., 2017). In the 
Republic of Benin, a decoction of the bark is used for the treatment of angina, dysentery 
and haemorrhage, and in combination with other plants, is used for the treatment of 
rheumatism, diarrhoea, leprosy and gastrointestinal disorder. In addition, the leaves are 
used for beverage flavour while the resins are used for fumigation and as incense 
(Kohoude et al., 2017).  
 
There is limited literature on B. dalzielii, evident from the search results obtained from 
ScienceDirect (21), Web of Science (no record found), PubMed (8) and Scopus (20). As 
such, other species belonging to the same genus will be discussed. B. dalzielii belongs to 
the family Burseraceae and genus Boswellia where Boswellia genus is reported to have 
thirty-three recorded accepted plant species by The Plant List (2013); African Plant 
Database and Tropicos documented thirty-two plant species. The most studied species 
of the Boswellia genus include B. serrata, B. carterii, B. frereana and B. sacra, this could 
be due to the economic importance in commercializing the resin (olibanum) collected 
from these plants. Resin extracts obtained from Boswellia trees have been used for 
centuries as a remedy for the treatment of diseases and disorders such as heart disease, 
inflammatory disease, diabetes, cancer and infection among others (Hamidpour et al., 
2013). Literature review on both phytochemistry and pharmacology will mention 
reported studies on other members of the Boswellia family.  
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 PHYTOCHEMISTRY 
Although, reports on the phytochemical analysis of B. dalzielii are very few, that of other 
species belonging to the genus Boswellia have been reported. There are different 
compounds present in various Boswellia species and the composition changes from 
species to species depending on climate and harvest conditions as well as geographical 
location (Hamidpour et al., 2013). The frankincense of Boswellia species is reported to 
contain 60-85% resins (which constitute mostly pentacyclic triterpenes), 6-30% gums 
most of which are sugars (pentose and hexose sugar) and 5-9% essential oil (mainly 
mixture of monoterpenes, diterpenes and sesquiterpenes) (Rijkers et al., 2006).  
1.5.1.1 Terpenes 
The most abundant terpenes are the boswellic acids and some identified terpenes 
(Figure 1.2) include α and β-boswellic acids, 3-acetyl-11-keto-β-boswellic acid, 3-acetyl-
β-boswellic acid, 11- keto-β-boswellic acid, 3-keto-tirucallic acid, 3-O-acetyl-α-tirucallic 
acid, 9,11-dehydro-α-boswellic acid, acetyl-9,11-dehydro-α-boswellic acid, lupeolic acid, 
incensole, acetyl-lupeolic acid and 3-O-acetyl-β-tirucallic acid (Y. Liu et al., 2014; 
Ammon, 2016; Mannino, Occhipinti and Maffei, 2016; Sharma et al., 2016).  
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Figure 1. 2: Chemical structures of some boswellic acids 
1.5.1.2 Essential oils 
Essential oils in plant mostly occur as volatile aliphatic alcohols present in small 
concentrations. Literature reported the presence of the following essential oils in B. 
dalzielii which include α-terpinene, α-pinene, α-phellandrene, cryptone, p-isoprophyl 
benzyl alcohol, caryophyllene oxide, linalool, 3-carene, β-phellandrene, isolongifolene, 
myrcene, Z-β-farnesene, β-selinene, torreyol, 1,6-humulanedien-3-ol and terpinen-4-ol 
among others (Kubmarawa et al., 2005; Kohoude et al., 2017).  
1.5.1.3 Others 
Phenolic compounds isolated from the stem bark of B. dalzielii include protocatechuic 
acid, gallic acid and 4′-methoxy-(E)-resveratrol-3-O′rutinoside (Alemika, Onawunmi and 
Olugbade, 2005, 2006). In addition, Savithramma and colleagues identified phenols in 
both stem bark and leaves of B. ovalifoliolata including melilotic acid, salicylic acid, 
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coumarin, phloretic acid, gentisic acid and cinnamic acid, while flavonoids identified 
from stem bark include luteolin, rutin, petunidin, gorientin and vitexin, and those 
reported in the gum include rutin, vitexin and quercetin (Savithramma et al., 2010). 
 PHARMACOLOGY 
Boswellia dalzielii belongs to the genus Boswellia, and like the other genus members, it 
is claimed to have ethnopharmacological importance, some of which  include anti-
infection (stem), immunomodulatory (leaves) and anti-tumour effects (resins, leaves 
and stem) (Dalziel, 1910; Adamu et al., 2005; Ibrahim et al., 2006; Abubakar et al., 2007; 
Younoussa, Nukenine and Esimone, 2016).  
1.5.2.1 Anti-microbial activity 
Aqueous, ethanol and methanol extracts of B. dalzielii stem bark exhibited broad 
spectrum activity against Gram positive bacteria (Staphylococcus aureus and Bacillus 
cereus), Gram negative bacteria (Escherichia coli, Pseudomonas aeroginosa and Proteus 
mirabilis) and fungi (Candida albicans and Microsporum audouinii) with MIC and MBC 
value between 2 – 22mg/mL and 4– 50mg/mL, respectively (Olukemi, Kandakai-Olukemi 
and Mawak, 2006; Adelakun et al. 2001). However, the studies conducted by Nwinyi et 
al. (2004) reported contrasting result showing that at a concentration of 2mg/mL, the 
aqueous extract of B. dalzielii stem bark has no antimicrobial activity against S. aureus, 
B. subtilis,  E. coli, P. mirabilis, P. aeruginosa, C. albicans and M. audouinii.  Also, the 
essential oil of B. dalzielii was shown to have antimicrobial activity against B. subtilis, S. 
aureus and C. albicans with a minimum inhibitory concentration (MIC) of 0.25mg/ml, 
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1mg/ml and 2mg/ml, respectively (Kubmarawa et al., 2005). In addition, among four 
boswellic acids (β-boswellic acid, acetyl-11-keto-β-boswellic acid (AKBA), 11-keto-β-
boswellic acid (KBA) and acetyl -β-boswellic acid (ABA)) tested for antimicrobial activity, 
AKBA was shown to exhibit better antimicrobial activity mostly against Gram-positive 
bacteria with a MIC of   2µg/ml for S. aureus, 2-4µg/ml for methicillin resistant strain of 
S. aureus (MRSA), 4-8µg/ml for E. faecalis, E. faecium  and S. epidermidis and 2-8µg/ml 
for vancomycin resistant E. faecalis (Kubmarawa et al., 2005). 
1.5.2.2 Anti-cancer activity 
Presently, there is very little literature on anticancer properties of extracts obtained 
from Boswellia dalzielii. One of the most recent literature is the study on the 
cyclohexane, dichloromethane, ethyl acetate and methanol extract of B. dalzielii which 
were shown to have cytotoxicity activity at 50mg/L against ovarian cancer cell line 
IGROV-1 using MTT assay and percentage inhibition reported were 92.60 ± 1.40%, 75.10 
± 2.80%, 64.50 ± 2.80% and 23.50 ± 2.50%, respectively (Kohoude et al., 2017). Literature 
on the other member of Boswellia reported that the ethanol extract of B. serrata gum 
resin was used against five human leukemia cell lines (HL-60, K562, U937, MOLT-4 and 
THP-1) and growth inhibition reported was in the range of 57.0 - 124.1 µg/mL, 
moreover, the ethanol extract, containing AKBA among other constituents, was shown 
to have more potency against MOLT-4, K-562 and U-937 cell lines than AKBA (Hostanska, 
Daum and Saller, 2002). In addition, the cytotoxicity effect of ethanol extract of B. 
ovalifoliolata leaves was tested against two triple-negative breast cancer cells including 
Page | 19  
 
MDA-MB-231 and MDA-MB-453, and the IC50 values reported were 67.48±5.45 μg/mL 
and 70.03±4.76 μg/mL, respectively (Thummuri et al., 2014).  
The anticancer activity of plants belonging to genus Boswellia is mostly attributed to 
boswellic acids, examples can be seen in the studies of Hostanska, Daum and Saller 
(2002), Liu et al., (2002),Park et al., (2011), Shen et al., (2012), Du et al., (2015), Xue et 
al., (2016), Conti et al., (2018) and Li et al., (2018). Triterpenes including 11-keto-β-
boswellic acid (KBA), 3-O-acetyl-β-boswellic acid (ABA), β-boswellic acid (BA) and 3-O-
acetyl-11-keto-β-boswellic acid (AKBA) were reported to inhibit the synthesis of protein, 
RNA and DNA in human leukemia HL-60 cells. These triterpenes were also shown to 
inhibit cell growth and AKBA was shown to be more potent with IC50 values of 0.6, 0.5 
and 4.1 µM on DNA, RNA and protein synthesis, respectively (Shao et al., 1998; Huang 
et al., 2000). Four different concentrations of AKBA including 5μM, 10μM, 20µΜ and 
40μM were used against three colorectal cancer cell (CRC) lines RKO, SW48, and SW480 
and the result showed a dose dependent activity of AKBA with 40μM having the highest 
growth inhibition activity in a range of 89–98% in all treated cell lines after 72 hours 
treatment (Shen et al., 2012).  Furthermore, AKBA was shown to downregulate CXC 
chemokine receptor 4, a mediator  in tumour metastasis,  in pancreatic cell lines BxPC-
3 and PANC-28 after treatment for 12 hours using 50μmol/L concentration (Park et al., 
2011). 
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1.5.2.3 Others 
The extracts of B. dalzielii leaves were subjected to antioxidant assay against 1,1 – 
diphenyl-2-picrylhydrazyl free radical (DPPH) and results reported include 11.54 ± 0.20% 
at a concentration of 100 mg/L for essential oil extract while IC50 value of 
6.10 ± 0.01 mg/L, 15.20 ± 0.01 mg/L, 78.10 ± 0.10 mg/L and IC50 > 100 mg/L was reported 
for methanol, ethyl acetate, dichloromethane and cyclohexane extracts (Kohoude et al., 
2017).  The aqueous extract of B. dalzielii was shown to have no significant effect on 
total serum protein concentration, serum albumin component, bilirubin and serum 
alkaline phosphate activity, however, a significant decrease was observed on serum 
transaminases in female Wistar albino rats  (Aliyu, Gatsing and Jaryum, 2007). Studies 
on other species in genus Boswellia showed that frankincense oils from B. carterii 
containing 1-octanol, linalool and α-pinene as active ingredients were shown to 
decrease oedema in a formalin-inflamed mouse hind paw model after 8hours 
treatment, and inhibited the development of ear oedema in xylene-induced ear oedema 
mouse model. Thus, frankincense oil was reported as an anti-inflammatory and 
analgesic agent and the activity was shown to be via the inhibition of nociceptive 
stimulus-induced inflammatory infiltrates and overexpression of COX-2 (Li et al., 2016). 
More so, the essential oil of B. carterii was shown to have radical scavenging activity and 
IC50 value reported was 0.64µl/mL and the positive control used was butylated 
hydroxytoluene with a reported IC50 value of 7.4µg/mL. In addition, the essential oil of 
B. carterii was also reported to have a 51.68% inhibition of the oxidation of linoleic acid 
while the control had 69.60% inhibition (Prakash et al., 2014). 
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 ISOLATION OF MEDICINAL COMPOUNDS 
 EXTRACTIONS 
Plant used as medicine could be directly chewed to exact desired effect, example is seen 
in the use of Salvadora persica stem for cleaning the teeth and gums, however, most 
plant materials undergo certain forms of extractions either with the aid of water, organic 
solvents and ointments, therefore hydrophilic components will sparingly dissolve or not 
dissolve in certain organic solvents such as hexane. The most fundamental aspect of 
every extraction process is the polarity of constituent compounds in a plant material. 
Other influencing factors include temperature, duration of extraction and pH (Hanson, 
2005). The success in the extraction of bioactive compounds from natural products 
depends on the extraction procedure employed, and factors such as matrix properties 
of the plant part (leaves, stem, flower, fruit and bark), temperature, time and solvent 
contribute to this success (Hernández, Lobo and González, 2009). An example is seen in 
the extraction of alkaloids where stationary phase requires to be charged (Takla et al., 
2018).  
For hundreds of years, extraction techniques have aimed at isolation of targeted 
bioactive compounds, and these techniques are either conventional or non-
conventional. The conventional method includes three classic techniques namely 
soxhlet extraction, maceration and hydrodistillation. The Soxhlet extraction method 
employs the use of Soxhlet extractor invented by Franz Ritter von Soxhlet in 1879. In this 
technique, weighted plant sample is placed in a thimble which is then placed in the 
extraction chamber. The solvent of choice is heated to reflux to be recycled once the 
Page | 22  
 
Soxhlet chamber is full. The chamber is then emptied via the syphon. The advantage of 
this method is the recycling of a single batch of solvent and lack of required filtration 
step, however thermolabile bioactive compounds could decompose due to prolonged 
heating of solvents (Luque de Castro and Priego-Capote, 2010).  
Maceration/steeping is as old as time and it is as simple as making a cup of tea. Although, 
this technique is the most common, simplest and inexpensive procedure for obtaining 
bioactive compounds, it involves several steps which include grinding of plant material 
to powdered or smaller particle to increase surface area expose to solvent (usually in a 
closed vessel with constant stirring), strain out solution, and filtration of solution which 
is then dried/concentrated on the rotary evaporator to yield crude extract (Seidel, 
2006). Although maceration is less likely to result in the decomposition of thermolabile 
compounds, it is time-consuming and may result in ineffective extraction of compounds 
that have poor solubility at room temperature (Seidel, 2006). Hydrodistillation method 
is mostly used for the extraction of essential oil from plants. This method involves the 
use of hot water or steam as the influencing factor in the extraction of compounds from 
plant. However, it is time-consuming and could affect the integrity of thermolabile 
compounds (Pessoa et al., 2007). 
The limitations associated with conventional extraction techniques, especially for 
commercial purposes lead to the development of new techniques classified as non-
conventional extraction methods, some of which are supercritical fluid extraction (SFE) 
and enzyme assisted extraction (EAE). Unlike the conventional method of extraction 
where a large volume of organic solvent waste is generated, the SFE technique is 
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environmentally friendly. Most widely used supercritical solvent for extraction is the 
supercritical CO2 due to its low critical properties of 31.10C and 73.8 bar, other 
supercritical solvents include ethane, butane, nitrous oxide, trifluoromethane, water 
and ammonia.  The critical point of a compound is paramount to its extraction and is 
defined as the highest temperature and pressure at which the compound can exist in a 
vapour-liquid equilibrium. A supercritical fluid is a single homogeneous fluid, as heavy 
as a liquid with a penetration power of gas is formed at temperatures and pressures 
above critical point (Nahar and Sarker, 2006). 
Compounds of interest are sometimes trapped in a matrix such as polysaccharide-lignin 
network via chemical bonding, thus extraction of such compounds using extraction 
solvents could result in low yield. Therefore, the addition of specific enzymes such as 
cellulose and amylase during extraction results in better yield. The success of this 
technique relies on the enzyme composition and concentration, solid to water ratio, 
enzyme hydrolysis time and particle size of plant material (Azmir et al., 2013; Vergara-
Barberán et al., 2015).  
 PURIFICATION 
The most common form of purification is the use of separating funnel and 
chromatography. Chromatography is a method defined in the early 1900s by the work 
of a Russian botanist, Mikhail S. Tswett, whose work focused on separating compounds 
from plant pigment. Chromatography, a technique used in the separation of two or 
more compounds or ions from a mixture, relies on the differences in affinity or 
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interaction of compounds with a solid or stationary phase and the solvent system 
(mobile phase) (Ettre and Sakadynskii, 1993). Although different chromatographic 
techniques have been developed, thin layer chromatography (TLC), column 
chromatography and high performance chromatography (HPLC) were used in the 
present study.  
Thin-layer chromatography is a microscale technique used for verifying the identity of a 
compound, monitoring the progress of a reaction, determining the number of 
components in a mixture, determine appropriate conditions for column 
chromatography and analysing the fractions obtained from column chromatography. 
This technique is a solid-liquid form of chromatography involving a polar absorbent 
which could be alumina (Al2O3.xH2O) or silica (SiO2.xH2O) particles coated on a glass slide 
or plastic sheet creating a thin layer of the particular stationary phase, and a mobile 
phase which could be a single or combination of solvents. The affinity of the stationary 
phase for compounds depends on their polarity where the polar stationary phase has a 
stronger affinity for compounds with polar functional groups (Gorman and Jiang, 2004).  
Although, all chromatographic methods have a principle similar to that of TLC, in the 
case of HPLC, column is used as stationary phase and contains a solid support over which 
the mobile phase flows with the sample in solution (See Figure 1.3). Chemical 
compounds in the solution migrate according to the non-covalent interactions of the 
compounds with the stationary phase. The high pressure pumps are needed to force the 
solvent through the stationary phase packed in the column. The interaction between 
the mobile phase, column and sample determine the degree of migration and 
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separation of components contained in the sample solution. Compounds with short 
retention time have a stronger interaction with the mobile phase than with the 
stationary phase thus elute from the column faster. This method is highly automated, 
sensitive and specific due to the use of specific wavelength, column type and flow rate. 
However, HPLC together with mass spectrometry is reported to be substantial in 
analytical studies of chemical compounds (Snyder, Kirkland and Dolan, 2010). The 
stationary phase column is the most important component in HPLC analysis and the 
following characteristics are considered when selecting a column, geometry-related 
properties responsible for column efficiency and flow resistance such as packing density 
and uniformity, surface area and particle shape, size and its distribution. Another 
characteristic considered is the surface chemistry related properties responsible for 
analyte retention and separation selectivity, such properties include ligand bonded to 
the surface of the base material (silica, polymeric, zirconia et cetera) and bonding 
density (Kazakevich & LoBrutto, 2007). 
 
Figure 1. 3: Schematic illustration of HPLC system (Waters, 2016). 
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 SPECTROSCOPY AND SPECTROMETRY 
Spectroscopy involves the study of the interaction between light and compounds while 
spectrometry is used to obtain the quantitative measurement of compounds. This study 
employs the use of nuclear magnetic resonance (NMR) to determine the structure of an 
organic compound through the measurement of magnetic moments of hydrogen atom 
present in a compound. C-13 NMR observes the magnetic behaviour of carbon-13 
nucleus; the sample is dissolved in a suitable inert solvent such as deuterated 
dimethylsulfoxide [(CD3)2SO], deuterated dichloromethane [CD2Cl2] and deuterated 
water [D2O], peaks and their chemical shift values in part per million (ppm) are 
presented as a spectrum. The peaks presented in the spectrum provides information on 
unique carbon atoms environment in the structure and any symmetry in the structure 
affect the results by providing less number of peaks in the C-13 spectrum than the 
number of carbons present in the structure of the compound. For Hydrogen spectrum, 
spectral signals may appear as singlet, doublets or triplets which is due to the interaction 
between the protons attached to adjacent carbon atoms (Harborne, 1973; Williams and 
Fleming, 1995). 
The spectrometric method used to obtain the actual molecular mass and compound 
composition of extracted compounds was the high-resolution mass spectrometry 
(HRMS). This method is used to obtain high resolution and high accuracy mass 
measurements due to its sensitivity, precision, accuracy and specificity for quantitative 
and qualitative analysis (Hamelin et al., 2013; Stock, 2017). Just like other mass 
spectrometry, HRMS characterised compounds via the measurement of the m/z ratios 
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of ions and product ions after activation in tandem mass spectrometry (Figure 1.4) 
(Volmer, 2014). 
 
Figure 1. 4: Illustration of the tandem mass spectrometry (Murray, 2016). 
 
 BIOMOLECULAR INTERACTIONS 
To understand synergy, it is important to understand polypharmacology. In drug 
discovery, the one gene, one drug, one disease approach involves the design of selective 
ligands that interact with particular target proteins, whereas polypharmacology involves 
the search for a drug that binds to multiple targets, or multiple drugs that bind to 
different targets within a network (Reddy and Zhang, 2013; Zhang et al., 2016).  These 
phenomena can only be appreciated through understanding drug –target interactions 
as well as the molecular networks involved. Polypharmacology, either as the therapeutic 
(healing) or adverse (harmful) effect, involves the binding of a drug, or drugs, to different 
multiple targets within networks. The polypharmacology approach evolved due to the 
lack of drug efficacy observed from one gene-one disease associated target drugs (Xie 
et al., 2012). Therapeutic polypharmacology involves the simultaneous targeting of 
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multiple targets by one or more drugs in the treatment of diseases, where the targeted 
network or biochemical process may hypothetically be reset to its physiological state. A 
simple example is the use of β-lactamase inhibitors and β-lactam antibiotics to 
overcome antibiotic resistance. Another example is provided by the tyrosine kinase 
inhibitor Sorafenib, used for the treatment of some types of cancer, which not only 
inhibits Raf kinase isoforms, but also the platelet-derived and vascular endothelial 
growth factor receptor tyrosine kinases (Boran and Iyengar, 2010). Adverse 
polypharmacology occurs when drugs bind to targets other than the therapeutic target 
or drugs bind to the therapeutic target in non-target tissue resulting in negative effects. 
An example of adverse effects can be seen in the inhibition of both cyclooxygenase-1 
and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs. Cyclooxygenase-2 has 
a physiological role in many tissues and organs such as the kidney, where renal 
prostaglandins play a role in maintaining renal perfusion and glomerular filtration rate. 
Inhibition of cyclooxygenase-1 decreases the levels of prostaglandins responsible for 
pain and inflammation while inhibiting cyclooxygenase-2 decreases the level of 
prostaglandins results in tissue damage such as causing ulcer, acute renal failure and 
cardiovascular adverse effects (White, 2007; Boran and Iyengar, 2010; Xie et al., 2012).  
The function and expression level of a particular protein in a physiological process is 
controlled by the networks to which the protein belongs. Therefore, when one protein 
malfunctions or the process becomes aberrant, the whole signalling network which 
consists of the hormones, protein receptors, ligands, enzymes, transcription factors, 
ions and DNA/RNA that regulate this biochemical process, will be affected (Boran and 
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Iyengar, 2010). Understanding the pathophysiology of disease and disorder at molecular 
level coupled with –omics technologies (genomics, transcriptomics, proteomics, and 
metabolomics) may help us to understand the cross-link between biochemical networks 
and occurrence of diseases and disorders. This is especially true for multi-faceted 
diseases such as neurodegenerative diseases and cancer (Chandra and Padiadpu, 2013; 
Ellingson, Smith and Baudry, 2014; H. Liu et al., 2014; Anighoro et al., 2015).  
 EFFECT OF SINGLE CHEMICALS ON NETWORKS 
Cancer is seen as a multifactorial disease, involving the reconstruction of the molecular 
networks essential for cell proliferation, differentiation or cell death (Sunil and Kamath, 
2017). A commonly used chemotherapy drug is Paclitaxel, and the established, and 
widely accepted, mechanism of action of this drug is to prevent the depolymerization of 
microtubules by binding to the β-subunit of tubulin, thus inhibiting the metaphase 
anaphase transition and inducing apoptosis (Jordan and Wilson, 2004; McGrogan et al., 
2008; Gascoigne and Taylor, 2009). However, paclitaxel also activated the c-Jun N-
terminal kinase/stress-activated protein kinase signalling pathway, via activation of the 
Ras and apoptosis signal-regulating kinase pathways in a dose-time-dependent manner 
(Wang et al., 1998, 1999). The drug was further shown to induce p53 and p21 at low 
concentration, resulting in G1 and G2 arrest in a human alveolar adenocarcinoma cell 
line  (Giannakakou et al., 2001).  
A holistic study of paclitaxel’s mode of action showed a more complex chain of activities. 
Proteomic analysis of paclitaxel-treated HeLa cells identified several proteins that were 
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responsive to treatment. Some proteins were up-regulated and some were down-
regulated (Lee et al., 2005). The results were later confirmed by gene expression studies 
to include p53, MAPK, ErbB, Mtor, VEGF and T-cell receptor signalling pathway, focal 
adhesion and apoptosis (Qiao et al., 2011). These findings correlate with those of 
proteomic findings, showing paclitaxel target-specific proteins to be involved in signal 
network, cellular processes and immune responses (Lee et al., 2005).  More recently, 
paclitaxel was reported to induce apoptosis by reduction of p53, NFkB factors, pErk and 
BCL2 in NB4 leukaemia cells; and increase expression of Bax, caspase3 and 9 (Morales-
Cano et al., 2013). This implicates paclitaxel involvement in an array of multiple 
signalling pathways, some of which might not yet be understood and/nor elucidated.  
The above mentioned studies on paclitaxel show that the drug affects several pathways 
simultaneously, inferring that it did not act in isolation as it had been made out to be. It 
has become more widely accepted that not all drugs are selective, and at least some 
bind to several physiologic targets. 
 SYNERGY 
Polypharmacology can either be synergistic - where the total effect of discrete agents is 
greater than the sum of the individual effects -, additive - where the more potent drug 
acts like the more concentrated form of the other -, or antagonistic - presenting a 
combined effect less than expected magnitude (Tallarida, 2006, 2012; Tallarida and 
Raffa, 2010). In ethnobotany, these concepts are frequently associated with the effect 
of herbal extracts due to the plethora of chemical compounds that are present in a plant. 
These chemicals may not necessarily act on the same receptors, and the presence of 
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one may not affect the biochemical interaction of the other but could have a similar 
effect. Therefore, in a situation where one metabolic pathway or signal network is 
blocked or impaired, other pathways might be enhanced.  
We can see the interrelationship of metabolic pathways in tumour cells, where 
uncontrolled growth requires major changes in metabolism. Acceleration of aerobic 
glycolysis is used to sustain the demands for additional energy and biosynthetic 
precursors necessary for proliferation (the Warburg effect). The activity of the Krebs 
cycle is also enhanced and consequently anaplerotic pathways are activated to replenish 
the Krebs cycle intermediates which are also essential building blocks for lipid, protein, 
and nucleic acid biosynthesis. Notably, increased activity of pyruvate carboxylase is 
considered important to fulfil the high anabolic demands for growth in lung tumour 
tissues (Fan et al., 2009). 
Although synergistic/additive effects are regularly alluded to in 
phytochemistry/phytotherapy they are not usually accounted for. Quantifying this 
effect could serve as a guide for the overall combined effect, and for designing 
experiments to determine a mechanism of action. The most commonly used method to 
quantify combined drug effects for drugs with different relative potency is the 
isobologram, a graph of equally effective dose pairs (isoboles) for a single effect level 
(Tallarida, 2012). This method has been used in the study of paclitaxel (Photiou et al., 
1997) and β-Lapachone (Lamberti et al., 2013) as well as a herbal combination used as 
as antitumor on prostate cancer cell lines (Chung, Tattersall and Cheung, 2004; Adams 
et al., 2006). Further appropriate statistical analyses, e.g. regression analysis are 
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required to determine the nature of the interaction. Other quantitative approaches 
reported include the additive composite curve and the response surface analysis 
(Tallarida, 2001).  
A recent study showed the potency of plant extracts compared to single approved 
constituents. Oral administration of Taxus chinensis taxane extracts improved the 
bioavailability and inhibitory activity of paclitaxel (Liu et al., 2015). The anticancer effect 
of β-carboline alkaloids-enriched extract from Poa pereira was reported and this extract 
was also shown to enhance the cytotoxicity of carboplatin (Yu and Chen, 2014). Binary 
combinations of ginger (Zingiber officinale) phytochemicals synergistically inhibit 
proliferation of prostate cancer cells (Brahmbhatt et al., 2013). Another example is the 
use of plant combinations in the treatment of diseases, which is a usual ethnobotanical 
practice. An example is an in-vitro antimicrobial synergy of plant combination used in 
the treatment of diarrhoea (van Vuuren, Nkwanyana and de Wet, 2015), however, the 
synergy was not quantified. The literature on the synergy between synthetic drugs and 
herbal medicines show several case studies evidencing interaction of herbal products 
and conventional drugs, where the herbal products either increase the action of 
conventional drugs or decrease its action (Izzo et al., 2005; Ulrich-Merzenich, 2014). 
 ANTIMICROBIAL RESISTANCE 
The first break in understanding infection was the Koch postulate in the 19th century 
where the cause of infective foci was attributed to microbial growth. Although Joseph 
Lister, a Professor of surgery, used carbolic acid for wound sterilization and the 
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prevention of sepsis in 1867, aseptic surgery was not a standard practice until the 1880s. 
The success of managing infections was observed with the discovery of penicillin by 
Alexander Fleming and the introduction of septic techniques, however, the emergence 
of antibiotic resistant bacterial strains due to indiscriminate use of antimicrobials is still 
eminent (Singhal and Kuar, 2018). In 1952, Selman Waksman was reported to have 
described antibiotic as a compound produced by a microorganism that kills or inhibits 
the growth of another microorganism. This description was said to define the activity of 
antibiotics but not the word, however, the term “antibiotic” is used to describe any class 
of molecule that inhibits or kills microbes by specific interactions with bacterial targets, 
without any consideration of the source of the particular compound or class, as such 
purely synthetic therapeutics are also considered as antibiotics examples include the 
sulfonamides, and trimethoprim (Davies and Davies, 2010). These compounds possess 
either bacteriostatic (prevention of bacterial growth) or bactericidal (causation of 
bacterial death) effect. However, the activity of certain bacteriostatic antibacterial 
agents may be bactericidal to certain susceptible organism at a higher concentration. 
Similarly, at lower concentrations, bactericidal agents could exhibit bacteriostatic 
activity. Chloramphenicol is reported as a bactericidal agent against S. pneumonia but 
bacteriostatic against S. aureus. More so, quinupristin-dalfopristin considered as a 
bactericidal agent against most strain of staphylococci and streptococci is reported as 
bacteriostatic against Enterococcus faecium (Pankey and Sabath, 2004).  
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 ACTION OF ANTIBIOTICS  
Most mono-therapeutic antibiotics are said to cripple an entire network rather than a 
single target, either by targeting multiple protein targets or the products of the action 
of multiple genes or the gene products themselves, thus low probability to drug 
resistance have been reported (Brötz-Oesterhelt and Brunner, 2008; Silver, 2012). The 
major targets of antibiotics include cell membrane (e.g mupirocin), structure or 
inhibition and/or regulation of enzymes involved in cell wall biosynthesis (e.g beta-
lactams, vancomycin and bacitracin), nucleic acid metabolism/repair (rifampicin and 
quinolones) and protein synthesis (e.g tetracyclines, macrolides, and mupirocin) 
(Hancock et al., 2005; Kapoor, Saigal and Elongavan, 2017) (See Figure 1.5). 
 
Figure 1. 4: Major targets of antibiotics (Bugg et al., 2011).  
Page | 35  
 
Bacterial cell wall biosynthesis is catalysed by the enzymes MurA–F and MurG. 
Peptidoglycan units are then transported by bactoprenol-phosphate, a carrier lipid, 
across the cell membrane, generating Lipids I and II. In the cell wall, transglycosylation 
and pyrophosphorylation occur, where sugars and phosphates are added and a peptide 
bond between the peptide chains is formed (Walsh, 2003). Penicillin binding proteins 
(PBPs) catalyses the cross-linking of peptidoglycan (PGN) peptides in PGN biosynthesis, 
hence recognise the terminal alanine dipeptide (AD) unit (Scheffers and Pinho, 2005; 
Brötz-Oesterhelt and Brunner, 2008). β-Lactams antibiotics are known to interfere with 
the activity of more than one essential PBP due to their similar stereochemistry to AD, 
however, no β-Lactams antibiotics inhibit all the PBPs. Furthermore, they are reported 
to derange the activity of the PG biogenesis machinery, thus depleting cellular resources 
by inducing a substrate cycle of PGN synthesis and degradation (Cho, Uehara and 
Bernhardt, 2014). In most bacteria, the PBPs are reported to be encoded by more than 
a single gene (Brötz-Oesterhelt and Brunner, 2008), Scheffers and Pinho (2005) reported 
12 PBPs for Escherichia coli, 14 PBPs for Bacillus subtilis, 5 PBPs for Staphylococcus 
aureus and 6 PBPs for Streptococcus pneumonia. Goffin and Ghuysen (1998) showed 
that all PBPs have three conserved motifs (SXXK, SXN AND KTG, where X is any amino 
acid) in common, occurring in the same order and the active site serine is in SXXK. Unlike 
the β-Lactams antibiotics, the glycopeptides vancomycin inhibits the process of 
transglycosylation by targeting the D-ala-D-ala terminus of lipid II peptidoglycan 
precursor, a substrate to multiple enzymes (Brötz-Oesterhelt and Brunner, 2008; 
Tortora, Funker and Case, 2010). 
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Certain antibiotics such as chloramphenicol inhibit protein biosynthesis by inhibiting the 
formation of peptide bonds in a growing peptide chain by reacting with the 50S subunit 
of the 70S prokaryotic ribosomal RNA (rRNA). Aminoglycosides group of antibiotics such 
as gentamicin act by changing the shape of the 30S of the 70S prokaryotic rRNA, 
resulting in misreading of mRNA and induction of nonsense protein.  Tetracycline 
prevents the binding of aminoacyl-tRNA to A-site of the 30S of the 70S prokaryotic rRNA, 
thus preventing protein translation. Antibiotics that function by preventing DNA 
replication interfere with nucleic acid synthesis function by inhibiting DNA polymerase 
and DNA helicase as well as RNA polymerase, therefore preventing replication and 
transcription. Example of such antibiotics are the quinolones which are broad-spectrum 
antibiotic and act by inhibiting the bacterial DNA gyrase as a result preventing DNA 
replication (Tortora, Funke and Case, 2010). 
 RESISTANCE TO ANTIMICROBIAL AGENT 
Presently, about 700 thousand individuals are reported to die of antimicrobial resistance 
per year, and by 2050 that number is estimated to increase to about 10 million. The 
resistance to antimicrobial agent is not a new phenomenon, it is used by microorganisms 
as a survival mechanism against other organisms. However, their ability to resist 
antimicrobial agents means we stand to lose more lives to life-threatening infectious 
diseases such as pneumonia, tuberculosis, human immunodeficiency virus (HIV) and 
malaria (O’Neill, 2016). Since the discovery of antibiotics in the 19th century, there has 
been a lack of new novel antibiotics (Figure 1.6), thus giving room to the emergence of 
resistance which is contributed by misuse of antimicrobial agents.  
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Figure 1. 5: Time-line of antibiotic discovery  (ReACT, 2018).  
 
 Staphylococcus aureus 
S. aureus is naturally susceptible to antibiotic, however, could develop resistance 
through horizontal transfer to genes from outside sources, chromosomal mutation or 
antibiotic selection. This gram-positive bacterium has the ability to colonize normal 
individuals without any symptoms, particularly in the nose and on the skin. Carriers of 
S. aureus are at high risk of infection when exposed to surgery, hemodialysis, chronic 
ambulatory peritoneal dialysis, or have an impaired immune system. This 
microorganism is easily spread among individuals via direct contact either through skin-
to-skin contact with colonized or infected individuals or contaminated objects (Liu, 
2009).  
Methicillin-resistant Staphylococcus aureus (MRSA) are strains of S. aureus that are 
resistant to methicillin and other β-lactams such as oxacillin, nafcillin, carbapenems, 
penicillin, and amoxicillin (Hal, Lodise and Paterson, 2012). This intrinsic resistance is 
shown to be associated with the production of penicillin binding protein (PBP2a) 
encoded by the mecA gene unique to MRSA.  This protein has a low binding affinity for 
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β-lactam antibiotics (Chambers, 1988).  Infections due to MRSA are associated with 
increased morbidity, mortality, length of hospital stay and costs. MRSA infection is 
prevalent in both community and health care settings and is associated with numerous 
infections such as those of the bloodstream, lower respiratory tract, soft tissues, skin, 
endocarditis, osteomyelitis and urinary tract (Hassoun, Linden and Friedman, 2017; 
Emaneini et al., 2018). In 2015, the presence of 16.8% MRSA was reported among 
invasive S. aureus isolates in Europe (ECDC, 2016) whereas, some years earlier in the 
USA, as much as 51.3% of S. aureus isolates were reported as MRSA (CDC, 2013). Also, 
<50% MRSA was reported for most African countries in 2013, however, an increase in 
prevalence was observed since 2000 (Falagas et al., 2013).  In 2008, 44% of heath 
associated infection in hospitals of Iceland and Norway were associated with MRSA 
(Köck et al., 2010). Example of antibiotic used in the management of MRSA related 
infection include vancomycin, a glycopeptide antibiotic that targets the cell wall 
synthesis was reported to be less effective for the management of serious MRSA 
infections, as shown in the meta-analysis study conducted by Hal and colleagues, 2012 
where the MIC (>2) of vancomycin was reported to be associated mortality irrespective 
of methodology (Hal, Lodise and Paterson, 2012). In order to predict the efficacy of 
vancomycin, the use of pharmacokinetic/pharmacodynamic parameter (the ratio of 
AUG/MIC) was suggested because is a time-dependent antibiotic. In addition, 
individualization of vancomycin therapy was suggested, using pharmacodynamics as the 
key to achieving successful disease management (Toutain, Bousquet-Mélou and 
Martinez, 2007).  Other antibiotics used for managing MRSA related infection are listed 
in Table 1.2.  
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Site of 
Infection  
Empirical 
therapy  
Alternatives  Future 
Considerations  
Other notes 
Bacteremia/IE Vancomycin Daptomycin 
Teicoplanin 
Daptomycin + Ceftaroline 
(synergy) 
Ceftaroline 
Ceftobiprole 
Avoid: 
Clindamycin 
TMP-SMX 
Tigecycline 
Mild SSTI with 
abscess <5 cm 
Incision and 
drainage 
   
Moderate SSTI TMP-SMX 
Clindamycin* 
Doxycycline/Mi
nocycline 
Linezolid 
  * Limited due 
to increased 
resistance 
Severe or 
complicated 
SSTI 
Vancomycin Daptomycin 
Linezolid 
Telavancin* 
Ceftaroline 
Ceftobiprole 
Dalbavancin 
Oritavancin 
Tedizolid 
* Only to be 
used when 
alternative 
treatments are 
not suitable 
due to safety 
concerns 
Pneumonia Vancomycin 
Linezolid 
Telavancin* Ceftobiprole * Only to be 
used when 
alternative 
treatments are 
not suitable 
due to safety 
concernsAvoid: 
Daptomycin, 
Tigecycline 
Bond and joint 
infections 
Vancomycin Daptomycin 
Vancomycin + Rifampin 
Linezolid 
Consider: 
TMP-SMX 
Clindamycin 
Fluroquinolone* 
Doxycycline/Minocycline 
Tedizolid *Not to be 
used as 
monotherapy 
Table 1. 2: Recommended antibiotic for MRSA related infection (VanEperen and Segreti, 2016). 
 
 
 ANTIBACTERIAL SCREENING 
Different methods have been developed for antibacterial screening and for plant 
extract, the recommended concentration to be used in testing is below 1 mg/mL for 
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crude extract and 100 µg/mL for isolated compounds.  The most common methods used 
for antimicrobial testing so far include diffusion methods, dilution methods and 
bioautographic method  (Mukherjee and Houghton, 2009). 
The diffusion methods require the use of plant extract on an inoculated medium which 
could be either a hole, cylinder or disc, then the diameter around the medium is 
measured. The diffusion techniques are advised for polar compounds, because the use 
of an inappropriate solvent for non-polar compounds may result in false negative 
results, although the hole – plate technique is adequate for non-polar solvent. The 
diffusion method required the tested plant extract to be dissolved in an appropriate 
solvent as such both the cylinder and paper disc method is appropriate for water soluble 
extract. Although the diffusion methods are used for rapid preliminary screening, they 
are not appropriate for determining the minimum and maximum inhibitory 
concentrations of antimicrobial agents. However, with the standardized techniques and 
recommendations such as that provided by British Society for Antimicrobial 
Chemotherapy (BSAC) and Clinical and Laboratory Standard Institute (CLSI), the 
technique is simple, inexpensive, easy to interpret and can be used for enormous 
screening of antimicrobial agents and microorganism suspension of 0.5 McFarland 
(Balouiri, Sadiki and Ibnsouda, 2016). 
The dilution techniques are usually used to determine the lowest concentration of the 
tested antimicrobial agent to inhibit visible growth of the microorganism tested. The 
methods required the use of known microbial and antimicrobial agent concentrations, 
the suspension is then incubated, and bacterial growth is determined by turbidimetry 
Page | 41  
 
or tetrazolium salts and values are a measure of mg/mL or µg/mL. Standard approaches 
are provided for both fastidious and non-fastidious microorganisms so to obtain 
replicable relevant clinical data, such guideline provided include that of CLSI and 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (Balouiri, Sadiki 
and Ibnsouda, 2016; Mukherjee and Houghton, 2009). The bioautographic method 
requires the use of separated compounds on thin layer chromatography for the 
detection of growth inhibition directly on the TLC which can be achieved through direct 
spraying of broth culture on developed TLC; immersion bioautography which involved 
covering a developed TLC plate with molten seeded agar; and contact method where 
compounds developed on TLC are transferred on to agar medium previously inoculated 
with microorganism to be tested. Each of the mention bioautographic method have 
different incubation time, however, visualization is mostly achieved by the use of 
tetrazolium salts where the salts are converted into a coloured product by the enzyme 
dehydrogenases present in the cells. These techniques are used for both fungi and 
bacteria and compounds with antimicrobial activity can easily be identified, however, 
the concentration of a particular compound on TLC chromatogram could result in false 
negatives (Balouiri, Sadiki and Ibnsouda, 2016; Mukherjee and Houghton, 2009).  
In order to combat antimicrobial resistance, combination therapies are exploited 
increasingly, an example is the use of WHO-approved combination therapies to prevent 
said resistance. Thus, combination therapies involving bioactive drugs and non-
antibiotic plus bioactive drugs are exploited to tackle resistance to antibiotics and results 
obtained could be either synergistic interaction or reduced efficacy (Owen and Laird, 
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2018). The synergy between drugs is defined as “a greater effect in combination than 
the sum of the individual effects of the combined substances” (Efferth and Koch, 2011). 
There are three methods commonly used to screen the interaction of compounds 
against micro-organism and these include the E-test, microdilution checkerboard and 
Time-kill method (Orhan et al., 2005; Sopirala et al., 2010).  The most popular method 
is the checkerboard method where screening is conducted in a microtiter plates and 2-
fold dilution of one compound is done along the y-axis and the other compound on the 
x-axis and fractional inhibitory concentration index (FICI) can be analysed using a specific 
equation reported by Doern (2014) and the most common interpretation used are those 
reported by Odds (2003). 
 CANCER  
Cancer as a disease involves the growth of abnormal cells, with the ability to ignore the 
rules of cell division, thus disrupting the balance between cell division and quiescence. 
This disease could further be described as a multi-genetic event involving different 
malfunctioned proteins, which result in changing the molecular network essential to cell 
proliferation, differentiation and cell death (Hassanpour and Dehghani, 2017). 
Gradually, these cells develop autonomy by decreasing their contact with normal cells 
thus destabilizing haemostasis; producing growth factors from oncogenes; overriding 
antigrowth signals from tumour suppression genes; inducing the growth of new blood 
vessel (Angiogenesis) for supply of oxygen and nutrient as well as providing a channel 
for transporting cancer cells (CCs) to other sites (metastasis); and finally by evading 
immune detection and destruction by the immune system (Boik, 2001). Cancer is 
Page | 43  
 
reported by WHO as the second leading cause of death globally and responsible for an 
estimated 8.8 million deaths in 2015. More so, Breast cancer is said to be the fifth cause 
of death with an estimate of 571,000 deaths in 2015, globally (WHO, 2018). 
 BREAST CANCER 
Cancer is the second cause of death worldwide (Siegel, Naishadham and Jemal, 2013) 
and breast cancer is the most common cancer-related death among women with an 
estimated expected new cases of 252,710 in 2017 (Siegel, Naishadham and Jemal, 2013; 
Qu et al., 2015; Klevos et al., 2017). In Africa, breast cancer constitutes 25% of all 
diagnosed cancer and its prevalence varies across African nations. In Nigeria, 26% of 
breast cancer cases were categorised as triple-negative breast cancer and 27% as 
estrogen receptor negative (Lukong, Ogunbolude and Kamdem, 2017). The cause of 
breast cancer remains obscure however it begins with the development of a malignant 
tumour in breast tissue. Reported associated risk factor include obesity, estrogen 
exposure and the inheritance of susceptible genes such as BRCA1 and BRCA2 (Klevos et 
al., 2017). Different options are available for the management of breast cancer 
depending on the type and stage, example include the use of surgery, chemotherapy 
such as anthracyclines, taxanes and 5-fluorouracil, hormone therapy for ER/PR positive 
cancer including selective estrogen receptor modulators, aromatase inhibitor and 
anastrozole, and HER2- targeted therapy (Klevos et al., 2017).  
Some of the therapeutic agents used for managing breast cancer are derived from plant 
example include taxol extracted from the bark of Taxus brevifolia and vinblastine from 
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Vinca rosea. The screening of plants for anti-cancer properties led to the report of 
commonly used plants believed to be cytotoxic against breast cancer cells due to their 
phytochemicals, some examples include Echinacea purpurea, Allium sativum, Curcuma 
longa and Arctium lappa (Shareef, Ashraf and Sarfraz, 2016). In Africa, breast cancer 
patients lack adequate access to social and economic resources and available treatment 
are expensive for most patient due to lack of funds and limited available financial 
options. As such, there is a prevalence in the use of alternative treatment for promoting 
homeostasis and preventing/suppressing certain type of cancer (Lukong, Ogunbolude 
and Kamdem, 2017).  The anti-cancer effect of numerous natural products such as plant 
extracts have been tested both in in-vitro and in-vivo model, and phytochemicals 
belonging to different categories such as flavonoids, polyphenols, terpenes and alkaloids 
are believed to be responsible for these anticancer effects (Hosein Farzaei, 
Bahramsoltani and Rahimi, 2016). 
1.9.1.1  GENUS BOSWELLIA AND BREAST CANCER 
Plants belonging to genus Boswellia are extensively studied for their biological 
properties which is mostly attributed to compounds belonging to the pentacyclic 
triterpenoids class, in other words, boswellic acids (Hussain et al., 2017). These boswellic 
acids, mainly boswellic acid (BA), acetyl-β-boswellic acid (ABA), 11-keto-β-boswellic acid 
(KBA) and acetyl-11-keto-β-boswellic acid (AKBA), are reported to be majorly obtained 
from the frankincense (resin) of plants belonging to genus Boswellia (Iram, Khan and 
Husain, 2017). 50µmol/L of AKBA was shown to downregulate CXC CHEMOKINE 
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RECEPTOR 4 in MDA-MB-231 and MCF7 breast cancer cell line, thus preventing cellular 
invasion (Park, Sung, et al., 2011).  
The essential oil of Boswellia sacra obtained via hydrodistillation was reported to induce 
specific cytotoxicity in MCF-7, MDA-MD-231 and T47D cell lines (Suhail et al., 2011). 
Ethanol extract of B. ovalifoliolata leaves was reported to exert cytotoxic effect on 
breast cancer cell lines which include MDA-MB-231 and MDA-MB-453 and the reported 
IC50 are 67.48 ± 5.45 µg/mL and 70.03±4.76 µg/Ml, respectively. In addition, the ethanol 
extract was shown to have effects on both antiapoptotic (Bcl2) and proapoptotic (Bax) 
proteins by decreasing the level of Bcl2 and increasing the expression of Bax (Thummuri 
et al., 2014).  
1.9.1.2 OTHER PLANTS USED IN THIS STUDIES  
1.9.1.3 Spondia mombin   
The stem bark of Spondia mombin (local name: Tsada) was collected from the Northern 
part of Nigeria precisely from Kaduna State, Nigeria. The plant was authenticated as 
belonging to the Anacardiaceae family (Vouchers number: 2384) at the herbarium 
situated at Ahmadu Bello University, Zaria by Namadi Sunusi. 
1.9.1.4 Detarium microcarpum  
The stem bark of Detarium microcarpum (local name: Taura) was collected from the 
Northern part of Nigeria precisely from Kaduna State, Nigeria. The plant was 
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authenticated as belonging to the Fabaceae family (Vouchers number: 480) at the 
herbarium situated at Ahmadu Bello University, Zaria by Namadi Sunusi. 
1.9.1.5 Sclerocarya birrea  
The stem bark of Sclerocarya birrea (local name: Danya) was collected from the 
Northern part of Nigeria precisely from Kaduna State, Nigeria. The plant was 
authenticated as belonging to the Anacardiaceae family (Vouchers number: 6871) at the 
herbarium situated at Ahmadu Bello University, Zaria by Namadi Sunusi. 
1.9.1.6 Vitellaria paradoxa  
The stem bark of Vitellaria paradoxa (local name: Kade) was collected from the Northern 
part of Nigeria precisely from Kaduna State, Nigeria. The plant was authenticated as 
belonging to the Sapotaceae family (Vouchers number: 90072) at the herbarium 
situated at Ahmadu Bello University, Zaria by Namadi Sunusi. 
 CYTOTOXICITY SCREENING METHOD 
Over the years, different anticancer agents of natural origin have been reported, for 
example Alvaradoin E from the leaves of Alvaradoa haitiensis, Palmerolide A from 
Synoicum adareanum and Silvestrol from the fruit and twigs of Aglaia foveolata 
(Kinghorn, Chin and Swanson, 2009). In the screening for compounds with cytotoxicity 
activity from natural products, different screening techniques have been used, most are 
colorimetric method used in determining cell viability. 
Page | 47  
 
1.9.2.1 In-vitro cytotoxicity screening 
The first reported quantitative colorimetric method of screening cell proliferation, 
survival and cytotoxicity was reported in 1983. This assay was designed to avoid the use 
of radioisotope and washing steps to improve result precision. The method reduced (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl terazolium bromide (MTT) salt in active 
mitochondria in all metabolic active cells, producing a dark blue formazan product which 
can be spectrophotometrically measured at 570nm (Mosmann, 1983). The studies by 
Stockert et al (2012) disputed the claim that mitochondrial succinate dehydrogenase is 
responsible for the reduction of MTT salt to its formazan using two main properties of 
the mitochondria. The mitochondria have an oxidizing power rather than a reducing 
property and the presence of reduced nicotinamide adenine dinucleotide (NADH) 
coenzyme should not make MTT assay a direct method for the determination of 
mitochondrial activity, rather an indirect one (Stockert et al., 2012). Studies suggested 
that tetrazolium salts can be reduced to formazan by plasma membrane-bound NADPH 
oxidase and the reduction of the salt is dependent on the rate at which glycolytic NADH 
is produced in the endoplasmic reticulum (Stockert et al., 2012). Microscopic and 
colocalization studies revealed that formazan accumulates in lipid droplets rather than 
mitochondria and lysosomes  (Diaz et al., 2007; Stockert et al., 2012). Although MTT 
assay is commonly used as a cytotoxicity screening technique, studies by Angius and 
Floris (2015) indicated that this assay is prone to error in cytotoxicity screening involving 
liposomes as drug vehicles.  The error is said to be due to the lipophilic nature of MTT –
formazan which can be stored in liposomes thus increasing cell viability (Angius and 
Floris, 2015).  Other factors that can affect MTT assay result include metabolic 
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perturbations, effects of oxidoreductases and superoxidase (Berridge, Herst and Tan, 
2005). Although MTT is widely used and in some cases could provide a false positive 
result, the assay is recommended to be accompanied by non-metabolic assay 
(Stepanenko and Dmitrenko, 2015). The zebrafish model was shown to complement 
MTT assay (Li et al., 2012). Other tetrazolium salts used are the water soluble salts 
including 5-(3-(carboxymethoxy)phenyl)-3-(4,5-dimethyl-2-thiazolyl)-2-(4-sulfopheny)-
2H-tetrazolium inner salt (MTS), sodium 5-(2,4-disulfophenyl)-2-(4-iodophenyl)-3-(4-
nitrophenyl)-2H tetrazolium inner salt (WST) and sodium 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-5-((phenylamino)-carbonyl)-2H tetrazolium inner salt (XTT) (Berridge, 
Herst and Tan, 2005). 
Apart from tetrazolium salts, resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide) is 
also used for dye reduction assay. Resazurin is a blue dye that converts to a pink 
fluorescent resorufin in the presence of mitochondria enzymes. The reduction is 
measured with fluorescence spectroscopy using 560nm as excitation wavelength and 
the emission wavelength is 590nm, this setting is because peak absorption of resorufin 
is 570nm (Borra et al., 2009).  Samples are considered potentially cytotoxic if the mean 
viability is reduced to <70% when compared to blank control (ISO, 2017; Liu et al., 2018). 
Another screening technique used is the direct cell count/dye exclusion assay. The 
principle behind this assay is that the presence of intact cell membranes in living cells 
prevent the uptake of certain dyes such as trypan blue and eosin and reversal is the case 
in dead cells, consequently having a blue cytoplasm (Strober, 2001). This technique is 
considered as a simple and rapid means of determining cell viability because the 
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materials required are trypan blue dye and transmission microscope. However, the 
integrity of the cell membrane does not necessarily define the functionality of a cell and 
the subjectivity of the method in terms of dye uptake by injured cells put this method 
under scrutiny. Thus, dye exclusion assay is recommended to be performed with a 
fluorescent dye and observed under a fluorescence microscope (Strober, 2001). In 
addition, to overcome the limitations associated with dye exclusion assay, Avelar-Freitas 
et al. (2014) suggested the use of flow cytometry for cell viability assay. This suggestion 
was attributed to the formation of trypan blue complexes with either bovine serum or 
cytoplasmic proteins which emit fluorescence at 660nm and the complexes are said to 
be detectable with flow cytometry using 650nm low-pass band filter (Avelar-Freitas et 
al., 2014). 
The use of biomarkers for the measurement of cell viability and cytotoxicity is another 
in-vitro screening technique. The biomarkers used are reported to exhibit proteolytic 
activities associated with cell viability/death, for example, the activity of cellular 
protease reduces rapidly in dead cells. Thus, biomarker activities can be measured with 
the aid of a luminogenic substrate which can be combined with a fluorogenic substrate 
to increase assay sensitivity (Niles, Moravec and Riss, 2009).  
Although extensive data can be generated from an in-vitro assay, results obtained are 
limited by the complexity of the human biology, such in-vitro results cannot be used to 
predict the outcomes of human clinical trial. 
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1.9.2.2 In-vivo cytotoxicity screening 
In-vivo screening model is advantageous in anticancer drugs development in terms of 
cost, time and most importantly improve the prediction of drug efficacy. One of the 
common in-vivo model for screening anticancer drugs and validating their action is the 
zebrafish. The zebrafish (Danio rerio) models are considered a powerful tool for rapid 
drug discovery and biosafety studies in the screening of drugs efficacy for the nervous, 
digestive, reproductive and immune system among other (Huiting, Laroche and Feng, 
2015). This consideration is because most organ development in zebrafish is similar to 
mammals (Wilkins and Pack, 2013). The zebrafish is used due to associated advantages 
including rapid development of its embryo, determination of drug bioavailability and 
drug toxicity at the tissue level (Huiting, Laroche and Feng, 2015). Zebrafish models use 
for cancer studies are generated using various methods which include the use of 
carcinogens such as N-nitrosodimethylamine, inactivation of tumour suppressor genes 
such as p53, transgenesis to generate transgenic zebrafish expressing mammalian 
oncogenes, and the use of xenograft to transplant human cancer cell into zebrafish 
(Terriente and Pujades, 2013; Wilkins and Pack, 2013; Huiting, Laroche and Feng, 2015; 
Wyatt, Trieu and Crawford, 2017). 
Another widely used animal model is the mouse model (Mus musculus) and the 
advantages associated with this model include similarity in genetic material with human 
genetics, similar biological/organ system with human and their relatively small size. 
Certain limitations are associated with the mouse model, most importantly the mouse 
factor which is an umbrella term used to describe certain characteristics associated with 
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different strains, thus putting in consideration that the mouse factor contributes to 
results obtained, independently. These characteristics include the presence of different 
lesions in different mouse strains, strains and age-related diseases, variability among 
mouse models (Kohnken, Porcu and Mishra, 2017). Like the zebrafish model, mouse 
model used for cancer research are generated using carcinogens, xenograft and 
transgenesis (Gould, Junttila and de Sauvage, 2015; Kohnken, Porcu and Mishra, 2017). 
 ENDOPHYTES  
Endophyte is a term derived from the Greek words “endo meaning within” and phyton 
meaning plant”. Endophytes are microorganisms (bacteria, archaea, fungi and protist) 
that are found in plant endosphere and have a symbiotic association which could be 
obligate or facultative without causing harm to host plant (Hardoim et al., 2015). 
Obligate endophytes are those microorganisms that depend on plant metabolism for 
survival while facultative endophytes are those that survive outside the plant host and 
associate with the host via its neighbouring soil environment and the atmosphere 
(Hardoim, van Overbeek and Elsas, 2008; Abreu-Tarazi et al., 2010). These 
microorganisms are said to be beneficial to host plant by promoting plant growth via 
synthesizing phytohormones such as indole-3-acetic acid and cytokinins (Ahmed and 
Holmström, 2014; Santoyo et al., 2016); solubilize phosphorus in soil (Oteino et al., 
2015); improve plant host tolerance/resistance to stress by preventing ethylene 
synthesis in plants (Glick, 2014); control and prevent microbial pathogens by producing 
antimicrobial compounds (Esmaeel et al., 2016; Larran et al., 2016; Kandel et al., 2017); 
increase plant biomass and height (Shi, Lou and Li, 2009; Barra et al., 2016); produce 
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pigments (Qiu et al., 2010)  and enzymes(Bischoff et al., 2009); and uptake of nutrients 
such as nitrogen (Robertson-Albertyn et al., 2017), among others. 
Colonization of host plant by endophytes was elucidated to occur via the soil-root 
interface i.e. the rhizosphere which was shown to involve two principle elements namely 
root exudates and microorganism quorum sensing compounds. In addition, 
geographical location, plant phenotype, plant developmental stage, soil type, plant 
nutritional status, climate changes and environmental factors such as level of carbon 
dioxide and oxygen and changes in temperature also contribute to the distribution and 
localization of endophytes in host plant (Kandel, Joubert and Doty, 2017; Liu et al., 
2017). 
 ISOLATION AND IDENTIFICATION  
Endophytes are said to be present in different plant parts as shown in the studies 
conducted on the leaves of Phaseolus vulgaris (de Oliveira Costa et al., 2012); the bark 
of Populus euramericana (de Oliveira Costa et al., 2012); the seeds of Urochloa ramose 
(Verma and White, 2018); the buds of Atractylodes lancea (Zhou et al., 2018); the root 
and seed of Paullinia cupana (Silva et al., 2018); the  roots, leaves, stems and flowers of 
Rhizophora stylosa and Rhizophora mucronata (Zhou et al., 2018) and the soil-root 
interface (Liu et al., 2017).  
Prior to the use of molecular techniques, endophytes were isolated by a conventional 
approach which involves isolation of endophytes from sterile plant tissue. Nowadays, 
they are isolated via DNA sequencing of targeted regions such as 16S rRNA gene and the 
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internal transcribed spacer regions (ITS1 and ITS2) or via whole genome sequencing 
(Taghavi et al., 2009; Sessitsch et al., 2012). 
 APPLICATIONS OF ENDOPHYTES 
Some applications of endophytes include their role as source of bioactive compounds; 
bioremediation, biotransformation/bioconversion and biodegradation; and enzyme 
production (Bartholdy, Berreck and Haselwandter, 2001; Lu and Shen, 2007; Bischoff et 
al., 2009; Tomsheck et al., 2010; Joseph and Priya, 2011; Kumar et al., 2011; Russell et 
al., 2011; Bezerra et al., 2012). The review will focus on bioactive compounds from 
endophytes and bioconversion. 
 BIOACTIVE COMPOUNDS FROM ENDOPHYTES 
Bioactive compounds produced by endophytes are shown to belong to have different 
bioactivity such as anticancer, antimicrobial and antioxidant among others. Example is 
paclitaxel, an alkaloid which is an anticancer agent produced by Metarhizium anisopliae 
(Liu et al., 2009), Phoma medicaginis (Zaiyou, Li and Xiqiao, 2017) and Cladosporium 
cladosporioides (Zhang, Zhou and Yu, 2009) which were all isolated from Taxus species 
namely Taxus chinensis, Taxus wallichiana and Taxus media, respectively. More so, 4'-
hydroxy-deacetyl-18-deoxycytochalasin H, isolated from Trichoderma harzianum, an 
isolate of Cola nitida leaves was shown to have cytotoxic activity against cancer cell lines 
including murine lymphoma (L5178Y) and human ovarian cancer (A2780 sens) cell lines 
with IC50 values of 2.55 and 6.97 µM, respectively (H. Chen et al., 2015). In addition, 
phenochalasin B obtained from endophyte Eutypella scoparia which was isolated from 
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Hevea brasiliensis leaf was shown to have potent cytotoxic effect against KH-oral cavity 
cancer cell lines (IC50 value of 2.46µM) (Kongprapan et al., 2015). 6-formamide-
chetomin, an isolate of Chaetomium species which was obtained from the plant 
Huperzia serrata, was shown to have cytotoxic effect against human cervical (HeLa), 
human gastric (SGC-7901) and lung adenocarcinoma (A-549) cancer cell lines with IC50 
values of 21.6 nM, 23.0 nM and 27.1 nM. Furthermore, 6-formamide-chetomin was 
shown to possess antibacterial activity against Staphylococcus aureus, Enterococcus 
faecalis and Salmonella typhimurium with a reported MIC of 0.78 μg/mL across the three 
microorganisms (Yu et al., 2018). 5-butyl-6-(hydroxymethyl)-4-methoxy-2H-pyran-2-
one and 4-methoxy-6-methyl-5-(3-oxobutyl)-2H-pyran-2-one were obtained from 
endophyte Alternaria phragmospora, an isolate of Vinca rosea and both have cytotoxic 
activity against myelogenous leukemia cell line K562 with reported IC50 values of 4.5 and 
1.5 µM, respectively (Metwaly et al., 2014). Studies by Sang et al. (2017) showed that 
two α-pyrone derivatives were isolated from Endophytic Phoma species namely 
phomones D and phomones E, and both were subjected to cytotoxicity studies against 
human leukemia HL-60,  human prostate PC-3 and human colon HCT-116 cancer cell 
lines with a reported range of 0.65-9.84 µM IC50 values. Rhytidchromones A and 
Rhytidchromones, oxygenated chromones obtained from, Rhytidhysteron rufulum, an 
endophytic fungus isolated from Bruguiera gymnorrhiza, were reported to have 
cytotoxicity against MCF-7 with reported IC50 value of 19.3 ± 2.5 and 17.7 ± 3.7 and 
against Kato-3 with reported IC50 value of 23.3 ± 1.1 and 16.0 ± 1.9 µM, respectively 
(Chokpaiboon et al., 2016). 
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Examples of other bioactivity properties attributed to bioactive compounds from 
endophyte is seen in the studies of Leylaie and Zafari (2018), where trichodermin 
obtained from Trichoderma koningiopsis, an endophytic fungus isolated from Vinca 
major, was shown to have antifungal effect with MIC of 3.25 µg/mL across all tested 
microbes namely Pyricularia oryzae, Botrytis cinerea and Aspergillus fumigatus. 3-(4-
nitrophenyl)-5-phenyl isoxazole, isolated from Aspergillus niger, was shown to inhibit 
the enzyme adenosine deaminase, and inhibit the growth of liver cancer cell lines HepG2 
and SMCC-7721 cells with IC50 values of 0.347 and 0.380 mM, respectively (Zhang et al., 
2018). Actinoallolide A isolated from Actinoallomurus fulvus was shown to have 
antitrypanosomal activity against Trypanosoma species namely T. b. brucei, T. b. 
rhodesiense and T. cruzi with IC50 value of 0.0049, 0.086 and 0-226 µg/mL (Inahashi et 
al., 2015). 3-methylcarbazoles obtained from endophytic Streptomyces sp., an isolate of 
Alpinia galangal root, was reported to have a potent anti-inflammatory effect and 
suppressed the production of inflammatory mediators such as PGE2, NO, TNF-a, IL-6 and 
IL-10 in a dose-dependent manner which was studied in RAW264.7 macrophages 
(Taechowisan et al., 2012). Antibiotics are also reported to be obtained from 
endophytes example include ecomycins,  Pseudomycin A, Munumbicins, Kakadumycin 
A and Xiamycin-A isolated from Pseudomonas viridiflava, Pseudomonas syringae, 
Streptomyces sp. (NRRL 30562), Streptomyces sp. (NRRL 30566) and Streptomyces sp. 
strain GT2002/1503, respectively (Christina, Christapher and Bhore, 2013). 
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 BIOCONVERSION 
Bioconversion/biotransformation involves the use of micro-organisms as biocatalysts 
and is increasingly used in the preparation of pharmaceutical products (Hegazy et al., 
2015). In the field of natural product research, most compounds isolated are in minute 
quantity and in most cases the amount required for clinical trials are mostly chemically 
synthesized, thus resulting in the accumulation of chemical waste. However, this 
challenge can be tackled with the use of biotransformation where biocatalyst can result 
in the production of complex drugs and drugs intermediates (Hegazy et al., 2015). 
Ultimately, removing the necessary step of chemical catalysis reaction, complicated 
separation and purification steps. In bioconversion, the catalytic activity of micro-
organisms which involve several chemical reactions plays a vital role in the specific 
modification of a specific compound to a product with similar structure (Lilly, 1994). 
Bioconversion complies with green chemistry since it results in the pharmaceutical 
processes with minimal waste production and energy consumption (Guria, Guha and 
Bhattacharyya, 2014). Most chemical processes of drug production are conducted in less 
favourable conditions which are mostly less environmentally friendly and expensive, in 
contrast, bioconversion is enantiomer-specific and region-specific, environmentally 
friendly and less expensive (Collins and Kennedy, 1999; Rozenbaum et al., 2006). The 
reactions involved in biotransformation include addition, elimination, substitution, 
pericyclic, rearrangement and redox reaction (Hegazy et al., 2015).  
The micro-organisms mostly used in bioconversion are endophyte species. The fungus 
Glomerella cingulata was reported to hydroxylate tetrahydrogeraniol and 
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tetrahydrolavandulol to hydroxycitronellol and 5-hydroxytetrahydrolavandulol, 
respectively (Hirokazu Nankai, Miyazawa and Kameoka, 1997). Hegaxzy and colleagues 
(2015) and Cao and colleagues (2015) published a comprehensive data on microbial 
transformation of certain phytochemicals such as monoterpenes by Absidia gluaca and 
sesquiterpenes by Kluyveromyces marxianus, Aspergillus alliaceus, and Rhodotorula 
glutinous among others (Cao et al., 2015; Hegazy et al., 2015). Some bioactive natural 
products were also reported to have undergone biotransformation example include 
artemisinin bioconversion by Streptomyces griseus to artemisitone-9, 9α-hydroxy-
artemisinin, 9β-hydroxy-artemisinin and 3α-hydroxy-deoxyartemisinin (Liu et al., 2006). 
Biotransformation of taxol/cephalomannine was also reported, this was achieved using 
Streptomyces sp. resulting in the products 10-hydroxyacetyl-10-deacetyltaxol, 3-(4-
hydroxyphenyl)-3-dephenyltaxol and 4-hydroxycephalomannine (Chen et al., 2001). 
Recent literature reported the bioconversion of halimane to 2-oxo-derivative by 
Fusarium oxysporum whereas Myrothecium verrucaria transformed it to 18-19-
dihydroxy, 18-formyl and 18-carboxyl products. Also, both F. oxysporum and M. 
verrucaria were shown to transform labdane to 7α-hydroxy and 7α/3β-hydroxy, 
respectively (Monteiro et al., 2017). Other studies also reported  the transformation of 
glycerol to polyhydroxyalkanoates by Pseudomonas mediterranea and Pseudomonas 
corrugate (Licciardello et al., 2017); ginsenosid Rb1 to ginsenoside Rg3 by Burkholderia 
sp. (Fu, Yin and Yin, 2017); astragalosides to astragaloside IV by Penicillium canescens 
(Yao et al., 2014) and  ergopeptines to lysergic acid by Rhodococcus erythropolis 
(Thamhesl et al., 2015).  
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Finally, it is important to point out that a recent literature showed that endophytes, 
isolated from three medicinal plant namely Caralluma acutangula, Rhazya stricta and 
Moringa peregrine, were shown to possess antioxidant properties and contain bioactive 
(flavonoid and phenolic) metabolites (Khan et al., 2017). Thus, the question whether 
certain pharmacological attributes subscribed to a particular plant could be a result of 
the interaction between the host plant and endophytes is worth exploring.  
 AIM and OBJECTIVES OF THIS THESIS 
The work presented in this thesis describes the antibacterial and cytotoxicity 
investigation of Boswellia dalzielii bark using the aqueous extract of B. dalzielii against 
microorganisms (Staphylococcus aureus and its methicillin-resistant strain) and cancer 
cell (breast cancer cell MCF7 and MCF10A as control). 
 STRUCTURE OF PROPOSED THESIS 
This thesis has been divided into seven chapters: 
Chapter 1 provides background information on ethnopharmacology, plant as medicine, 
phytochemistry and pharmacology of the plant of interest i.e. B. dalzielii, methods of 
isolation and identification of compounds, antimicrobial resistance, cancer and 
endophytes. 
Chapter 2 entails detailed information of materials and apparatus used for 
phytochemistry, microbial and cytotoxicity assays, in addition, it provides information 
on microbial strains used and their storage. 
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Chapter 3 describes detailed antibacterial screening of aqueous and 50% methanol 
extracts of B. dalzielii against S. aureus and its methicillin-resistant strain. This chapter 
also provides detailed bioactivity guided screening of active extracts using Disc diffusion 
method to obtain compounds responsible for the antibacterial activity and said 
compounds were identified. Methods of minimum inhibitory concentration and synergy 
of said compounds were also provided. 
Chapter 4 provides detail experimental procedure and results for the rationale on the 
role of microorganisms in aqueous extract of B. dalzielii and their capability to 
biotransform phytochemicals to other metabolites. Also, methods used in identifying 
these microorganisms was provided. 
Chapter 5 includes detail method used in cytotoxicity screening of aqueous extracts of 
B. dalzielii (alone and in combination with four other plants) and the bioactivity guided 
assay that led to the isolation and identification of active compound.  
Chapter 6 describes the identification of microorganisms responsible for the production 
of anticancer compound catechol, and the isolation and identification of the compound 
transformed in aqueous B. dalzielii bark fermented extract. 
Chapter 7 gives detail method developments using vanillin sulphuric reagent, -
anisaldehyde reagent, m-anisaldehyde using aqueous extracts of B. dalzielii.  
Chapter 8 provides references used in this thesis.  
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2  
MATERIALS 
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 Plant material 
The stem bark of Boswellia dalzielii was collected from the Northern part of Nigeria 
precisely from Kaduna State, Nigeria. The plant was authenticated as belonging to the 
Burseraceae family (Vouchers number: 2448) at the herbarium situated at Ahmadu Bello 
University, Zaria by Namadi Sunusi. 
 Reagents 
 Reagent used for microbial analysis 
Mueller Hinton agar and broth (Oxoid, UK), purchased gallic acid (98% Agros Organic), 
pyrogallol (99% Alfa Aesar), cefotaxime and vancomycin (Sigma Aldrich, UK), cellulose 
acetate (Aldrich), MacCONKEY agar (consisting of bile salt, crystal violet, sodium 
chloride, lactose, peptone, protease peptone, neutral red and agar) (Oxiod), Lugol`s 
iodine solution (Fischer), 95% alcohol, safranin (Fisher), crystal violet (Fisher), oil 
immersion (Sigma), API®20E™ biochemical test kit and reagents (Biomerieux), sterile 
distilled water, ultrapure agarose (Invitrogen), 0.5 × TBE (Tris base,Boric acid and 
Ethylenediaminetetraacetic acid (EDTA)) (Invitrogen) and DNA ladder (Bioline). 
 Reagent used for phytochemical analysis  
2.2.2.1  
HPLC water and acetonitrile grade, distilled water, methanol, hexane, ethyl acetate, 
vanillin, sulphuric acid, m- anisaldehyde, p-anisaldehyde, formic acid, acetic acid, 
methanol and ethanol. Compounds used as references were gallic acid (98% Agros 
Organic), pyrogallol (99% Alfa Aesar), catechol (99% Alfa Aesar), protocatechuic acid 
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(97% Agros Organic) and compounds purchased from Sigma Aldrich include steroids (β-
sitosterol and stigmasterol), flavonoids (kaempferol and nobiletin), and terpenes 
(farnesol and terpinene). 
 Reagent used for cytotoxicity analysis  
MCF7 AND MCF10A were purchased from European Collection of Authenticated Cell 
Culture. Cell culture media (DMEM and DMEM/F12), Fetal bovine serum, Dulbecco`s 
phosphate buffered saline (DPBS), Trypsin-Ethylenediaminetetraacetic acid (EDTA), 
Trypan blue stain and Dimethyl sulfoxide (DMSO) were obtained from Fischer Scientific. 
MCF10A media supplement including Insulin, Hydrocortisone, Epithelial growth factor 
(EGF) were sourced from Fischer Scientific. Thiazolyl blue tetrazolium bromide (MTT) 
was purchased from Sigma Aldrich. 
 APPARATUS 
General apparatus used include sterile pipettes and corresponding tips (1mL, 200µL, and 
10µL).  
 Apparatus used for Microbial analysis 
Apparatus used for microbial analysis include sterile cotton swab, sterile 96 well plate, 
sterile multichannel pipette, Eppendorf vials, sterile 1mL Pasteur pipettes,6mm 
whatmann glass filter paper, Innova incubator shaker, UV measuring device 
(SpectraMax Plus), LEICA ICC50 HD microsystem and glass slides, Oxidase strips, Bunsen 
burner, PCR machine (PIKOREAL 96), UV- cabinet, vortex, mini plate spinner (MPS 
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1000TM), Kinetex 5µm C18 (150 × 2.1mm), Bio-Rad illuminator, minisart sterile syringe 
filter (pore size of 0.2µm) sartorius, sterile loop, sterile spreader, cryopreservation 
beads, 50mL sample bottles and Innova incubator shaker.  
 Apparatus used for phytochemical analysis 
Apparatus used for phytochemical analysis include B. dalzielii plant bark, measuring 
cylinder, 3mL disposable Pasteur pipettes, 2000W hot air gun, 100mL Duran bottle, foil 
paper, TLC silica plate (Macherey Nagel SIL-A UV-254) , TLC tank, 5µL spotters, spray 
bottle, ice box, mechanical shaker, fume cabinet, clean micro spatula, brush, FTIR 2 
Bruker Alpha spectrometer, NMR tubes, Deuterated dimethyl sulfoxide and water, 
400Bruker Avance Spectrometer, HPLC Agilent 1100 series and VisionHT C18 HL 5µ (250 
× 4.6 mm) column, HPLC sample vial and 50mL sample bottles. 
 Apparatus used for cytotoxicity analysis 
1.5mL microcentrifuge tubes, 10mL and 5mL serological pipettes, 96-well microtiter 
plates (flat-bottomed), 25 cm2 and 75cm2 culture flasks and 15mL centrifuge tubes were 
also purchased from Fischer Scientific. Cell culture work was conducted in HERA safe 
biosafety cabinet (Class II), haemocytometer was used to obtain cell number, samples 
were incubated in Hera cell 150 incubator and GloMax microplate reader was used for 
measuring absorbance. Other materials used include 1mL, 200µL and 10µL pipette and 
corresponding sterile pipette tips, multichannel pipette and serological pipette 
controller. 
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 MICROORGANISM STRAINS 
Methicillin-resistant Staphylococcus aureus (MRSA) NCTC 12497 and Staphylococcus 
aureus NCTC 6571 were used in this studies. These organisms were transferred from the 
master store by taking the wrong end of a sterile swab and transferring a bead into 10mL 
nutrient broth, and incubated at 37°C at 100RPM using the incubator shaker series 
(innova®44), for 24hours. Other microorganisms used were those isolated from B. 
dalzielii bark namely Enterobacter cloacae, Pantoea spp and Klebsiella pneumonia strain 
B and E. 
 STORAGE OF MICROORGANISMS 
From inoculums, microorganisms were plated using sterile loops, labelled and incubated 
in 37°C incubation room for 18hours. From plated microorganisms, colonies were picked 
using a sterile loop and transferred to small tubes containing cryopreservation beads 
immersed in cryo-solution, purchased from technical services. Once organisms were 
transferred, the tube was closed and gently shake and allow to stand for 30 seconds, 
then the cryo-solution was gently removed using a pipette, then stored in the freezer at 
-20°C. 
 PREPARATION OF MEDIA AGAR AND BROTH 
All agar and broth were prepared according to the manufacturer`s instructions. For 
instance, Mueller Hinton agar (CM0337) was measured as instructed (38g in 1 Litre of 
distilled water) and nutrient broth (CM0405) was measured as instructed (21g in I Litre 
of distilled water). Both broth/agar solutions were autoclaved at 121oC for 15 minutes. 
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3  
ANTIBACTERIAL SCREENING OF Boswellia DALZIELII 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“All infections, of whatever type, with no exceptions, are products of 
parasitic beings; that is, by living organisms that enter in other living 
organisms, in which they find nourishment, that is, food that suits 
them, here they hatch, grow and reproduce themselves” 
- Bassi 1773-1856 
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ABSTRACT 
The activity-guided fractionation of aqueous fractions obtained from Boswellia dalzielii 
bark against Staphylococcus aureus and its methicillin-resistant strain resulted in the 
identification of two antibacterial compounds namely gallic acid and pyrogallol which 
were identified using HPLC, TLC, NMR, FTIR and HRMS. The Minimum Inhibitory 
Concentration for pyrogallol and gallic acid against S. aureus growth are 508 and 753 
µM, while against MRSA growth are 254 and 2032 µM, respectively. A growth Inhibition 
assay showed the activity of gallic acid as bacteriostatic, while that of pyrogallol as 
bacteriocidal against tested microorganisms. Interestingly, pyrogallol was isolated from 
the 24 hours aqueous extract of B. dalzielii macerated for 24hours at 37°C. 
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 INTRODUCTION 
In most phytochemical investigations, plants that are reported to be used by specific 
ethnic groups and that are expected to have pharmacological effects, are screened using 
organic solvents such as methanol, ethyl acetate, acetone, dichloromethane and hexane 
(Iloki-Assanga et al., 2015; Dhawan and Gupta, 2016; Thouri et al., 2017; Hernández-
Sánchez et al., 2018). Some studies use 50% hydroalcoholic solvents, but only a few use 
water in studying the phytochemistry and pharmacological properties of plants with 
suspected ethnopharmacological properties (Ben Yakoub et al., 2018; Ferreres et al., 
2018; Mishra et al., 2018). Nevertheless, water is an abundantly available solvent and 
most commonly used in the preparation of herbal extracts in folk medicine. As such; it 
is advisable to use water as the solvent of extraction in ethnopharmacology (Hanson, 
2005).  
The rationale used in this study is to use water as the solvent used in preparing herbal 
extracts, in an effort to stay as close as possible to the traditional preparation methods. 
In addition, a 50% aqueous methanol was also used to address the possibility that the 
antibacterial effect of B. dalzielii could be attributed to non-polar compounds present in 
the plant. Although, the bioautographic method is an easy assay, the BSAC disc diffusion 
(BSAC, 2013), CLSI microdilution (CLSI, 2017) and microdilution checkerboard methods 
(Odds, 2003) were used in this study because these methods require the use of specific 
sample measurements while in the bioautographic method, the concentration of 
compounds present in sample are unknown.  
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This chapter will discuss the antibacterial activities of B. dalzielii bark via activity guided 
fractionation which was screened against Staphylococcus aureus and its Methicillin-
resistant strain. S. aureus is one of the most common causes of infection in humans, 
some examples include bacteraemia, infective endocarditis and device-related 
infections (Bowler, Duerden and Armstrong, 2001; Tong et al., 2015).  
 METHODS  
 DISC DIFFUSION ASSAY (British Society for Antimicrobial 
Chemotherapy (BSAC)) 
3.2.1.1 Sample preparation 
100mg/ml of plant extracts and fractions of B. dalzielii bark was dissolved in sterile 
distilled water (5%DMSO) (DMSO: water = 95:5) or 100% sterile distilled water 
depending on the extraction procedure.  
3.2.1.2 Method 
Microorganisms were cultured in Mueller Hinton broth at 37°C overnight, the 
suspension was adjusted to 0.5 McFarland standard by diluting 1ml of inoculum with 
9ml of broth and absorbance was read at 625nm which was between 0.08-0.13 (similar 
to the density of a 0.5 McFarland standard). Where absorbance reading obtained was 
below required range, the suspension was adjusted by adding 0.5mL-1mL of inoculum 
and if reading is above required range, 0.5mL-1mL of broth was added.  
Petri dishes were placed in the 37°C incubation room to dry off water on the lids for 
about 15 minutes. The working environment was sterilized and the Bunsen burner was 
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on to provide a sterile environment. A sterilized cotton swab was used to spread micro-
organisms on the plate and labelled accurately. Autoclaved discs obtained from 6mm 
Whatmann glass filter paper were placed immediately on each plated Petri dish. This 
was repeated for all Petri dishes and 10µL (equivalent to 1mg) of the test sample was 
placed on the 6mm disc. 5% DMSO in sterile water or 100% sterile water was used as 
negative control. Petri dishes were incubated in the 37°C incubation room for 18hours. 
The results were interpreted by measuring the diameter of the clear zone around the 
wells and experiments were conducted in triplicates. Selected fractions were tested on 
micro-organisms using Mueller Hinton agar to further select compounds with better 
activity. Samples with activity were purified and submitted for identification analysis. 
 IDENTIFICATION TECHNIQUES  
3.2.2.1 Fourier-transform infrared spectroscopy (FTIR)  
FTIR analysis was conducted using FTIR Bruker Alpha spectrometer having a platinum 
diamond ATR sampling accessory. Samples were loaded on FTIR device with the aid of a 
clean spatula and scanned 16 times over the range of 4000-360 cm-1 and the spectral 
resolution was 2 cm-1. Data obtained as absorbance spectrum was processed on OPUS 
software 7.2. 
3.2.2.2 Nuclear magnetic resonance (NMR) 
20mg of all samples were transferred into labelled NMR tubes and accurately labelled 
in 700µL deuterated solvent (dimethyl sulfoxide for gallic acid and water for pyrogallol). 
The operating settings on the Bruker av400 spectrometer include 399.94MHz at 298 K 
Page | 70  
 
operating frequency, 64 scans, 6.5 µs pulse, 32, 768 data points and 4,800 Hz spectral 
width was conducted to acquire spectra which were further processed on Topspin 2.1 
software. 
 MINIMUM INHIBITORY CONCENTRATION (Clinical and Laboratory 
Standard Institute (CLSI)) 
3.2.3.1 Sample preparation  
A stock solution of 5000mg/L was prepared using sterile water for extracted compounds 
(gallic acid and pyrogallol), and positive control (cefotaxime for S. aureus and 
vancomycin for MRSA). And the following concentrations 1024, 512, 256, 128, 64, 32, 
16 and 8 µg/mL were obtained for all compounds. 
3.2.3.2 Method 
Three well-isolated colonies were selected from a 24hrs culture on Mueller Hinton agar 
plate and transferred into 10mL of Mueller Hinton broth which was incubated at 37˚C 
overnight. The suspension turbidity was adjusted via measuring absorbance between 
0.08-0.013 at 625nm, similar to that of a 0.5 McFarland standard. From this suspension, 
0.1ml was transferred into a tube containing 9.9ml of broth, a 1:100 dilution which is 
said to be 1 × 106 CFU/mL, which when 50µL is added to an equal volume of antimicrobial 
agent solution should give a final cell number ranging from 2 × 105 CFU/mL to 8 × 105 
CFU/mL.  Control was prepared by adding 50µL of Mueller Hinton broth to 50µL of cell 
suspension, while blank was prepared by adding 50µL of sterile water to 50µL of Mueller 
Hinton broth. Plates were inoculated within 30 minutes of standardizing the inoculum 
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suspension at 37°C for 18 ± 2 hours. MIC was read as the lowest concentration without 
visible with turbidity similar to the negative control. The purity of the test suspension 
used was checked by transferring 10uL aliquot from the growth control well into 10mLs 
of Mueller Hinton broth, from which 100µL was spread over the surface of Mueller 
Hinton agar plate and incubated overnight. Accepted number of colonies recommended 
is between twenty to eighty colonies. The graph is a presentation of the subtraction of 
absorbance read before incubation from absorbance read after 24hours incubation at 
37°C. 
 INHIBITION OF BACTERIAL GROWTH 
3.2.4.1 Sample preparation  
Samples were prepared as per the Minimum Inhibitory Concentration and 2-fold 
concentration of the MIC obtained for both micro-organisms was prepared. For S. 
aureus, concentrations of gallic acid used include 256, 128 and 64 µg/mL and that of 
pyrogallol used include 128, 64 and 32 µg/mL. While for MRSA, concentrations of gallic 
acid used include 512, 256 and 128 µg/mL and that of pyrogallol used include 64, 32 and 
16 µg/mL. 
3.2.4.2 Spectroscopic Method 
Minimum Inhibitory Concentration method was employed and the 96-well plate was 
covered with sterile gas permeable moisture barrier seal. The 96 well plate containing 
samples was incubated in the spectrophotometer, which was set to have a temperature 
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of 37°C, a wavelength of 625nm and the absorbance was set to be taken at every hour 
interval for 18hours.  
3.2.4.3 10µL Spot assay 
Minimum Inhibitory Concentration method was employed and samples were prepared 
in sterile bottles and incubated at a temperature of 37°C.  
3.2.4.3.1 Examining the effect of centrifuging step 
Two sterile bottles were inoculated to 1 × 106 CFU/mL and labelled as “Sample A” and 
“Sample B”. At zero hours, 100µL of the inoculum was transferred from bottle A into 
sterile Eppendorf tube and 900µL sterile phosphate buffered saline was added. Samples 
were centrifuged at 8000rpm for 10 minutes and the supernatant was discarded. This 
was repeated twice, before re-suspending pellet in 1mL of sterile water and serially 
diluted to 10-8. Sample B was treated similar to sample A without the centrifuging step. 
10µL of each diluent was spread over labelled Mueller Hinton agar plates in triplicate. 
Plates were incubated overnight at 37°C. Colony forming unit per millilitre (CFU/mL) was 
determined by multiplying the average number of colonies by the dilution factor.  
3.2.4.3.2 Method 
Sterile bottles containing relevant agents were inoculated to 1 × 106 CFU/mL. At 
different time interval of 0, 4, 8, 12 and 24 hr(s), samples were treated similarly to 
sample A. Colony forming unit per millilitre (CFU/mL) was determined by multiplying the 
average number of colonies by the dilution factor. Bactericidal activity is determined 
Page | 73  
 
when there is ≥3 log10 (99.9%) reduction in colony forming units per mL after 18- 24 
hours incubation. The experiment was two independent studies.  
 CHECKERBOARD SCREENING METHOD 
3.2.5.1 Sample preparation 
Samples were prepared as per that of Minimum Inhibitory Concentration. 
3.2.5.2 Method 
Microorganisms were prepared as per the Minimum Inhibitory Concentration method. 
50µL of cell suspension was added to the well and adjusted to 100µL with 25µL of each 
of the two antimicrobial agents. Absorbance was read at 625nm before incubation and 
plate were incubated at 37°C for 24hours, and after incubation, absorbance was read 
again. The difference between readings before and after incubation was calculated (i.e. 
absorbance in one well after incubation – absorbance in that well after incubation), 
giving an absorbance change value. Bacterial growth is shown as an absorbance change 
of greater than 0.05. The lowest combination of antimicrobials together to inhibit 
growth are thus determined and fractional inhibitory concentration index (FICI) is 
calculated in order to establish the antimicrobial relationships: synergy, addition, 
indifference or antagonism. 
Thus, FICIs were calculated using the equation: 
FICI = FIC antimicrobial A + FIC antimicrobial B = (MIC antimicrobial A in combination ÷ MIC antimicrobial A 
alone) + (MIC antimicrobial B in combination ÷ MIC antimicrobial B alone) 
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Interactions are then determined from the following limits: Synergy (S): FICI < 0.5, 
addition (A): 0.5 ≤FIC≤1, indifferent (I): 1 < FICI ≤2, antagonism (An): FICI > 2. 
 RESULTS AND DISCUSSION 
 BIOACTIVITY GUIDED FRACTIONATION (BGF) 
3.3.1.1 Extraction procedure one  
200g of dried and powdered bark was macerated in 2L of 50% aqueous methanol at 
room temperature, in the dark on a rotary shaker. The extract was filtered using a 
Büchner funnel with Whatman Nr 1 filter paper and extracted with ethyl acetate (3 × 
300mL). The ethyl acetate fraction was evaporated under reduced pressure to obtain a 
dry residue, which was labelled fraction 1 (1.08g). The water fraction was acidified by 
dropwise addition of fuming hydrochloric acid to a final concentration of 2M HCL.  The 
mixture was left to hydrolyse by boiling for 30 minutes and, after cooling, washed with 
ethyl acetate (3 x 300 mL) to obtain fraction 2 (1.72g).  
Fraction 1 was run through a flash column (silica 60Å particle, 35-70micron, column 
dimensions 30cm x 3cm ID) using dichloromethane: methanol: formic acid (72: 18: 0.1) 
Fractions of 10mL were collected and tested by TLC. Similar looking fractions were 
pooled, resulting in four fractions: i.e. fraction 1A (4-10), 1B (11-14), 1C (15-20) and 1D 
(21-50).  Fraction 2 was also run through a flash column under similar conditions and six 
fractions were collected, i.e. fraction 2A (13-16), 2B (17-27), 2C (28-57), 2D (58-97), 2E 
(98-121) and 2F (122-145) (see Figure 3.1).  
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Figure 3. 1: Extraction procedure using 50% aqueous methanol as solvent 
All column fractions obtained were prepared for antimicrobial disc diffusion assay. 
Absorbance recorded for adjusted suspensions of Staphylococcus aureus and MRSA was 
0.112 and 0.108, respectively. Zone of inhibition obtained from the screening are shown 
in Table 3.1 and are recorded in millimetres ± standard deviation. 
 
Table 3. 1: Zone of Inhibitions recorded for fractions obtained from 50% aqueous extract of B. 
dalzielii 
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From the result obtained, 1B and 1C were selected for further purification, TLC of 
Fraction 1B and 1C revealed carryover of compounds from fraction 1B, due to this, the 
fractions were pooled together. Column chromatography was conducted using ethyl 
acetate: water: acetic acid (80: 10: 10) and four fractions were collected and named 
fraction 1Ba, 1Bb, 1Bc and 1Bd (see Figure 3.2). Fractions collected were further tested 
on both S. aureus and MRSA. Only fraction 1Bc had activity against both micro-
organisms. From this fraction, 3.2mg compound was obtained, purified and labelled B1 
via chromatography using ethyl acetate: water: acetic acid (86: 7: 7). 
 
Figure 3. 2: Fractions tested against S. aureus and MRSA 
3.3.1.2 Extraction procedure two 
200g of plant material was macerated in 2L of 100% distilled water for six hours at room 
temperature, extract was filtered and vacuum-concentrated on freeze dryer. Crude 
extract was washed with ethyl acetate to obtained fraction 1. With the aid of 10-40µ 
silica gel, fraction 1 (0.76g) was column chromatographed with ethyl acetate: water: 
acetic acid (80: 10: 10) and 10 fractions were collected, namely, A (3-5), B (6-9), C (10-
19), D (20-24), E (25-31), F (32-42), G (43-49), H (50-60), I (61-83) and J (84-92) (see Figure 
3.3). 
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Figure 3. 3: Extraction procedure using distilled water as solvent for six hours 
Equivalent of 100mg/mL of all fractions were prepared for antimicrobial disc diffusion 
assay using distilled water as solvent. Absorbance recorded for adjusted suspensions of 
Staphylococcus aureus and MRSA were 0.13 and 0.110, respectively. From these 
fractions, only fractions F and G had activity as shown in Table 3.2. 
 
Table 3. 2: Zone of inhibition recorded for fractions obtained from aqueous extract of B. 
dalzielii 
The TLC of both F and G reveal similar TLC chromatogram when viewed under the short 
wavelength, therefore both fractions were combined and further purified to obtain 
compound B2 (1.6mg) (see figure 3.4) 
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Figure 3. 4: TLC illustration of fraction F and G 
3.3.1.3 Extraction procedure three 
The extraction was conducted as used ethno-pharmacologically, the plant material is 
normally macerated in water for as long as the plant compounds dissolved in water with 
water being added when depleted, and the colour is an indication of when the plant 
cannot be extracted further. The plant extraction can be left for as long as a week, the 
visible change in the plant extract is the odour if left untouched.  
200g of plant material was macerated in 2L of distilled water for 24hrs, the extract was 
filtered and vacuum-evaporated. The crude extract obtained was washed with ethyl 
acetate to obtained fraction 1. With the aid of 35-70µ silica gel, fraction 1 (1.26g) was 
column chromatographed with hexane: ethyl acetate: water: acetic acid (5: 15: 5: 5) and 
5 fractions were collected, namely B1 (1-15) 206mg, B2 (16- 35) 197mg, B3 (40-55) 
86mg, B4 (56-64) 62mg and B5 (70-89) 94mg (see Figure 3.5). All fractions (equivalent 
of 50mg/mL) collected were tested on S. aureus and MRSA. Absorbance recorded for 
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adjusted suspensions of Staphylococcus aureus and MRSA were 0.110 and 0.106, 
respectively.  
 
Figure 3. 5: Extraction procedure using distilled water as solvent for 24hrs at 37°C 
 
Of the five fractions, only two fractions had activity as seen in Table 3.3. 
 
Table 3. 3: Zone of inhibition recorded for fractions obtained from 24hours maceration 
Fraction B1 and B2 were pooled together and further column chromatographed on 10-
40µ silica gel to give six fractions labelled fraction 1 (1-20), fraction 2 (22-27), fraction 3 
(38-46), fraction 4 (98-113), fraction 5 (116-135) and Fraction 6 (139-159). TLC of 
fractions was conducted using hexane: ethyl acetate (50:50 and a drop of formic acid). 
Fraction 2 and fraction 3 has similar chemical profile as seen in Figure 3.6 below, 
therefore the fractions were pooled together and labelled fraction 3.  
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Figure 3. 6: TLC chromatogram of fractions tested against S. aureus and MRSA 
 
50 mg/mL of all the five fractions was measured and tested on S. aureus and MRSA using 
the disc diffusion method and sterile distilled water was used as solvent. Absorbance 
recorded for adjusted suspensions of S. aureus and MRSA were 0.123 and 0.118 (See 
Figure 3.7), respectively. Zones of inhibition were measured for fraction 3, fraction 4 and 
fraction 6, see Table 3.4. 
 
Table 3. 4: Zone of inhibition recorded for fractions obtained from pooled fraction B1 and B2 
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Figure 3. 7: Image showing clear zone of inhibition obtained for B. dalzielii fractions against S. 
aureus and MRSA 
Major compounds of fraction 3 and fraction 4 were purified on 10-40µ silica gel using 
hexane: ethyl acetate (50:50 and a drop of formic acid) and labelled as B3 (8.6mg) and 
B4 (19mg). Major compound present in fraction 6 was not purified, this was due to the 
unstable nature of the compound in the extract. 
3.3.1.4 Compounds obtained via BGF 
TLC analysis of B1 obtained from procedure 1, B2 obtained from procedure 2, B3 
obtained from procedure 3 and B4 obtained from procedure 3 was conducted using 
hexane: ethyl acetate (50:50 and a drop of formic acid) (see Figure 3.8). Result showed 
that compound B1, B2 and B3 have similar rf value of 0.20 while B4 has a rf value of 0.61.  
Purified compounds were then submitted for NMR, FTIR and HRMS analysis. 
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Figure 3. 8: TLC chromatogram comparing all compounds collected from the three extraction 
procedures 
 
In the present study, manual fractionation was conducted using column 
chromatography, although this technique is tedious, it leads the researcher to specific 
compounds with biological activity i.e. antimicrobial activity. Different research studies 
have used the bioactivity guided fractionation in the search for active compounds in 
plants and natural products. Examples can be seen in the works of Michel et al., (2013) 
seeking compounds with antihyperglycemic and anti-inflammatory activities from 
Pterocarpus dalbergioides; and that of  Cunha et al., (2017) in seeking compounds with 
antimicrobial and cytotoxic activities from Cassia bakeriana. However, the main 
challenges of this technique are obtaining a low yield of active compounds in most cases 
and the dereplication of known compounds with little/no special interest in the 
discovery of a lead compound in drug discovery (Weller, 2012).  Bioactivity guided 
fractionation of the bark of B. dalzielii lead to the extraction of two active compounds 
which were purified and submitted for identification analysis.  
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 IDENTIFICATION OF COMPOUNDS B1 AND B4 
3.3.2.1 High resolution mass spectrometry (HRMS) results 
5mg of compound B1 and B4 plus respective references were used for HRMS which was 
conducted at EPSRC National Facility Swansea. Results showed that observed mass of 
B1 was measured as MW 170.0179g/mol [C7H6O5]; MS, m/z [E1-, %], 169.0142 (M-H, 
100%) (See Figure 3.9) and predicted molecular composition was C7H5O5. While that of 
B4 was predicted as MW 126.0280g/mol [C6H6O3]; MS, m/z [E1-, %], 125.0247 (M-H, 
100%) (see Figure 3.10) and predicted molecular composition is C6H5O3. 
 
 
Figure 3. 9: HRMS spectrum of compound B1 and purchased gallic acid suggesting that 
extracted compound B1 might be gallic acid. 
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Figure 3. 10: HRMS spectrum of Compound B4 and purchased pyrogallol suggesting that 
extracted compound B4 might be pyrogallol 
 
3.3.2.2 Fourier-transform infrared spectroscopy (FTIR) results 
Samples analysed include extracted compound B1 (Figure 3.11) and B4 (Figure 3.12), 
and control compounds used are gallic acid and pyrogallol purchased from Sigma 
Aldrich. Figure 3.11 and Figure 3.12 show prominent peaks at 3267.5 cm-1 and 3210.32 
cm-1, which are indicative of compounds with hydrogen bonded alcohols/phenols in 
both extracted and purchased gallic acid and pyrogallol, respectively. 
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Figure 3. 11: FTIR spectrum of gallic acid overlaying that purchased from Sigma Aldrich. The 
spectra of purchased gallic acid is consistent with that extracted from plant bark of B. dalzielii. 
 
Figure 3. 12: FTIR spectrum of pyrogallol overlaying that purchased from Sigma Aldrich. The 
spectra of purchased pyrogallol is consistent with that extracted in this study. 
 
3.3.2.3 Nuclear magnetic resonance (NMR) results 
NMR analysis was conducted using a 20mg sample and reference gallic acid in 700µL 
deuterated dimethyl sulfoxide for both 1H and 13C analysis, and 20mg sample and 
reference pyrogallol in 700µL deuterated water for both 1H and 13C analysis. 1H-NMR 
spectrum of gallic acid (sample and reference) showed a single signals at δH 6.92 ppm 
(2H, s), δH 8.82 ppm (H, s), δH 9.18 ppm (2H, s) and carbonyl proton at δH 12.23 ppm 
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(H, s) (Figure 3.13) while 13C-NMR spectrum showed five signals at δC 145.4 ppm (C-3, C-
1), δC 137.9 ppm (C-2), δC 120.4 ppm (C-5), δC 108.7 ppm (C-4, C-6), and δC 167.4 ppm 
for carbonyl group (Figure 3.14). 1H-NMR spectrum of pyrogallol (sample and reference) 
showed two signals at δH 6.42-6.46 ppm (2H, d) and δH 6.60-6.67 ppm (1H, t) (Figure 
3.15) while 13C-NMR spectrum showed four signals at δC 145.37 ppm (C-3, C-1), 
δC 132.34 ppm (C-2), δC 120.50 ppm (C-5) and δC 108.38 ppm (C-4, C-6). 
 
Figure 3. 13: 1H-NMR spectrum of purchased gallic acid is consistent with that extracted from 
plant bark of B. dalzielii. 1H-NMR spectrum was obtained using bruker av400 spectrometer at 
399.94 MHz using deuterated dimethyl sulfoxide. 
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Figure 3. 14: 13C-NMR spectrum of gallic acid is consistent with that extracted from plant bark 
of B. dalzielii. 13C-NMR spectrum was obtained using bruker av400 spectrometer at 100.58 MHz 
using deuterated methanol. 
 
 
Figure 3. 15: 1H-NMR spectrum of purchased pyrogallol is consistent with that extracted from 
plant bark of B. dalzielii. 1H-NMR spectrum was obtained using bruker av400 spectrometer at 
399.94 MHz using deuterated methanol. 
Although both extracted and purchased gallic acid (3,4,5-trihydroxybenzoic acid) have 
similar signals, the 13C signals reported is identical to that reported in the studies 
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conducted on the oxidation of gallic acid (López et al., 2013). H-NMR of gallic acid 
reported in the present study is similar to that reported in the studies on phenolic acids 
present in mango and papaya (López-Martínez et al., 2015). Both the 13C and 1H signals 
of gallic acid reported in the present studies correspond with that extracted from 
Elaeagnus angustifolia (Abri, 2015). The studies conducted by Crisponi and colleagues 
(1990) reported an identical 13C-NMR signal of pyrogallol (1,2,3-trihydroxybenzene) 
(Crisponi et al., 1990). 
 MINIMUM INHIBITORY CONCENTRATION 
The Staphylococcus strain used in the present studies is S. aureus NCTC 6571. This strain 
is susceptible to almost all antibiotics except colistin and polymyxin and is usually used 
as a control strain (PHE, 2017). MRSA NCTC 12497 was used as a test strain. MIC results 
presented were obtained from three independent studies and results are the mode of 
repeated concentrations.  The graph shows data presented as the mean of absorbance 
and the error bars represent the standard deviation of the means.  
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Figure 3. 16: Growth inhibition graph of pyrogallol and gallic acid against MRSA 
 
Figure 3. 17: Growth inhibition graph of pyrogallol and gallic acid against S. aureus 
 
The MIC of pyrogallol against MRSA and S. aureus growth are 32 and 64 µg/mL, 
respectively, which correspond to 254 and 508 µM. While, that of gallic acid against 
MRSA and S. aureus growth are 256 and 128 µg/mL, respectively, which correspond to 
2032 and 753 µM (Figure 3.16 and Figure 3.17). In addition, no visible growth was 
observed for all positive control. From the data obtained, pyrogallol was observed to 
have better antibacterial activity against MRSA compared to gallic acid and act poorly 
against the control strain. The studies of Borges et al., (2013) showed that gallic acid has 
a MIC of 1750 µg/mL against S. aureus CECT 976. Gallic acid was shown to have 
antibacterial activity against Pseudomonas strains with MIC values above 2000 µg/mL 
(Sorrentino et al., 2018). Pyrogallol was shown to have antibacterial activity with MIC 
value of 32 – 64 µg/mL against V. parahaemolyticus isolated from leg shrimp 
(Litopenaeus vannamei) (Tinh et al., 2016).  
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 INHIBITION OF BACTERIAL GROWTH 
3.3.4.1 Spectroscopic method 
 
 
Figure 3. 18: Spectrophotometric growth curve of gallic acid concentrations of 512, 256 and 
128 µg/mL against MRSA 
 
 
Figure 3. 19: Spectrophotometric growth curve of pyrogallol concentrations of 64, 32 and 16 
µg/mL against MRSA 
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Figure 3. 20: Spectrophotometric growth curve of gallic acid concentrations of 256, 128 and 64 
µg/mL against S. aureus 
 
 
Figure 3. 21: Spectrophotometric growth curve of pyrogallol concentrations of 128, 64 and 32 
µg/mL against S. aureus 
Growth inhibition assay was conducted using spectrophotometer at 625nm. The data 
obtained showed a decrease in absorbance when both microbial strains were treated 
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with pyrogallol (as seen in Figures 3.19 and 3.21) when compared to gallic acid (as seen 
in Figures 3.18 and 3.20). It is easy to speculate that gallic acid could be bacteriostatic 
while pyrogallol could be bactericidal, however, this speculation could be wrong. Thus, 
the 10µL spot assay was conducted to determine the minimum bactericidal 
concentration via obtaining the number of viable bacteria cells after treatment with 
gallic acid and pyrogallol.  
3.3.4.2 10µL Spot assay 
The method of Hamoud et al., (2014) was modified in determining the MBC values of 
both pyrogallol and gallic acid against MRSA and S. aureus. However, a neutralizer was 
not used in arresting the action of both gallic acid and pyrogallol on both bacteria strains 
used. Therefore, a centrifuging step was introduced. T-test analysis assuming unequal 
variance was used and p-value (0.35) obtained was greater than 0.05, indicating that 
there is no significant difference between the two data obtained for centrifuged and un-
centrifuged samples. 
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Figure 3. 22: Growth Inhibition of S. aureus by gallic acid 
 
Figure 3. 23: Growth Inhibition of MRSA by gallic acid 
At 24hours, gallic acid was shown to affect the growth of S. aureus with an average log 
reduction of 2.6 CFU/mL at a concentration of 256 µg/mL (1506µM), reducing bacterial 
growth to 6.9 CFU/mL from 9.5 CFU/ml (Figure 3.22) whilst its effect on the growth of 
MRSA was an average log reduction of 1.9 CFU/mL at a concentration of 512 µg/mL 
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(3012µM) (Figure 3.23), thus suggesting that gallic acid exhibit bacteriostatic function, 
preventing bacterial growth at a very high concentration. 
 
Figure 3. 24: Growth inhibition of S. aureus by pyrogallol 
 
 
Figure 3. 25: Growth Inhibition of MRSA by Pyrogallol 
At 24hours, pyrogallol completely inhibits the growth of both MRSA and S. aureus 
(Figure 3.24 and 3.25). At 12hours at a concentration of 128 µg/mL (1016µM), the 
compound affects the growth of S. aureus with an average log reduction of 7.1 CFU/mL, 
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reducing bacterial growth from 9.2 CFU/mL to 2.1 CFU/mL (Figure 3.24). Whilst its effect 
on the growth of MRSA was an average log reduction of 7.0 at a concentration of 64 
µg/mL (508µM), reducing bacterial growth from 9.1 CFU/mL to 2.1 CFU/mL (Figure 
3.25), thus indicating bactericidal function. 
 CHECKERBOARD SCREENING  
The checkerboard screening method was used to determine potential interactions 
between pyrogallol and gallic acid against tested organisms (S. aureus and MRSA). The 
test was conducted in a three independent studies. 
Gallic acid 
(µg/mL)       
512      
256      
128 1.625 2.011 2.794   
64 1.653 1.582 2.1209   
32 20.166 1.609 1.8179   
Pyrogallol 
(µg/mL) 16 32 64 128 256 
Table 3. 5: FICI obtained for S. aureus using equation provided. All combinations used are either 
indifferent or antagonistic. 
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Gallic acid 
(µg/mL)       
512      
256 2.0180 1.9992 2.3653   
128 18.7909 18.9504 1.5956   
64 18.7909 5.4345 5.2093   
Pyrogallol 
(µg/mL) 16 32 64 128 256 
Table 3. 6: FICI obtained for MRSA using equation provided. All combinations used are either 
Indifferent or antagonistic. 
Absorbance obtained was used in calculating fractional inhibitory concentration index 
(FICI) and from the data obtained, no synergy interaction was observed for the 
combinations of pyrogallol and gallic acid used against S. aureus (Table 3.5) and MRSA 
(Table 3.6), in both cases, the FICI was above 0.5.  
 CONCLUSION 
The checkerboard method was conducted as a screening method to evaluate the 
interaction between gallic acid and pyrogallol. The rationale behind the assay is due to 
the fact that B. dalzielii is used in the Northern part of Nigeria, a region that has a tropical 
dry climate. The country experiences a temperature range of 13 – 41°C (55.4 – 105.8°F) 
(Cooke and Mohammed, 2009). Micro-organisms are known to grow at different 
temperature in natural habitat example is the presence of leucothrix mucor on seaweeds 
(Hollants et al., 2013). Plants and the soil on which they grow are natural habitats to 
micro-organisms, an example is the presence of Arthrobacter globiformis in soil (Casida 
and Jr., 1969). Maceration of plant materials in a tropical region could results in 
bioconversion by microorganisms present on the said plant. The presence of these 
microorganisms could be a result of contamination and/or habitat ecosystem. In the 
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end, ingesting plant extract obtained via cold maceration could contain both plant 
phytochemicals and metabolites obtained via bioconversion after a certain time 
interval.  In the case of the present study, an individual could be ingesting both gallic 
acid and pyrogallol, where the latter was shown to have better antibacterial activity 
against S. aureus and its methicillin-resistant strain when compared to the former. 
Having more than one antibacterial compound in an extract could results in the 
possibility of synergetic interaction between the compounds, thus attributing the 
activity of said extract to the interaction. Therefore, it is important to evaluate their 
interaction. However, the checkboard screening assay showed that the interaction 
between gallic acid and pyrogallol is not synergistic rather antagonistic and indifferent 
for both MRSA and S. aureus depending on concentrations (see Table 3.5 and 3.6). The 
possibility of pyrogallol as a metabolic by-product of bioconversion was further 
investigated (See next Chapter). To the best of the author`s knowledge, this is the first 
work reporting the presence of pyrogallol in 24 hrs aqueous extract of B. dalzielii bark.  
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4  
BIOCONVERSION OF GALLIC ACID BY Enterobacter cloacae 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"The art of healing comes from nature and  
not from the physician. Therefore, the physician  
must start from nature with an open mind."  
– Paracelsus 1493-1541 
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ABSTRACT 
The role of endophyte was investigated on aqueous extract of Boswellia dalzielii bark, 
this led to the isolation and identification of Enterobacter cloacae and Pantoea spp. 
However, only E. cloacae bioconverted gallic acid to pyrogallol. The 16S rRNA sequences 
of both E. cloacae and Pantoea spp are deposited in the GenBank nucleotide database 
under the accession number MH764584 and MH764583, respectively.  
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 INTRODUCTION 
In folk medicine, maceration is one of the conventional method of extraction used and 
the matrix properties of the plant part, temperature and time contribute to the extract 
obtained. Ethnopharmacologically, this process is mostly a septic technique where the 
sterile conditions of materials used and that of the environment is not put into 
consideration. Thus, the source of contamination of plant macerated extract could be 
from the plant itself, the water and material used, and the environment.   
The Hausa in the Northern part of Nigeria macerate the bark of B. dalzielii in cold water, 
and the resulting extract is used as a dietary supplement, or in the treatment of 
infections and tumours. Cold maceration of plants leads to the release of hydrophilic 
phytochemicals which may subsequently be metabolised by microorganisms residing in 
the herbal material, especially in temperate regions, resulting in a chemical and physical 
change (Young, 1974; Schaffner and Beuchat, 1986; Hilton and Cain, 1990). Almost all 
plants in nature are thought to live in symbiosis with endophytes which help fight 
pathogenic infection and environmental stress condition, thus promoting plant growth 
(Santoyo et al., 2016). Specific microorganisms such as Rhizobia and endophytes have a 
symbiotic close relationship (agonism or mutualism) with their host plant; a further 
example is the interaction between some Poaceae grass family and endophytic fungi 
belonging to the genus Epichloë (Clavicipitaceae) (Gunatilaka, 2006; Saikkonen et al., 
2016).  Therefore, microorganisms living on the surface or inside plants can be isolated, 
identified and their role can be defined (Hallmann et al., 1997). 
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The previous chapter on the antimicrobial activity of B. dalzielii reported that pyrogallol 
was identified in an aqueous extract after maceration for 24h, whereas this compound 
was not detected in extracts either after six hours in water or after 24h in 50% aqueous 
methanol extracts. Therefore, it is important to further investigate the 24hours extract. 
This chapter covers the effect of temperature on aqueous extraction of B. dalzielii, and 
identification of microorganisms on the bark of B. dalzielii. The effect of microbial 
species on the phytochemical profile of aqueous extract of this plant will be 
characterised. 
 METHODS 
 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
4.2.1.1 Preparation of standard solution 
Standard solutions were prepared by dissolving 1mg of purchased compounds (gallic 
acid and pyrogallol) in 2mL of methanol which is equivalent to 500ppm (500mg/L).  
Aliquots of the standard solution were used to prepare samples for a calibration curve. 
Six solutions were prepared from the standard working solution, this include: 250ppm 
(0.5mg/mL), 200ppm (0.4mg/mL), 150ppm (0.3mg/mL), 100ppm (0.2mg/mL), 50ppm 
(0.1mg/mL) and 25ppm (0.05mg/mL).  
4.2.1.2 HPLC analysis 
HPLC Agilent series 1100 system composed of autosampler and diode array detector 
was used qualitative and quantitative analysis. The separation was performed on 
VisionHT C18 HL 5µ (250 × 4.6 mm). A binary solvent system was used as mobile phase 
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consisting of 0.1% acetic acid in water and 0.1% acetic acid in acetonitrile in a ratio of 
95/5 (v/v). The column temperature was set to 40°C with a solvent flow rate of 1mL/min 
and an injection volume of 5μL. The diode array detector was monitored at 280nm and 
run time was 30minutes. Chromatographic peaks were identified for both gallic acid and 
pyrogallol, and compared to the retention time of peaks present in B. dalzielii bark crude 
extracts in subsequent experiments. A linear calibration curve was plotted for the 
standard solutions for both compounds and equation generated was used to calculate 
the concentration of both compounds in prepared samples. 
 EFFECT OF TEMPERATURE ON AQUEOUS EXTRACT OF B. dalzielii 
Three sterile bottles were labelled 4°C, 25°C and 37°C and one gram of plant bark was 
macerated in each of the sterile bottles using 10mL sterile distilled water and incubated 
for 24hrs at 4°C, 25°C and 37°C, respectively. Samples were filtered using minisart sterile 
syringe filter and 5µL was ran on the HPLC in triplicate using the method described in 
section 4.2.1.2. Compounds affected were selected as peaks on the HPLC 
chromatogram. 
 ISOLATION OF MICRO-ORGANISMS  
10mL of sterile distilled water was added to three different 50mL sample bottles labelled 
A1, A2 and A3, and then one gram of plant material was added. Sample bottles were 
incubated at 37°C shaking at 100RPM for two hours. From each sample bottle, 10µL was 
plated on Mueller Hinton agar plate using a sterile spreader, this was conducted in 
triplicate and appropriately labelled. Single colonies of the most common visible micro-
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organisms were selected and inoculated in 10mL sterile Mueller Hinton broth and 
incubated overnight at 37°C shaking at 100RPM. Overnight cultures were plated on 
Mueller Hinton agar plate with the aid of a sterile loop and incubated overnight at 37°C. 
Isolated colonies were then stored on cryopreservation beads and appropriately 
labelled.   
 EFFECT OF MICRO-ORGANISMS ON AQUEOUS EXTRACT OF B. dalzielii 
4.2.4.1 Method I 
One gram of the plant bark of B. dalzielii was macerated in 10mL of sterile distilled water 
in nine sterile bottles labelled 1, 6, 18, 24, 30, 42 and 48 hour(s) and samples were 
incubated at room temperature, placed on a mechanical shaker at 100RPM. At the 
specified time, samples were collected for thin layer chromatography (TLC) analysis was 
conducted on silica plate using hexane and ethyl acetate (50:50) plus a drop of formic 
acid as eluent. TLC analysis was also conducted on 6 and 24hours samples, together with 
the sample collected from one gram of plant bark of B. dalzielii macerated in 10mL 50% 
aqueous methanol overnight, using 0.5mg/mL of pyrogallol and gallic acid in methanol 
as standard references. Vanillin spray reagent was prepared using 2 grams of vanillin, 
98mL ethanol and 2mL sulphuric acid. TLC plates were treated with vanillin spray 
reagent and heat with hot air blower for few seconds to visualise compounds.  Also, at 
specific time, 1mL was collected from samples, filtered into HPLC sample vial using the 
minisart sterile syringe filter and appropriately labelled sterile (S) plus designated time. 
HPLC analysis was conducted using the method mentioned in section 4.2.1.2. and 
column used was VisionHT C18 HL 5µ. 
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4.2.4.2 Method II 
One gram of plant bark was macerated in 10mLs of sterile distilled water. The sample 
was incubated for 24hours at 37°C. 1.3g of cellulose acetate was measured as instructed 
by the manufacturer and loaded onto glass column. 10mL of 24hours aqueous extract 
at 37°C was centrifuged and the supernatant was passed through cellulose acetate, then 
the cellulose acetate was washed with methanol to recover pyrogallol. Recovered 
pyrogallol was TLC analysed against pyrogallol standard using hexane and ethyl acetate 
plus a drop of formic acid as solvent.  
In addition, 3mg pyrogallol was dissolved in 3mL of HPLC grade methanol. 1mL was 
transferred into HPLC sample vial and labelled “Not filtered”, 1mL was filtered with 
minisart sterile syringe filter into HPLC sample vial and labelled “Filtered”. 1mL of 
methanol was then used to rinse the syringe filtered to recover the pyrogallol bonded 
to the cellulose acetate in the filter and this was labelled “Methanol recovered”. 
Samples were HPLC analysed using the method mentioned in section 4.2.1.2. 
4.2.4.3 Method III 
From labelled sample bottles labelled 1, 6, 18, 24, 30, 42 and 48 hour (s) prepared in 
METHOD I, 3mL was collected from samples into labelled Eppendorf vials and 
centrifuged at 8000rpm for 10 minutes, then filtered with Whatman filter paper. 1mL of 
the filtrate was transferred into HPLC sample vial and appropriately labelled non-sterile 
(NS) plus designated duration of incubation. HPLC analysis was conducted using the 
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method mentioned in section 4.2.1.2. Samples were plated on Mueller Hinton agar 
plates to investigate the presence of microbial growth.  
 CONFIRMING THE EFFECT OF ISOLATED MICROORGANISMS ON 
AQUEOUS EXTRACT OF B. dalzielii  
Three well-isolated colonies of both bacteria (colony X and Y) were transferred into 
three different 10mL sterile media including water, Mueller Hinton broth and six hours 
aqueous plant extract and incubated at 37°C overnight. Samples were filtered using 
minisart sterile syringe filter and 1mL was transferred into HPLC vial for analysis. HPLC 
analysis was conducted using the method mentioned in section 4.2.1.2.  
 IDENTIFICATION OF MICROORGANISMS  
4.2.6.1 Gram staining method 
Isolated bacterial colonies were used to prepare smears for Gram staining. Fixed smears 
were stained with crystal violet for 60secs, excess stain was washed with water, then 
Lugol`s iodine solution was applied for 60 seconds which was also washed off with 
water. 95% alcohol was used to wash off the slides to remove the purple stain then 
water was used to wash the slide. The slides were stained with safranin for 60 seconds 
then washed with water and allowed to dry before examining under the oil immersion 
objective lens. 
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4.2.6.2 Oxidase strip method 
Oxidase strip was further used to determine the identity of unknown microorganisms. 
This diagnostic test is for the detection of the cytochrome oxidase activity of 
microorganism within a minute. In the presence of some Gram-negative bacteria 
cytochrome oxidase enzyme, the N,N-dimethyl-p-phenylenediamine and α-naphthol 
react to indophenol. Smears of microorganisms to be tested was prepared on a slide and 
the paper zone saturated with a solution of N,N-dimethyl-p-phenylenediamine and α-
naphthol was placed on the smear and allowed to stand for a minute. A positive result 
is obtained when the paper zone changes to a dark blue or black colour while a negative 
result is obtained when the paper remains pink. 
4.2.6.3 MacCONKEY agar method 
MacCONKEY agar plate test was further used to verify the identity of bacterial colonies 
isolated. Isolated colonies were plated on the said agar plate with the aid of a sterile 
loop and allowed to grow for 24 hours at 37°C. 
 API®20E BIOCHEMICAL ASSAY 
The API®20E™ biochemical assay was conducted using the manufacturer’s instruction 
and this test is specific to Enterobacteriaceae and/or non-fastidious Gram-negative rods. 
The inoculum of bacteria colonies isolated from B. dalzielii (white and yellow colonies) 
were prepared with sterile water and transferred into AP1 solutions on the strip. The 
strip box was sealed and incubated for 24hrs at 37°C. After the incubation period, the 
sections of tryptophan deaminase, indole test and Voges-Proskauer test were treated 
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with drops of appropriate reagent provided by the manufacturer and allowed to react 
for 10 minutes. Visual assessment of the strip was conducted as either positive or 
negative, using colour chart provided by manufacturer as control. Result obtained was 
entered into the online API identifier and identity of bacteria were obtained. 
 POLYMERASE CHAIN REACTION (PCR) 
PCR analysis was conducted for both isolated bacteria (White and yellow colonies) from 
B. dalzielii using the following universal primers: 
• 16S rRNA forward primer: AGAGTTTGATCCTGGCTCAG  
• 16S rRNA reverse primer: ACGGCTACCTTGTTACGACTT  
A 50µl master mix was prepared to contain 25µL of Bioline Mix (MyTaqTM HS Red Mix), 
1µL 10µM 16S rRNA forward primer, 1µl 10µM 16S rRNA reverse primer and 23µL of 
RNase-free water. A colony of the tested microorganisms was stabbed using a 10µL 
pipette tip and added into the PCR tube containing the master mix, the experiment was 
conducted in a UV- cabinet for PCR operation (UVT-B-AR). Samples were vortexed and 
spun in a mini plate spinner (MPS 1000TM) at 2500RPM (500×g), before placing it in the 
PCR machine (PIKOREAL 96). PCR reaction was allowed to run for 55mins using the 
following programme: Initial denaturation step at 95oC for 3minutes, 30 cycles 
consisting of denaturation at 95oC for 15seconds, annealing at 52oC for 15seconds and 
extension at 72oC for 20seconds, and a final extension period of 2minutes at 72oC. 
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4.2.8.1 Gel electrophoresis  
1% (w/v) ultrapure agarose was prepared by adding 0.5g of agarose to a 50mL solution 
containing SYBR safe DNA stain in 0.5 × TBE and dissolved by heating in the microwave 
for 1 minute, then poured into casting tray fitted with a comb and allowed to solidify. 
3μL of DNA ladder (Bioline) and PCR products each were loaded and allowed to run at 
60V for 90minutes with the aid of Bio-Rad.  The resulting gel was visualized in a Bio-Rad 
illuminator with a chemiDocXRS camera, using Quantity One software. Band obtained 
were compared to the Bioline Easy Ladder. 
 MICROBIAL BIOCONVERSIONS 
5g of plant material was macerated in 50mLs of distilled water for six hours at room 
temperature. The sample was filtered with a sterile microbial filter. 5ml filter-sterilised 
aqueous plant extracts were inoculated with 3 colonies each of isolated colonies (E. 
cloacae and Pantoea spp.) and incubated on a shaker (100RPM) at 37°C for 24hours. 
Incubated samples were centrifuged and filtered then 1mL was transferred into HPLC 
vials and analysed on HPLC in triplicate after 24hours. Six hours sterile plant extract was 
also analysed on HPLC in triplicate. HPLC analysis was conducted using the method 
described in section 4.2.1.2. 
 CONVERSION OF GALLIC ACID TO PYROGALLOL 
0.1% gallic acid was dissolved in sterile Mueller Hinton broth, which was then inoculated 
with E. cloacae. The inoculum was adjusted to ~108 using a wavelength setting of 625nm, 
before incubating at 37°C for 24hours. 1mL of 0.1% gallic acid in sterile Mueller Hinton 
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broth and Mueller Hinton broth alone was collected as control. After 6, 12, 18 and 24 
hour(s), 2mL of samples was transferred into a labelled Eppendorf vial and centrifuged 
at 8000rpm for 10 minutes, then filtered with Whatman filter paper. 1mL of the filtrate 
was transferred into HPLC sample vial for HPLC analysis using method detailed in section 
4.1.1.2, however, HPLC column used was Kinetex 5µm C18 (150 × 2.1mm) and binary 
solvent system used as mobile phase consisted of 0.1% acetic acid in water and 0.1% 
acetic acid in acetonitrile (99/1, v/v).  
 RESULTS AND DISCUSSION 
 HPLC ANALYSIS 
The 500PPM (1mg/2mL) stock solution prepared was used to prepare different 
concentrations and mean ± standard error of the compound peak was obtained. Using 
the area value of all working concentrations, a calibration curve for each of the standard 
compound (gallic acid and pyrogallol) was obtained.  
 
Figure 4. 1: HPLC chromatogram of Gallic acid having a retention time of 5.1 minutes  
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Figure 4. 2: HPLC chromatogram of pyrogallol having a retention time of 5.8 minutes  
 
 
Figure 4. 3: Calibration curve of gallic acid. Data represents mean ± standard error 
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Figure 4. 4: Calibration curve of pyrogallol. Data represents mean ± standard error 
 EFFECT OF TEMPERATURE ON AQUEOUS EXTRACT OF B. dalzielii  
Peaks selected for analysis had retention time 5.1 and 5.8, which are similar to gallic acid 
(Figure 4.1) and pyrogallol (Figure 4.2). The graph (Figure 4.5) showed the presence of 
pyrogallol in 25°C and 37°C samples, with a concentration of 86.3 and 140.8 mg/L, 
respectively. The peaks of compounds with the retention time of 4.1 and 9.5 present in 
4°C sample was observed to be absent in 37°C sample (Figure 4.6), suggesting that other 
phytochemicals are vital to the micro-organisms present in the plant extract. 
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Figure 4. 5: Effect of temperature on gallic acid and pyrogallol present in aqueous extract of B. 
dalzielii. Data represents mean ± standard error 
 
 
Figure 4. 6: HPLC Chromatogram of aqueous extract of B. dalzielii incubated in 4°C and 37°C for 
24hours 
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 ISOLATION OF MICROORGANISMS 
Microbial growth was visible for all samples grown on all Mueller Hinton agar plate and 
two dominant colonies were observed on the plates rather than a wide range of 
different colonies. These organisms were labelled colony “X” which is white in colour 
and “Y” which is yellow in colour (Figure 4.7). Isolated colonies were then transferred 
into storage vials containing cryopreservation beads (cryobeads) immersed in cryo-
solution and stored in the freezer at -20oC.  
 
Figure 4. 7: Microbial colonies observed in plant bark of B. dalzielii  
Furthermore, Mueller Hinton agar plates were exposed to working environment which 
include bench, laminar flow and shaker. The plates were then incubated overnight at 
37°C and no microbial growth was observed. Also, plant material was spike on to Mueller 
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Hinton agar and incubated overnight at 37°C for 24hours and only two types of bacterial 
colonies were observed (Figure 4.8). 
 
 
Figure 4. 8: Plant material spiked on Mueller Hinton agar plate.  
 EFFECT OF MICRO-ORGANISMS ON AQUEOUS EXTRACT OF B. dalzielii 
Microbial growth was visible only in the non-sterile sample and two dominant colonies 
were observed on Mueller Hinton agar plates. These organisms coincide with those 
labelled colony “X” and “Y” as seen in (Figure 4.9). 
 
Figure 4. 9: Microorganisms observed in extract of B. dalzielii 
TLC chromatogram of B. dalzielii bark conducted in 4.2.4.1 was sprayed with vanillin 
reagent to show different chemical profiling at different specified time showing the 
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presences of a compound labelled compound A at 12hrs (Figure 4.10). The 
chromatogram suggested that compound A is not a phytochemical present in the plant. 
This was verified by conducting a TLC with 1hr and 24hrs samples using purchased gallic 
acid and pyrogallol as standard references.  
 
Figure 4. 10: TLC chromatogram showing the presence of pyrogallol at 18hours when sprayed 
with vanillin reagent. Picture A was viewed at 254nm while picture B was viewed after vanillin 
spray treatment. 
Two compounds were previously identified in chapter 3 as gallic acid and pyrogallol, thus 
these compounds were purchased from Sigma Aldrich and used as references.  TLC was 
conducted with standard compounds of gallic acid and pyrogallol, against 1hr and 24hrs 
samples. TLC chromatogram confirms that compound A in Figure 4.10 is pyrogallol, since 
purchased pyrogallol has similar Rf value of 0.69 with a compound present in 24hrs 
sample (Figure 4.11).  
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Figure 4. 11: TLC chromatogram of gallic acid standard (1 and 5), pyrogallol standard (3), 1hr 
macerated plant bark (2) and 24hours macerated plant bark (4). 
 
Figure 4. 12: TLC chromatogram showing the presence of gallic acid in both 50% aqueous 
methanol and  six hours extract whereas pyrogallol was only present in 24hours extract. Where 
1 = 24 hours 50% methanol aqueous extract, 2 = gallic acid, 3 = 6 hours aqueous extract, 4 = 
pyrogallol and 5 = 24 hours aqueous extract 
The 50% aqueous extraction was also conducted to check that pyrogallol was not a 
phytochemical already present in the plant (Figure 4.12). From the TLC chromatogram, 
pyrogallol standard was shown to have similar Rf value of 0.68 with a compound in 
24hours extract and gallic acid was seen to have 0.24 Rf value with a compound in six 
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hours extract. HPLC chromatogram showed the appearance of pyrogallol after 24hours 
maceration at 37°C. 
HPLC analysis confirms the presence of gallic acid with a retention time of 5.1 in plant 
bark of B. dalzielii (non-sterile) macerated for 1hr, however, pyrogallol peak is not 
present in the sample. Unlike the 1hr non-sterile sample (Figure 4.13), the 24hrs non-
sterile sample is seen to have both gallic acid and pyrogallol with a retention time of 5.1 
and 5.8, respectively (Figure 4.14).  
 
Figure 4. 13: HPLC chromatogram showing the absence of pyrogallol peak in a one hour non-
sterile sample. 
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Figure 4. 14: HPLC chromatogram showing the presence of pyrogallol peak in a 24hours non-
sterile sample. 
 
Using the equation 𝑦𝑦 = 1005.2𝑥𝑥 (Figure 4.3) and 𝑦𝑦 = 551.25𝑥𝑥 (Figure 4.4) for gallic acid 
and pyrogallol, respectively, the concentration of both compounds in aqueous extracts 
were calculated. The HPLC analysis conducted on plant extract samples sterilized with 
minisart microbial filter 0.2µm showed that the optimal concentration of gallic acid was 
689.0 mg/L in the 30 hours sample. Whilst, the concentration of pyrogallol increased 
gradually with the 48 hours sample having the highest concentration of 323.7 mg/L 
(Figure 4.15). It is noteworthy to mention that the concentration of both gallic acid and 
pyrogallol in all samples were obtained using equation generated from the linear 
calibration curve of both compounds.   
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Figure 4. 15: Concentrations of gallic acid and pyrogallol in sterile plant bark of B. dalzielii at 
different time interval. Data are presented as mean ± standard error for both compound. 
Column chromatography conducted using cellulose acetate as stationary phase, lead to 
the use of methanol in washing the cellulose acetate after treating with 24hours, thus, 
pyrogallol was recovered. Eluted pyrogallol was TLC analysed against pyrogallol 
standard and TLC chromatogram showed that pyrogallol was trapped on cellulose 
acetate. Both recovered and purchased pyrogallol have similar Rf value of 0.67 (Figure 
4.16). In addition, the HPLC analysis conducted to confirm the effect of cellulose acetate 
on pyrogallol showed that of the 1.05mg/mL passed through the minisart syringe filter, 
about 0.34 mg/mL was bonded to the cellulose acetate and 0.53 mg/mL was recovered 
(Figure 4.17). 
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Figure 4. 16: TLC chromatogram of pyrogallol (PYR) and recovered pyrogallol from 24hours 
extract. 
 
Figure 4. 17: Effect of minisart syringe filter embedded with cellulose acetate. Data are 
presented as mean ± standard error. 
 
Furthermore, the HPLC analysis of the non-sterile samples was conducted and the 
amount of gallic acid and pyrogallol in plant bark extract was calculated for all samples. 
The concentration of gallic acid was seen to be optimal (565.5mg/L) in 18hours sample 
1.05
0.53
0.34
0.00
0.20
0.40
0.60
0.80
1.00
1.20
Not filtered Filtered MeoH Recovered
Co
nc
en
tra
tio
n 
(m
g/
m
L)
Concentration of Pyrogallol (mg/mL)
Page | 121  
 
while the concentration of pyrogallol was seen to be optimal (853.7mg/L) in 48hours 
sample (Figure 4.18).   
 
Figure 4. 18: Concentrations of gallic acid and pyrogallol in non-sterile plant bark of B. dalzielii 
at different time interval. Data are presented as mean ± standard error for both compound. 
The concentration of pyrogallol in sterile samples was observed to be lower across all 
samples when compared to non-sterile samples. The highest concentration obtained in 
the non-sterile sample was calculated to be 853.7 mg/L while that obtained in the sterile 
sample was 323.7 mg/L in 48 hours (Figure 4.19). 
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Figure 4. 19: Concentration of pyrogallol in both sterile and non-sterile samples. Data are 
presented as mean ± standard error for both compound. 
 
 CONFIRMING THE EFFECT OF ISOLATED MICROORGANISMS ON 
AQUEOUS EXTRACT OF B. dalzielii  
HPLC chromatogram of sterile water inoculated with isolated bacteria from plant bark 
of B. dalzielii showed no peaks while that of Mueller Hinton broth give two new peaks 
at 4.329 and 10.165 (Figure 4.20) after inoculation and 24hours incubation. However, 
the peaks observed were not similar to that of pyrogallol.  
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Figure 4. 20: HPLC Chromatogram of sterile Mueller Hinton broth, before and after inoculation 
 
 
Figure 4. 21: HPLC chromatogram of sterile plant extract before and after inoculation 
Figure 4.21 showed the presence of pyrogallol in the plant extract inoculated with 
bacteria isolated from the bark of B. dalzielii. This implicates pyrogallol as a metabolite 
of one of the two isolated bacteria. 
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 IDENTIFICATION OF MICROORGANISMS 
Gram-positive organisms stain purple because they resist decolourisation with alcohol 
and retain the primary stain (crystal violet) while Gram-negative organisms stain pink 
because they lose the primary stain during alcohol decolourisation stage, therefore they 
are free to take up the counterstain (safranin) (Coico, 2005). Both isolated colonies were 
Gram-negative rod bacteria and images were obtained using LEICA ICC50 HD microscopy 
at 1000 magnification using 1.25 oil lens (Figure 4.22)  
Oxidase strip test is reported to be positive for all Neisseria species and most non-
fermenting Gram-negative rods. Most fermenting Gram-negative rods are Oxidase 
negative except for some genus of Gram-negative bacteria such as Vibrios, Aeromonads 
and Pastuerella (Balows and Hausler, 1991). The Oxidase strip test conducted in the 
present study on both isolated bacteria was seen to be negative. 
MacCONKEY agar test showed that the white isolated colony was a mucoid lactose 
fermenting (pink) bacteria while the yellow colony is lactose negative and had no colour 
(Figure 4. 23). 
 
Figure 4. 22: Gram staining of white and yellow isolated colonies from B. dalzielii 
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Figure 4. 23: MacCONKEY agar test for both isolated bacteria from B. dalzielii  
 
 API®20E BIOCHEMICAL ASSAY 
The API®20E biochemical results obtained gave colourations, which were compared 
with control (Figure 4.24), results obtained from data entered into the API online 
database presented percentage identification of bacteria to be 98.9% for Klebsiella 
pneumonia spp 1 for white isolated colony “W” (Figure 4.25) and 99.1% for Cronobacter 
spp. for yellow isolated colony “Y” (Figure 4.26). 
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Figure 4. 24: API biochemical analysis of bacteria isolates of B. dalzielii 
 
 
Figure 4. 25: Result on percentage identity obtained for white isolate colony “W” with a 98% 
identity for Klebsiella pneumonia spp 1. 
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Figure 4. 26: Result on percentage identity obtained for yellow isolate colony “Y” with 98% 
identity for Cronobacter spp.  
Research showed that use of API 20E is prone to misinterpretation since is subjective 
because it involves visual detection of colour changes before and after inoculation with 
bacteria species (Tomas et al., 2018). Moreover, the diagnostic capability of this 
biochemical method in terms of accuracy was shown to be very low (Ferris et al., 2017; 
Tomas et al., 2018). For this reason, the use of molecular techniques involving specific 
markers such as 16S rRNA is encouraged to identify bacteria at a species level. 16S rRNA 
is a molecular marker having ~1500 base pair and it codes for catalytic RNA belonging 
to the 30S ribosomal subunit and is present in all prokaryotic cells. The 16S rRNA region 
consists of conserved sequences thus, the region is easily sequenced and use for 
accurate identification of bacteria species (Janda and Abbott, 2002; Srinivasan et al., 
2015). For this reason, 16S rRNA analysis was conducted.  
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 PCR ANALYSIS 
The 16S RNA size is ~1500bp which is above the highest base pair on the DNA ladder 
(Ikb). 40µL of each of the PCR products and 10 µL of both forward and reverse primer 
were submitted to Macrogen Europe Laboratory, Netherland for purification and 
sequencing. The gel results of 16S rRNA region for both PCR product of isolated bacteria 
gave a band above DNA ladder (Figure 4.27).  
 
Figure 4. 27: Gel electrophoresis image where lane 1 is DNA ladder, lane 2 is white isolated 
colony and lane 3 is yellow isolated colony. 
The PCR sequence results obtained for the isolated colonies for both forward and 
reverse primer were assembled on the CLC Main Workbench software and the 
consensus regions were obtained.  
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Figure 4. 28: Consensus region obtained for the white isolated colony of B. dalzielii  
 
 
Figure 4. 29: Consensus sequence obtained for the white isolated colony of B. dalzielii with 1009 
bases 
> Consensus White Colony Isolate 
GGGTAACGGCTCACCTAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACACTGGAA
CTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAG
CCTGATGCAGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGGGGA
GGAAGGCGATGAGGTTAATAACCTTGTCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACT
CCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGC
GCACGCAGGCGGTCTGTCAAGTCGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTCGA
AACTGGCAGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAG
AGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAGACTGACGCTCAGGTGCGA
AAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGTCGACTTGG
AGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACG
GCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTA
ATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCAGAGAACTTAGCAGAGATGCTTTG
GTGCCTTCGGGAACTCTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGG
GTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTTAGGCCGGGAACTCAAAG
GAAACTGCCAGTGATAAACTGGAAGAAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGA
GTAGGGCTACCCACTTGCTACAATGGCGCAAACAAAGAGAGCGACCTCGC 
 
Page | 130  
 
 
Figure 4. 30: Consensus region obtained for the yellow isolated colony of B. dalzielii  
 
 
Figure 4. 31: Consensus sequence obtained for the yellow isolated colony of B. dalzielii with 993 
bases 
The consensus regions obtained for both the white (Figure 4.28 and 4.29) and yellow 
(Figure 4.30 and 4.31) isolated colonies of B. dalzielii were used for NCBI Blast Search. 
The blast search for white isolated colony consensus return with 100 hits, all having 
> Consensus Yellow Colony Isolate 
GCCCAGATGGGTTAGCTTGTAGGTGGGTAACGGCTTACCTGGGGGACGATCCCTAGCTGGTTTG
AGGGGATGACCAGCCACACGGGAAATGAGACACGGTCCAGATTCCTACGGGAGGCAGCAGTGG
GGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTATGAAGAAGGCCTTCGG
GTTGTAAAGTACTTTTAGCGGGGAGGAAGGCGATGCGGTTAATAACCGCGTCGATTGACGTTAC
CCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCCAGCGTT
AATTGGAATTACTGGGCGTAAAGCGCACGCCGGCGGTCTGTCAAGTTGGATGTGAAATCCCCGG
GCTTAACCTGGGAACTGCATTCGAAACTGGCCGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCC
AGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGA
CAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCA
CGCCGTAAACGATGTCGACTTGGAGGCTGTTTCCTTGAGAAGTGGCTTCCGGAGCTAACGCGTTA
AGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCAC
AAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTACTCTTGACATCCAG
AGAACTTTCCAGAGATGCATTGGTGCCTTCGGGAACTCTGAGACAGGTGCTGCATGGCTGTCGTC
AGCTCGTGTTGTGAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAG
CGATTCGGTCGGGAACTCAAAGGAGACTGCCGGTGATAAACCGGAGGAAGGTGGGGATGACGT
CAAGTCATCATGGCCCTTACGAGTAGGGCTAC 
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100% query cover, 0.0 E value and 99% identity (Figure 4.32), mostly with Enterobacter 
species. No hit returned with a 100% similarity suggesting that the isolated sequence 
has not been submitted for this bacteria strain. 
 
Figure 4. 32: NCBI Blast Search for white isolated colony obtained from B. dalzielii 
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Taxonomy and lineage report was generated to select the most frequent organism 
similar to the white isolated colony (Table 4.1). The report showed that white colony 
isolate of B. dalzielii is suspected to belong to the family Enterobacteriaceae, having 105 
hits across 43 organisms; and belongs to the genus Enterobacter with 102 hits across 40 
organisms. The white colony isolate is suspected to belong to the Enterobacter cloacae 
complex, having 45 hits across 6 organisms belonging to the Enterobacter cloacae 
complex, with predominant hits (24) to Enterobacter cloacae. Each of the 24 hits has 
different accession number and submitted by different authors, thus implicating the 
possibility of the white isolated colony obtained from B. dalzielii as Enterobacter cloacae, 
as it has a maximum score of 1827 (Table 4.1).  Thus, the sequence was deposited in the 
GenBank database under the accession number MH764584 
(https://www.ncbi.nlm.nih.gov/nuccore/mh764584). 
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 Taxonomy Number of hits 
Number of 
Organisms Score 
Kingdom Bacteria  107 44  
Family Enterobacteriaceae 105 43  
Genus Enterobacter 102 40  
Species Enterobacter cloacae complex 45 6  
Organisms 
Enterobacter cloacae 24 1 1827 
Enterobacter hormaechei 12 3 1821 
Enterobacter cancerogenus 4 1 1821 
Enterobacter xiangfangensis 3 1 1821 
Enterobacter hormaechei subsp. 
Steigerwaltii 1 1 1827 
Enterobacter hormaechei subsp. 
Oharae 1 1 1823 
Table 4. 1: Taxonomy and lineage report of white colony isolated from B. dalzielii 
The blast search for the yellow isolated colony consensus return with 97 hits with 100% 
query cover and 0.0 E value, however, only 47 of these hits have 98% identity with the 
query submitted. And the hit with the maximum and total scores of 1736 is the Pantoea 
spp (Figure 4.33).  
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Figure 4. 33: NCBI Blast Search for yellow isolated colony obtained from B. dalzielii 
Taxonomy and lineage report was generated to select the most frequent organism 
similar to the yellow isolated colony (Table 4.2). The report showed that the yellow 
colony isolate of B. dalzielii is suspected to belong to the class Gammaproteobacteria, 
having 48 hits across 26 organisms; and belonging to the genus Pantoea with 25 hits 
across 9 organisms. From the NCBI blast result, the specific identity of the yellow isolated 
colony of B. dalzielii was inconclusive, however, it is confirmed that it is suspected to be 
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a Pantoea spp. Thus, the sequence was deposited in the GenBank database under the 
accession number MH764583 (https://www.ncbi.nlm.nih.gov/nuccore/MH764583). 
 Taxonomy Number of hits 
Number of 
Organisms Score 
Kingdom Bacteria  109  33  
Class Gammaproteobacteria 48 26  
Order Enterobacterales 46 24  
Family Erwiniaceae 26 10  
Genus Pantoea 25 9 1736 
Organisms 
Pantoea sp. FF5 1 1 1725 
Pantoea sp. 6 1 1725 
Pantoea septica 8 1 1724 
Pantoea stewartii 1 2 1720 
Pantoea agglomerans 3 1 1720 
Table 4. 2: Taxonomy and lineage report of yellow colony isolated from B. dalzielii 
PCR analysis of the 16S RNA region showed that the AP1 20E biochemical analysis is not 
a sensitive test for identification micro-organisms. However, the test did show that the 
yellow isolate identified as Pantoea spp. via 16S RNA analysis had 0.2% identity with 
Pantoea spp 3 (Figure 4.26). 
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 BACTERIUM RESPONSIBLE FOR THE PRODUCTION OF PYROGALLOL 
 
 
Figure 4. 34: Inoculated sterile aqueous plant extract of B. dalzielii with isolated bacteria 
(Pantoea spp. and E. cloacae) 
HPLC chromatogram (Figure 4.35) showed that Pantoea spp. utilises the extract (Figure 
4. 34) in producing a compound with a retention time of 12.78 while the compound with 
the retention time of 9.3 is seen to have decreased peak high in the presence of the 
bacteria. 
 
Figure 4. 35: Sterile plant extract inoculated with Pantoea spp. isolated from B. dalzielii 
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Figure 4. 36: Sterile plant extract inoculated with E. cloacae isolated from B. dalzielii 
Figure 4.36 above showed that the E. cloacae utilises the extract in producing pyrogallol 
with a retention time of 5.8, which is similar to the retention time of standard pyrogallol 
purchased from Sigma Aldrich, see Figure 4.2.  
 
Figure 4. 37: Comparing sterile plant extract inoculated with bacteria isolated from B. dalzielii  
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HPLC analysis (Figure 4.37) showed that the difference between sterile plant extract 
inoculated with the Pantoea spp. with that inoculated with E. cloacae is the presence of 
pyrogallol peak in the HPLC chromatogram depicted blue. The bacteria E. cloacae was 
shown to be responsible for the conversion of gallic acid to pyrogallol.  
 CONVERSION OF GALLIC ACID TO PYROGALLOL   
The absorbance recorded for the suspensions used for the bioconversion are 0.100 and 
0.099 Thin layer chromatography analysis detected the presence of pyrogallol in both 
samples.  2µg of gallic acid and pyrogallol was spotted as references while 2µl of sample 
was spotted for every specific hour samples (Figure 4.38). Figure 4.38A is an image of 
TLC chromatogram under short wavelength showing samples collected from inoculum 
with the absorbance of 0.099 at specific hour(s) of zero, six, 12, 18 and 24. Pyrogallol (Rf 
value = 0.54) was seen to be present in all sample inoculums with the absorbance of 
0.099 except at zero hour after spraying with vanillin reagent (Figure 4.38B). The same 
is said for Figure 4.38C, showing the presence of pyrogallol (Rf value = 0.69) in inoculum 
with the absorbance of 0.100.  
 
Figure 4. 38: TLC analysis of gallic acid conversion to pyrogallol by E. cloacae where 1 = Gallic 
acid reference standard, 2 = Mueller Hinton broth, 3 = zero hour sample, 4 = 6hours sample, 5 = 
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12 hours sample, 6 = 18hours sample, 7 = 24hours sample and 8 = pyrogallol reference 
standard.  
HPLC analysis was conducted on all samples and the amount of pyrogallol produced and 
that of gallic acid spent was calculated. From the inoculated sample with the absorbance 
of 0.099, 0.36mg/mL of pyrogallol (Figure 4.39) was produced, while 0.45 mg/mL of 
pyrogallol (Figure 4.40) was produced in the inoculated sample with the absorbance of 
0.100 after 24 hours. Thus, E. cloacae was shown to convert gallic acid to pyrogallol, and 
carbon dioxide is an addition expected product (Figure 4.41). 
 
Figure 4. 39: HPLC analysis of the bioconversion of gallic acid to pyrogallol from 0.099 sample. 
Data are presented as mean ± standard error for both compound. 
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Figure 4. 40: HPLC analysis of the bioconversion of gallic acid to pyrogallol from 0.099 sample. 
Data are presented as mean ± standard error for both compound. 
  
Figure 4. 41: Conversion of gallic acid to pyrogallol and carbon dioxide  by E. cloacae 
 
 CONCLUSION 
In the present studies, gallic acid was shown to be present in B. dalzielii which was later 
converted to pyrogallol by Enterobacter cloacae in 24hours water extract (Figure 4.41). 
This gave way to the possibility that in poor tropical regions where cooling facilities are 
rare, plant extract macerated for more than six hours could contain microbial metabolite 
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and the phytochemical profile may change dramatically over time, therefore, the 
ethnopharmacological claims of a plant could be misleading.   
E. cloacae belongs to the genus Enterobacter and family Enterobacteriaceae which are 
facultative anaerobic Gram-negative bacteria. This micro-organism is found in terrestrial 
and aquatic environments (Hoffmann and Roggenkamp, 2003). The strains of E. cloacae 
are known as commensal microflora in human and animal intestinal tract. These strains 
also play a pathogenic role in plants, insects and humans. E. cloacae is reported as an 
important nosocomial pathogen and is responsible for lower respiratory tract, urinary 
tract, endocarditis, soft tissue and skin infection (Sanders and Sanders, 1997; Lee et al., 
2002). Enterobacter species were reported to bio-convert glycerol and 2,3-butanediol 
to ethanol and diacetyl by E. aerogenes and E. cloacae, respectively (Nwachukwu et al., 
2012; Zhang et al., 2015).  In 1985, Yoshia and Yamada reported the production of 
pyrogallol via the decarboxylation of gallic acid by Citrobacter spp. (Yoshida and Yamada, 
1985). Similarly, pyrogallol production from gallic acid by Enterobacter spp. was also 
reported  (Soni, Sharma and John, 2012), however, both studies were specifically 
designed to study said bioconversion. More so, E. cloacae was shown to biodegrade 
hexahydro-1,3,5-trinitro-1,3,5-s-triazine using a two-phase partitioning bioreactor 
(Pudge, Daugulis and Dubois, 2003).  
In addition, another micro-organism isolated and identified in the bioburden of B. 
dalzielii aqueous extract is Pantoea spp. This strain belongs to the genus Pantoea which 
are rod shaped Gram-negative bacteria. Pantoea spp was reported to have been isolated 
from terrestrial and aquatic environment and also associate with animals, insects and 
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humans (Walterson and Stavrinides, 2015). Some of the species are plant pathogens, for 
example P. agglomerans, P. stewartii and P. ananatis (Roper, 2011; Nadha et al., 2012). 
Presently, Pantoea species are considered problematic due to their pathogenic role in 
both immunocompetent and immunocompromised patients. These species are 
reported to cause osteomyelitis, bacteremia, septicemia and septic arthritis among 
others (Walterson and Stavrinides, 2015). The Pantoea species isolated was shown to 
lack the decarboxylation of gallic acid property associated with E. cloacae. However, 
another Pantoea species, P. agglomerans, was reported to decarboxylate gallic acid to 
pyrogallol (Zeida et al., 1998). 
In conclusion, the biotransformation of gallic acid to pyrogallol was studied first in the 
plant extract via inoculating sterile aqueous extract of B. dalzielii obtained from six hours 
maceration. This was further confirmed by using purchased gallic acid 0.15% in Mueller 
Hinton broth then observing its biotransformation by E. cloacae at time interval with the 
aid of HPLC analysis. To the best of the author`s knowledge, this is the first work 
reporting the presence bioconversion of gallic acid to pyrogallol by E. cloacae in aqueous 
extract of B. dalzielii. 
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5  
CYTOTOXICITY SCREENING OF Boswellia dalzielii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Cancer is the name given to a collection of related diseases. In all 
types of cancer, some of the body`s cells begin to divide without 
stopping and spread into surrounding tissues.” 
- National Cancer Institute, 2018 
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ABSTRACT 
The activity-guided fractionation of aqueous Boswellia dalzielii bark extract against 
breast cancer cell line (MCF7) was conducted using MTT cytotoxicity assay and MCF10A 
was used as control. The crude extract of B. dalzielii was observed to have reduced cell 
viability to 87%, however, crude extract of five plant combination including Spondias 
Mombin, Detarium microcarpum, Sclerocarya birrea, Vitellaria paradoxa and B. dalzielii 
reduced cell viability to 68%. Moreover, 24 hours aqueous extract of B. dalzielii was 
shown to reduced cell viability to 45% and bioactivity-guided fractionation resulted in 
the identification of a cytotoxic compound, catechol, which was identified using HPLC, 
TLC, NMR, FTIR and HRMS. The half maximal effective concentration (EC50) of catechol 
against MCF7 cell line was 86µM. The growth inhibition effect of catechol was observed 
to be time- and concentration- dependent.  
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 INTRODUCTION 
This chapter will discuss the cytotoxicity screening of B. dalzielii bark on MCF-7 breast 
cancer cell using MCF-10A human breast epithelial cell line as control. This chapter will 
focus on the bioactivity guided fractionation of aqueous extract of Boswellia dalzielii. 
The rationale used in this chapter looks at how the plant material is used locally from 
the researcher`s knowledge. Water is used as solvent, mostly either by decoction or cold 
maceration. In this study, boiled and cold macerated samples were tested for cytotoxic 
effects. The plant is also used in combination with other plants and these combinations 
vary to different herbal practitioners and regions. 
From the researcher’s experience, there are different ways of preparing B. dalzielii which 
include using powdered stem bark in custard, cold maceration of whole stem bark in a 
container and preserving in the refrigerator and decoction i.e. boiling stem bark for 
about an hour to three hours. The plant bark is also used in combination with other 
plants including Spondias Mombin, Detarium microcarpum, Sclerocarya birrea and 
Vitellaria paradoxa. In this studies, MTT assay was used for the screening of plant bark 
of B. dalzielii, S. Mombin, D. microcarpum, S. birrea and V. paradoxa alone and in 
combination. 
 METHOD  
 HANDLINGS OF CELL LINES  
MCF7 were maintained in DMEM containing 10% fetal bovine serum (FBS). MCF10A 
were maintained in DMEM/F12 containing the following supplements 10% FBS, 
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20ng/mL of EGF, 10µg/mL of insulin and 0.5mg/mL of Hydrocortisone. For both MCF7 
and MCF10A, culturing conditions include 5% CO2, 95% air and 37°C. Cultured cells are 
passaged at 70-80% confluence every 2-4 days depending on culture flasks. Trypan blue 
dye exclusion was used to determine the number of viable cells on haemocytometer 
with the aid of an inverted microscope.  
In all assays conducted, the percentage final concentration of DMSO was < 0.2% v/v as 
recommended by the National Cancer Institute (NCI) (Selby et al., 2017). In terms of 
sample concentration, although 15µg/mL is recommended by NCI for first single dose 
concentration (NCI, 2015), 10µg/mL was used in the present studies making the 
screening stringent.  
 SELECTION OF WAVELENGTH  
200µL of different cell density of MCF7 including 5×103, 1×104, 1.5×105, 2×105 and 
2.5×105, cells/mL were seeded in 96-well plates in triplicate. The plate was incubated for 
12 hours to allow adherence of cells at 37°C in a humidified 5% CO2/95% air incubator. 
After cells adherence, media was suctioned out and 200µL of complete media was 
added and the plate was incubated for 24 hours at 37°C in a humidified 5% CO2/95% air 
incubator. After 24 hours, all media was suctioned out, 180µL of complete media was 
added to sample wells and 20µL of MTT 5mg/mL in PBS was added, then the plate was 
incubated for two hours. After two hours, media was suctioned out and 150µL DMSO 
was added to sample wells to solubilise generated formazan product. The plate was 
further incubated for 15 minutes and absorbance was measured with the aid of GloMax 
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microplate reader at 560nm and 600nm. Graph was plotted to select wavelength for 
subsequent experiments. Experiment was three independent studies and paired t-test 
was conducted. 
 MTT ASSAY 
200µL of cell (1×104cells/mL) were seeded in 96-well plates in triplicate. The plates were 
incubated for 12 hours to allow adherence of cells at 37°C in a humidified 5% CO2/95% 
air incubator. After cells adherence, media was suctioned out and 180µL of complete 
media was added, then 20uL of 10µg/mL samples in 0.1% DMSO was added to test wells, 
control wells were treated with 0.1% DMSO and blank with complete media.  The 
procedure was continued as stated in section 5.2.2 and absorbance was measured at 
560nm. % Cell viability was calculated using the formula:  
% 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑣𝑐𝑐𝑣𝑣𝑣𝑣𝑦𝑦 = (𝐴𝐴𝑇𝑇 − 𝐴𝐴𝐵𝐵)/(𝐴𝐴𝐶𝐶 − 𝐴𝐴𝐵𝐵) × 100 
Where AT represents the absorbance value of tested samples/compound, AB represents 
the absorbance value of blank and AC represents the absorbance value of control. 
Experiment was three independent studies. Tested sample(s) is/are considered 
potentially cytotoxic if the mean cell viability is reduced to <70% when compared to 
control. Thus, data obtained were only presented as mean ± standard error of mean 
(SEM). 
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 EXTRACTION PROCEDURE WITH BETTER ACTIVITY  
Two extraction procedure including Acid Based Extraction (ABE) and Acid Hydrolysis (AH) 
were employed to determine fractions with cytotoxicity activity against MCF7.  
5.2.4.1 Acid hydrolysis 
20 grams of plant bark of B. dalzielii was boiled in 200mL of distilled water for two hours. 
The sample was filtered using a Büchner funnel with Whatman Nr 1 filter paper and 
filtrate obtained was divided into two equal portions labelled portion A and portion B. 
Portion A was fractionated with ethyl acetate (3×20mL) with the aid of a separating 
funnel (Figure 5.1). The crude fraction obtained was dried on a rotary evaporator at 40°C 
and labelled non-hydrolysed, then stored in the refrigerator. 
 
Figure 5. 1:  Non hydrolysed procedure 
Whilst portion B was acidified with concentrated hydrochloric acid (HCL) to obtain 2M 
solution and heat was applied for 30 minutes (Figure5 .2).  With the aid of a separating 
funnel, ethyl acetate (3×20mL) was used in collecting organic compounds. The crude 
fraction obtained was dried on a rotary evaporator at 40°C and labelled as acid 
hydrolysed, then stored in the refrigerator. 
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Figure 5. 2: Acid hydrolysis procedure 
5.2.4.2 Acid base extraction 
The method of Sharma et al., (2016) was modified to collect organic acids present in 
plant bark of B. dalzielii. 10 grams of plant bark of B. dalzielii was boiled in 100mL of 
distilled water for two hours. The sample was filtered using a Büchner funnel with 
Whatman Nr 1 filter paper and adjusted to 3% sodium hydroxide (NaOH) solution, then 
the non-acidic part was collected by fractionating with ethyl acetate. The water fraction 
was acidified with 1N HCL and ethyl acetate and butanol were used to collect organic 
acid (3×20mL) (Figure 5.3). Samples collected were appropriately labelled and stored in 
the refrigerator.  
 
Figure 5. 3:  Acid base extraction procedure 
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10mg in 1mL DMSO of samples collected from both extraction procedures were 
prepared as stock solutions. 100µg/mL of prepared samples were used as working 
solution and the final concentration of sample tested on MCF7 cells is 10µg/mL for 24 
hours using the method outlined in section 5.2.3.  
 CYTOTOXICITY ACTIVITY OF FIVE PLANTS 
 
Plant bark of B. dalzielii is ethno-pharmacologically used alone and also in combination 
with other plants, an example of such combination include Spondias Mombin, Detarium 
microcarpum, Sclerocarya birrea and Vitellaria paradoxa for treatment of cancer with 
rashes symptoms. Thus, the cytotoxicity of each of the five plants alone was conducted 
using MTT assay. Samples were prepared for each of the five plant barks using the 
method outlined in section 5.2.4.1. To test the activity of the plants in combination, two 
grams of each of the five plant barks was measured and combined to give a total of 10 
grams, then the sample was also subjected to the procedure outlined in section 5.2.4.1. 
Also, the water fraction of the combined fraction was also prepared.  
10mg in 1mL DMSO of samples collected from both non-hydrolysed and hydrolysed 
samples were prepared as stock solutions. 100µg/mL of prepared samples were used as 
working solution and the final concentration of sample tested on MCF7 cells is 10µg/mL 
for 24 hours using the method outlined in section 5.2.3.  
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 BIOACTIVITY GUIDED FRACTIONATION OF ACID HYDROLYSED SAMPLE 
OF B. dalzielii  
10 grams of plant bark of B. dalzielii was boiled in 100mL of distilled water for two hours 
and acid hydrolysed using procedure outlined in section 5.2.4.1. However, only the ethyl 
acetate fraction (0.56g) of the acid hydrolysed portion was used for column 
chromatography (CC). CC was performed using hexane and ethyl acetate in an equal 
ratio (1:1) and four fractions were collected. 10mg in 1mL DMSO of fractions obtained 
were prepared as stock solutions. 100µg/mL of prepared samples were used as working 
solution and the final concentration of sample tested on MCF7 cells is 10µg/mL for 24 
hours using the method outlined in section 5.2.3. 
 CYTOTOXICITY ANALYSIS OF 24 HOURS AQUEOUS EXTRACT OF B. 
dalzielii  
10 grams of plant bark of B. dalzielii was macerated in 100mL of sterile distilled water 
for 24 hours at 37°C. Separating funnel was used to collect organic compound using 
hexane and ethyl acetate. Samples collected were dried on a rotary evaporator at 40°C, 
labelled properly and stored in the refrigerator. Another 10 grams of plant bark of B. 
dalzielii was boiled in 100mL of distilled water for two hours and the sample was 
subjected to acid hydrolysis using the method outlined in section 5.2.4.1. However, the 
acidified sample was subjected to fractionation using hexane and ethyl acetate 
(3×20mL). 10mg in 1mL DMSO of samples obtained from both 24 hours maceration and 
acid hydrolysis were prepared as stock solutions. 100µg/mL of prepared samples were 
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used as working solution and the final concentration of sample tested on MCF7 cells is 
10µg/mL for 48 hours using the method outlined in section 5.2.3. 
 CYTOTOXICITY ANALYSIS OF OLD AND NEW BATCHES OF B. dalzielii 
10 grams of plant bark of B. dalzielii (both old and new batch) was macerated in 100mL 
of sterile distilled water for 24 hours at 37°C. Separating funnel was used to collect 
organic compound using hexane and ethyl acetate. The samples collected were dried on 
a rotary evaporator, labelled properly and stored in the refrigerator. 10mg in 1mL DMSO 
of samples obtained from both old and new batches of B. dalzielii were prepared as 
stock solutions. 100µg/mL of prepared samples were used as working solution and the 
final concentration of sample tested on MCF7 cells is 10µg/mL for 48 hours using the 
method outlined in section 5.2.3. In addition, thin layer chromatography was conducted 
using hexane and ethyl acetate (70:30) as the mobile phase to compare hexane fraction 
of both old and new batches of B. dalzielii. 
 BIOACTIVITY GUIDED FRACTIONATION OF 24 HOURS AQUEOUS 
SAMPLE OF B. dalzielii  
10 grams of plant bark of B. dalzielii was macerated in 100mL of distilled water for 24 
hours in 100mL of sterile distilled water for 24 hours at 37°C. Separating funnel was used 
to collect organic compound using hexane (3×20mL) and the sample collected was dried 
on a rotary evaporator at 40°C. 0.38g crude extract was collected and column 
chromatography was conducted using hexane and ethyl acetate (70:30) as solvent and 
five fractions were collected. 10mg in 1mL DMSO of fractions obtained were prepared 
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as stock solutions. 100µg/mL of prepared samples were used as working solution and 
the final concentration of sample tested on MCF7 cells is 10µg/mL for 48 hours using 
the method outlined in section 5.2.3. The fraction with activity was purified and the 
active compound was identified using the methods outlined in Chapter three, section 
3.2.2. 
 HALF MAXIMAL EFFECTIVE CONCENTRATION (EC50)  
Different concentration of identified compound was prepared including 12.5, 10, 7.5, 5 
and 2.5µg/mL from a stock solution of 10mg in 1mL DMSO. Prepared samples were 
tested on MCF7 and MCF10A cells for 24, 48 and 72 hours. Control samples were treated 
with 0.125% DMSO and blank with complete media. Experiment was conducted using 
the method outlined in section 5.2.3. 
 RESULTS AND DISCUSSION 
 WAVELENGTH SELECTION 
The device GloMax microplate reader lacks absorbance selection of 570nm, the 
wavelength recommended for spectrophotometric measurement of the dark blue 
formazan product of MTT (Mosmann, 1983). Thus, screening was conducted to select 
the wavelength for the measurement of MTT formazan product. Figure 5.4 shows that 
in the absence of 570nm, 560nm is a better wavelength than 600nm on the GloMax 
microplate reader and P-value obtained was 0.0006 predicting a difference between the 
two wavelengths. Thus, 560nm was used in subsequent assays. 560nm was also used in 
the MTT assay cytotoxicity screening of different leaves extracts of Ricinus communis 
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against human Caucasian skin fibroblast and macrophage cell lines (Nemudzivhadi and 
Masoko, 2014). 
 
 
Figure 5. 4: Wavelength selection for MTT assay (p<0.05) and data are mean ± SEM 
 
 EXTRACTION PROCEDURE WITH BETTER ACTIVITY  
In the selection of the extraction techniques that will lead to the extraction of potential 
cytotoxic compounds, crude extracts obtained via acid hydrolysis and acid base 
extraction techniques were used. Although 10µg/mL of extracts obtained via acid base 
extraction of B. dalzielii has no cytotoxic effect on MCF7 cells, 10µg/mL of the acid 
hydrolysed extract of B. dalzielii reduced viability to 85% (Figure 5.5). Thus, acid 
hydrolysis was selected as the extraction procedure used in subsequent screening 
assays. 
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Figure 5. 5: Percentage cell viability of acid hydrolysed and acid base extraction extracts of B. 
dalzielii tested against MCF7. Data are presented as mean ± SEM. 
 
 CYTOTOXICITY ACTIVITY OF FIVE PLANTS 
To test the cytotoxic effect of plant combination on MCF7 cells, individual plants were 
first acid hydrolysed and tested on MCF7 cells, before testing the cytotoxic effect of the 
acid hydrolysed extract of the combined plants. Result obtained showed that none of 
the plants reduced the viability of MCF7 to <70%, however, the crude extract of B. 
dalzielii was seen to reduce cell viability to 87% (Figure 5.6). An equal amount of the five 
plants was tested in combination and cell viability was reduced to 68% (Figure 5.7). 
Similarly, the dichloromethane extract of S. mombin was reported to exhibit poor 
antiproliferation activity against oral (KB), breast (MCF7), cervical (C-33A) and lung 
(A549) cancer cell lines at a concentration of 50 µg/mL (Akinmoladun et al., 2015); and 
the extracts (hexane, dichloromethane, ethanol and water) of D. microcarpum was 
shown to have no cytotoxic activity against breast (MCF7), lung (A549), leukaemia (HL-
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60), hepatocarcinoma (SMMC-7721) and colon (SW480) (Iweala et al., 2015). Also, the 
water extract of S. birrea was shown to have no cytotoxic effect on not only MCF7 but 
also Hela and HT29 cancer cells (Tanih and Ndip, 2013). 
 
Figure 5. 6: Percentage cell viability of each of the five plants, showing that the acid hydrolysed 
extract has better cytotoxicity activity than the non-hydrolysed extract except for V. paradoxa 
where the non-hydrolysed extract was seen to have better activity. Data are presented as mean 
± SEM. 
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Figure 5. 7: Percentage cell viability of the combined plant bark material, showing that the 
hydrolysed extract of the combined plants reduced cell viability to 68%. Data are presented as 
mean ± SEM. 
 BIOACTIVITY GUIDED FRACTIONATION OF ACID HYDROLYSED SAMPLE 
OF B. dalzielii  
The fractions obtained were dried on a rotary evaporator and extract yield obtained 
include 65.6mg, 27.8 mg, 25.2 mg and 31.5mg for fraction A, B, C and D, respectively. 
Fractions were tested, however, the cytotoxicity activity associated with the plant 
(Figure 5.6) was lost after fractionation (Figure 5.8). This loss in activity could be due to 
the minimum amount of the potential cytotoxic component in the extract, which could 
be remedied by increasing the concentration of tested extract in the initial screening. In 
addition, the activity observed could be due to the interaction(s) between compounds 
present in the plant crude extract.  
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Figure 5. 8: Percentage cell viability of fractions obtained after column chromatography. Data 
are presented as mean ± SEM. 
 CYTOTOXICITY ANALYSIS OF 24 HOURS AQUEOUS EXTRACT OF B. 
dalzielii  
The hexane fraction of 24 hours aqueous extract decreases cell viability to 62% after 
exposure for 48 hours (Figure 5.9). In comparison, the boiled sample was seen to lose 
activity, again this could be as a result of splitting the crude sample into hexane and 
ethyl acetate fraction.  This result showed that the hexane extract obtained from 24 
hours macerated aqueous extract has better activity than the boiled aqueous extract. 
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Figure 5. 9: Percentage cell viability of fractions obtained from boiled aqueous and 24 hours 
cold macerated aqueous extracts. Data are presented as mean ± SEM. 
 
 CYTOTOXICITY ANALYSIS OF OLD AND NEW BATCHES OF B. dalzielii 
Due to shortage of the B. dalzielii plant batch initially used, a new batch was procured 
and also identified as B. dalzielii. The cytotoxicity assay was conducted to compare the 
old and new plant bark of B. dalzielii, although both hexane fractions of the new and old 
batches reduced MCF7 viability, the hexane fraction of the new batch was seen to have 
better activity reducing viability to 45% (Figure 5.11). TLC analysis showed that both old 
and new batches of B. dalzielii have similar phytochemicals labelled “a” (rf value = 0.57) 
and “b” (rf value = 0.41) which are visible under the short wavelength. However, the 
new batch of B. dalzielii was seen to have an additional compound labelled “c” (rf value 
= 0.32) (Figure 5.10). 
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Figure 5. 10: TLC chromatogram showing the presence compound “a” and “b” in both old (1B) 
and new (2B) batches of B. dalzielii  
 
 
Figure 5. 11: Percentage cell viability of fractions obtained from both old (first) and new 
(second) batches. Data are presented as mean ± SEM. 
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 BIOACTIVITY GUIDED FRACTIONATION OF 24 HOURS AQUEOUS 
SAMPLE OF B. dalzielii  
The hexane fraction of 24hours aqueous extract of B. dalzielii was subjected to column 
chromatography. The fractions obtained were dried on a rotary evaporator and extract 
yield obtained include fraction A (3.6mg), B (1.7mg), C (0.98mg), D (12mg) and E (0.7mg). 
Of all the five fractions were tested on MCF7. The fractions with cytotoxicity activity are 
fraction D and E, reducing the viability of MCF7 to 50% and 74%, respectively after 48 
hours (Figure 5.12). From the TLC chromatogram, it can be deduced that the activity of 
fraction E could be due to the carryover of compound “d” present in fraction D (Figure 
5.13). 
 
Figure 5. 12: Percentage cell viability of fractions obtained from column chromatography of 
hexane fraction of 24 hours aqueous extract. Data are presented as mean ± SEM. 
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Figure 5. 13: TLC chromatogram showing of fractions A-E 
Compound labelled “d” with the rf value of 0.62 in Fraction D was further purified and 
labelled as Compound D, then submitted for identification analysis. 
 IDENTIFICATION OF COMPOUNDS D 
5.3.8.1 Fourier-transform infrared spectroscopy (FTIR) results 
Compound D and reference compound (catechol) were analysed and the result obtained 
showed similar peaks between the extracted compound and catechol. The spectra of 
purchased catechol were consistent with that extracted from plant bark of B. dalzielii, 
suggesting that compound D is catechol (Figure 5.14). Figure 5.14 shows a prominent 
peak at 1260.54 cm-1 present in both extracted and purchased catechol. Although the 
whole spectrum was not provided, both extracted and purchased catechol were further 
analysed using NMR and HRMS analysis to further confirm the identity of compound D. 
Page | 163  
 
 
Figure 5. 14: FTIR spectrum of catechol overlaying that purchased from Sigma Aldrich. 
 
5.3.8.2 Nuclear magnetic resonance (NMR) results 
NMR analysis was conducted using deuterated methanol for both 1H analyses using 
20mg of extracted compound D and purchased catechol. Both compounds have similar 
1H-NMR spectrum showing signals at δH 6.67 ppm (2H, ddd) and δH 6.78 ppm (2H, ddd) 
(Figure 5.15). The spectrum provided had no expected hydroxyl signals, however, the 
result obtained is similar to that reported by (Choi et al., 2018). 
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Figure 5. 15: 1H-NMR spectrum of extracted catechol is consistent with that extracted from 
plant bark of B. dalzielii. 1H-NMR spectrum was obtained using bruker av400 spectrometer at 
399.94 MHz using deuterated methanol. 
5.3.8.3 High resolution mass spectrometry (HRMS) results 
5mg of compound D plus respective reference (catechol) were used for HRMS which was 
conducted at EPSRC National Facility Swansea. Results showed that observed mass of 
compound D was measured as Mw 110 [C6H6O2]; MS, m/z [E1-, %], 109.0295 (M-H, 
100%) (See Figure 5.16) and predicted molecular composition was C6H5O2.  
Page | 165  
 
 
Figure 5. 16: HRMS spectrum of Compound D and purchased catechol suggesting that 
extracted compound D might be catechol 
 HALF MAXIMAL EFFECTIVE CONCENTRATION (EC50) 
The cytotoxic effect of catechol was conducted on MCF7 at various hours of 24, 48 and 
72 hours and MCF10A was used as control.  A dose-response curve was generated via 
Hill equation using least squares regression to obtained EC50. Statistical analysis 
selected was non-linear regression, this is because, in ANOVA, grouping is not 
categorical thus the information that the same compound at different concentration 
was used is not recognised. And analysis of covariance was not used because it assumes 
a linear relationship between the response and covariate. However, t-test conducted 
between control containing growth media alone and control containing 0.125% DMSO 
indicated that there is no difference between the two controls (P= 0.48). 
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Figure 5. 17: Cytotoxicity effect of catechol at different concentrations tested against MCF7 
and MCF10A for 24 hours. Data are presented as mean ± SEM. 
 
 
Figure 5. 18: Cytotoxicity effect of catechol at different concentrations tested against MCF7 
and MCF10A for 48 hours. Data are presented as mean ± SEM. 
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Figure 5. 19: Cytotoxicity effect of catechol at different concentrations tested against MCF7 
and MCF10A for 72 hours. Data are presented as mean ± SEM. 
12.5ug/mL highest concentration of catechol (114µM) used in the present study showed 
cytotoxicity against MCF 7, reducing cell viability to 82%, 43% and 24% after treatment 
for 24 hours (Figure 5.17), 48 hours (Figure 5.18) and 72 hours (Figure 5.19), 
respectively, while no cytotoxicity effect was observed against MCF10A. 
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Figure 5. 20: EC50 of catechol obtained after 48 hours treatment was calculated to be 9.46 
µg/mL 
 
Figure 5. 21: EC50 of catechol obtained after 72 hours treatment was calculated to be 5.33 
µg/mL 
EC50 of catechol against MCF7 was calculated as 9.46µg/mL (86µM) after 48 hours 
treatment (Figure 5. 20) and 5.33 µg/mL (48.45 µM) after 72 hours (Figure 5. 21). In both 
48 and 72 hours studies, concentrations >2.5 µg/mL where seen to reduce MCF7 cell 
viability to <70% with 12.5 µg/mL reducing viability to 43% and 28%. Overall, the analysis 
showed that the activity of catechol is time and concentration dependent. The study of 
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Wellington et al., 2013 reported that catechol has a weak anticancer activity on MCF7 
with GI50 of 52.41µM after 48 hours treatment whereas Madrid Villegas et al., 2011 
reported IC50 of 98.4µM for catechol against MCF7 after 72 hours treatment. In addition, 
catechol was shown to inhibit Breast cancer cells (MCF7 and MDA 231-MB) in a dose-
dependent manner (Choi et al., 2018). 
 CONCLUSION 
The cytotoxicity of plants belonging to the genus Boswellia has been reported especially 
the plant, Boswellia serrata. B. serrata crude extracts and compounds mostly boswellic 
acids associated with cytotoxicity properties are collected using organic solvents 
(Bhushan et al., 2007; Farajian Mashhadi et al., 2016; Khan et al., 2016; Rajabian et al., 
2016). In the present studies, water was used as the extraction solvent and crude 
extracts from different extraction procedures were tested. The acid based extraction 
method was used because it is one of the method used to collect total organic acids 
(Sharma et al., 2016). Whilst, hydrolysis is used to separate aglycones from glycones 
(Nikolic, Stankovic and Markovic, 2005; Stalikas, 2007; Rivelli et al., 2011). In the present 
study, B. dalzielii extract obtained via acid based extraction was shown to have no 
cytotoxicity effect on MCF7 cell line. However, that obtained via acid hydrolysis was 
shown to have reduced cell viability to 85%. Furthermore, using the four other plants in 
combination with B. dalzielii decreased cell viability to 68% suggesting that the mixture 
has potential cytotoxic effect compare to the individual plants, as seen in Figure 5.6 and 
5.7.  
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The B. dalzielii crude extract with better cytotoxicity activity was that obtained from 24 
hours maceration, reducing MCF7 viability to 45% after 48 hours treatment. Column 
chromatography of this extract resulted in the collection of five fractions (A-E), from 
which fraction D had the best cytotoxicity effect by reducing cell viability of MCF7 to 
50%. The prominent compound present in this fraction was identified as catechol and 
EC50 obtained against MCF7 after 48 hours and 72 hours was 9.46µg/mL (86µM) and 
5.33µg/mL (4.8µM), respectively. This result suggested that the cytotoxic effect of 
catechol on MCF7 is time-dependent.  Figure 5.17, Figure 5.18 and Figure 5.19 suggested 
that the effect of catechol is also concentration dependent. 
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6  
BIOCONVERSION OF PROTOCATECHUIC ACID 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Examining this water...I found floating therein divers earthy particles, and 
some green streaks, spirally wound serpent-wise...and I judge that some of 
these little creatures were above a thousand times smaller than the smallest 
ones I have ever yet seen, upon the rind of cheese, in wheaten flour, mould, 
and the like.” 
– Antonie van Leeuwenhoek 1632 – 1723 
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ABSTRACT 
The role of endophyte was investigated on aqueous extract of Boswellia dalzielii bark 
used in cytotoxicity studies (Chapter five). Results obtained led to the isolation and 
identification of Klebsiella pneumonia B, Klebsiella pneumonia E and Pantoea 
agglomerans. However, only the isolated strains of K. pneumonia bioconverted 
protocatechuic acid to catechol and carbon dioxide. In addition, E. cloacae isolated in 
chapter four was also seen to bioconvert protocatechuic acid to catechol.  Furthermore, 
Klebsiella pneumonia B and Klebsiella pneumonia E were also capable of bioconverting 
gallic acid to pyrogallol and carbon dioxide. The 16S rRNA sequences of Klebsiella 
pneumonia B, Klebsiella pneumonia E and Pantoea agglomerans are deposited in the 
GenBank nucleotide database under the accession number MH762022, MH762023 and 
MH762024, respectively.  
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 INTRODUCTION 
Cytotoxicity screening conducted in Chapter Five showed that 24hours aqueous extract 
of B. dalzielii bark has cytotoxic effect when compared to boiled aqueous extract. The 
compound with cytotoxic effect was isolated and identified as catechol. Thus, the source 
of catechol need to be determined and to achieve this, a series of analyses need to be 
conducted. From previous chapter (Chapter Four), results obtained showed that 
pyrogallol was a product of bioconversion of gallic acid by suspected bacteria 
Enterobacter cloacae, thus experiment will be designed to verify the implication of 
microorganisms in 24hours aqueous extract of B. dalzielii bark. This will commence with 
isolating microorganisms present on the bark of B. dalzielii, which will be followed by 
observing the effect of isolated microorganism on sterile aqueous extract of B. dalzielii 
bark. It is noteworthy to mention that the plant material used for cytotoxicity screening 
was a new batch of B. dalzielii bark obtained from the same region as the previous batch 
used for antimicrobial screening (Chapter Three) and it was also identified at the same 
herbarium at Ahmadu Bello University, Zaria, Kaduna State Nigeria.   
 METHODS 
 ISOLATION OF MICROORGANISMS  
The method detailed in Chapter Four section 4.2.3 was used and samples were labelled 
B1, B2 and B3.   
Page | 174  
 
 EFFECT OF ISOLATED MICROORGANISMS ON AQUEOUS EXTRACT OF 
B. dalzielii  
10g of the plant bark of B. dalzielii was macerated in 100mL of sterile distilled water in 
a sterile 100mL bottle. The sample was placed on a mechanical shaker at 100RPM at 
room temperature for six hours. The sample was then sterilized using 0.2 micron 
Whatman sterile filter paper. 10mL of sterile aqueous extract was then transferred into 
six 50mL sterile sample bottles labelled control (reference), A, B, C, D, and E. And 
samples were inoculated with respective isolated microorganisms labelled A, B, C, D and 
E. Inoculated samples and control sample were incubated at 37°C overnight. TLC analysis 
was conducted on silica plate using hexane and ethyl acetate (50:50) plus a drop of 
formic acid and the analysis was repeated using hexane and ethyl acetate (70:30) as 
eluent and catechol as the reference compound. TLC chromatogram was treated with 
vanillin spray reagent to visualise compounds as mentioned in Chapter Four section 
4.2.4.1. In addition, previously isolated and identified compounds (gallic acid and 
pyrogallol) in chapter three were also used as compound references. Affected samples 
and 1mg/ml of compound references and compound 3 were further analysed on HPLC 
using method outlined in Chapter Four section 4.2.1.2, however, HPLC column used was 
Kinetex C18 (250 ×4.6mm) and run time was 15minutes.  
The main affected compound was obtained via column chromatography using hexane 
and ethyl acetate in a ratio of 50:50. Isolated compound was then identified using 
methods mention in Chapter Three section 3.2.2. 
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 IDENTIFICATION OF BACTERIA SPECIES  
Isolated microorganisms were used for gram staining, MacCONKEY agar plating and PCR 
analysis as detailed in Chapter Four sections 4.2.6.1, 4.2.6.3 and 4.2.8. 
 CONVERSION OF PROTOCATECHUIC ACID TO CATECHOL AND GALLIC 
ACID TO PYROGALLOL 
The conversion was conducted using method detailed in Chapter Four section 4.2.10., 
0.1% protocatechuic acid was prepared in sterile Mueller Hinton broth and three sterile 
bottles containing 10mL of 0.1% protocatechuic acid Mueller Hinton broth was 
inoculated with isolated Klebsiella pneumonia B, Klebsiella pneumonia E and E. cloacae, 
respectively. Similarly, 0.1% gallic acid prepared in sterile Mueller Hinton broth was also 
subjected to bioconversion by isolated Klebsiella pneumonia B and Klebsiella pneumonia 
E. All experiments were conducted in duplicate.  
HPLC analysis was conducted as detailed in Chapter Four section 4.2.10., however, HPLC 
column used was Kinetex 5µm C18 (250 × 4.6mm), 15minutes run time and binary 
solvent system used as mobile phase consisted of 0.1% acetic acid in water and 0.1% 
acetic acid in acetonitrile (95/5, v/v).  
 RESULTS AND DISCUSSION 
 ISOLATION OF MICRO-ORGANISMS 
Microbial growth was visible for all samples grown on all Mueller Hinton agar plate and 
five dominant colonies were observed on the plates (Figure 6.1). These organisms were 
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labelled colony A, B, C, D and E (Figure 6.2). Isolated colonies were further plated out to 
ensure that they are all single colonies, then transferred into storage vials containing 
cryopreservation beads (cryobeads) immersed in cryo-solution and stored in the freezer 
at -20oC. 
 
Figure 6. 1: Microbial colonies observed in plant bark of B. dalzielii where labelled A-E 
 
 
Figure 6. 2: Isolated microorganisms labelled A – E 
 
Page | 177  
 
 
 EFFECT OF MICRO-ORGANISMS ON AQUEOUS EXTRACT OF B. dalzielii 
6.3.2.1 TLC analysis 
 
 
Figure 6. 3: TLC chromatogram eluted with hexane and ethyl acetate (50:50) shows the 
presence of compounds in control and inoculated samples. Picture A viewed at 254nm shows 
the presence four prominent compounds labelled 2, 3 and 4 with Rf values of 0.79, 0.70, 0.42 
and 0.18. While picture B was viewed after vanillin spray treatment and two main compounds 
labelled 1 and 5 were observed, Rf values of 0.79 and 0.58 were recorded, respectively. 
TLC analysis showed that samples inoculated with isolated microorganisms A, C and D 
have similar chemical profiles (compound 2, 3 and 4) with the control sample, as seen 
in Figure 6.3. However, samples inoculated with isolated microorganisms B and E have 
different chemical profiles consisting of two prominent compounds 1 and 5, while 
compound 3 is absent in both chemical profiles, as seen in Figure 6.3. 
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Figure 6. 4: TLC chromatogram eluted with hexane and ethyl acetate (50:50 and 70:30), where 
CTL = sterile six hours aqueous B. dalzielii bark extract, G = gallic acid, B = sterile sample 
inoculated with Isolate B, P = pyrogallol, E = sterile sample inoculated with Isolate E, and Ca = 
catechol. 
Further TLC analysis was conducted with affected samples and compound references as 
seen in Figure 6.4B, where pyrogallol and catechol with Rf values of 0.64 and 0.85, 
respectively, were seen to be present in samples inoculated with Isolate B and Isolate E. 
Furthermore, gallic acid (Rf values of 0.18) was seen to be present in all samples as 
compound labelled 4, see Figure 6.4A. Figure 6.4 shows that catechol is present in 
samples inoculated with isolated microorganism B and E. Thus, TLC analysis suggested 
the involvement of microorganisms in obtaining catechol and HPLC analysis was 
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conducted to verify this claim. The affected compound in the control sample (compound 
labelled 3) was then isolated and identified. 
 ISOLATION OF COMPOUND 3  
200g of plant material was macerated in 2L of 100% water for 6hours at room 
temperature, the extract was filtered and vacuum-concentrated. The crude extract was 
washed with ethyl acetate (3×300mL) to obtained fraction 1. With the aid of 10-
40micron silica gel, fraction 1 (0.99g) was column chromatographed with Hexane: ethyl 
acetate (50:50) (Figure 6.5). Compound 3 was collected in fractions 17 – 24 and 
subjected to NMR, HRMS and FTIR analysis. 
 
Figure 6. 5: TLC chromatogram eluted with hexane and ethyl acetate (50:50) shows the 
isolated Compound 3.  Compound 3 was visible (Picture A) at 254nm while picture B was 
viewed after vanillin spray treatment and Rf value of 0.46. 
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Figure 6. 6: TLC chromatogram eluted with hexane and ethyl acetate (50:50), where GA = gallic 
acid, CTL = sterile six hours aqueous B. dalzielii bark extract, Comp3 = Isolated compound 3 and  
IsB = sterile sample inoculated with Isolate B. 
TLC analysis confirms the presences of compound 3 (Rf values of 0.45) in control samples 
and it absences in sample inoculated with Isolate B (see Figure 6.6), thus, suggesting that 
compound 3 might be crucial in the production of catechol.  
6.3.3.1 HPLC analysis 
 
 
Figure 6. 7: HPLC chromatogram of gallic acid with a retention time of 4.3 
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Figure 6. 8: HPLC chromatogram of pyrogallol with a retention time of 5.0 
 
Figure 6. 9: HPLC chromatogram of compound 3 with a retention time of 7.9 
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Figure 6. 10: HPLC chromatogram of catechol with a retention time of 11.2 
 
 
Figure 6. 11: HPLC chromatogram of sterile aqueous extract of B. dalzielii obtained after six 
hours  
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Figure 6. 12: HPLC chromatogram of sterile aqueous extract of B. dalzielii inoculated with 
Isolate B. 
 
 
 
Figure 6. 13: HPLC chromatogram of sterile aqueous extract of B. dalzielii inoculated with 
Isolate E. 
HPLC analysis (Figure 6.12 and 6.13) showed the presence of three major compounds in 
both samples inoculated with isolated microorganisms (Isolate B and Isolate E) while 
only two major compounds were observed in the untreated sample (control) (Figure 
6.11). In Figure 6.12 and 6.13, compound A has a similar retention time of 4.3 to that of 
gallic acid (see Figure 6.7), compound B has a similar retention time of 7.9 as isolated 
compound 3 (see Figure 6.9), compound C has similar retention time of 5.1 to that of 
pyrogallol (see Figure 6.8) and compound D has a similar retention time of 11.5 to that 
of catechol (See Figure 6.10).  
HPLC analysis confirmed the presence of catechol in both samples inoculated with 
isolated microorganisms Isolate B and Isolate E as shown in Figure 6.12 and 6.13, 
respectively. Also, the absence of catechol was observed in the control sample, see 
Figure 6.11. Compound 3 labelled B in Figure 6.11 with a retention time of 8.1 was 
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observed in HPLC chromatogram of control sample which is sterile aqueous extract of 
B. dalzielii bark obtained after six hours. However, a decrease in the level of compound 
3 was observed in samples inoculated with Isolate B (Figure 6.12) and Isolate E (Figure 
6.13). Thus, HPLC analysis further confirmed the involvement of compound 3 in the 
production of catechol. 
 IDENTIFICATION OF COMPOUND 3  
6.3.4.1 High Resolution Mass Spectrometry (HRMS) results 
5mg of compound 3 and respective reference (Protocatechuic acid) were used for HRMS 
which was conducted at EPSRC National Facility Swansea. Results showed that observed 
mass of Compound 3 was measured as Mw 154 [C7H6O4]; MS, m/z [E1-, %], 153.0197 
(M-H, 100%) and predicted molecular composition was C7H5O4 (Figure 6.14).  
 
Figure 6. 14: HRMS spectrum of Compound 3 and purchased Protocatechuic acid suggesting 
that extract compound 3 might be Protocatechuic acid 
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6.3.4.2 Fourier-Transform Infrared Spectroscopy (FTIR) results 
Samples analysed include extracted compound 3 and purchased protocatechuic acid 
from Sigma Aldrich. The spectra of purchased protocatechuic acid is consistent with that 
extracted from plant bark of B. dalzielii, suggesting that compound 3 is protocatechuic 
acid. Figure 6.15 shows a prominent peak at 3293.45 cm-1 present for compounds with 
hydrogen bonded alcohols/phenols in both extracted and purchased protocatechuic 
acid. 
 
 
Figure 6. 15: FTIR spectrum of protocatechuic acid overlaying that purchased from Sigma 
Aldrich. 
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6.3.4.3 Nuclear Magnetic Resonance (NMR) results 
NMR analysis was conducted with deuterated methanol for 1H analysis using 20mg of 
protocatechuic acid (extracted and purchased). 1H-NMR spectrum of protocatechuic 
acid showed signals at δH 6.82 ppm (1H, dd), δH 7.44 ppm (1H, dd) and δH 7.46 ppm 
(1H, dd) (Figure 6.16). The 1H-NMR spectrum obtained for both extracted and purchased 
protocatechuic acid is similar, suggesting that extracted compound 3 is protocatechuic 
acid. In addition, the study of Nguyen et al., 2015 reported similar 1H-NMR signals for 
protocatechuic acid. 
 
Figure 6. 16: 1H-NMR spectrum of extracted protocatechuic acid is consistent with that 
extracted from plant bark of B. dalzielii. 1H-NMR spectrum was obtained using bruker av400 
spectrometer at 399.94 MHz using deuterated methanol. 
 
 IDENTIFICATION OF MICROORGANISMS 
Isolated microorganisms A and C were unfortunately not identified with the methods 
mentioned. However, Isolate B, D and E were observed to be Gram-negative rod 
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bacteria and images were obtained using LEICA ICC50 HD microscopy at 1000 
magnification using 1.25 oil lens (Figure 6.17). MacCONKEY agar test showed that both 
isolate colony B and E were mucoid lactose fermenting (pink) bacteria while isolate 
colony D is lactose negative and had no colour (Figure 6.18). 
 
Figure 6. 17: Gram staining image of isolate B, D and E. 
 
 
Figure 6. 18: MacCONKEY agar test for Isolate B, D and E obtained from B. dalzielii bark, 
respectively. 
 
 PCR ANALYSIS 
40µL of each of the PCR products and 20 µL of both forward and reverse primer were 
submitted to Macrogen Europe Laboratory, Netherland for purification and sequencing. 
Gel results obtained was viewed in a Bio-Rad illuminator with a chemiDocXRS camera, 
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using Quantity One software. Band obtained were compared to the Bioline Easy Ladder. 
PCR products bands obtained were above DNA ladder (Figure 6.19). 
 
Figure 6. 19: Gel electrophoresis image where lane 1 is DNA ladder, lane 2 is Isolate B, lane 3 is 
Isolate D and lane 4 is Isolate E. 
The sequence of the PCR products of isolated B (Figure 6.20 and 6.21), D (Figure 6.22 
and 6.23) and E (Figure 6.24 and 6.25) bacteria were obtained for both forward and 
reverse primer were assembled on the CLC Main Workbench software and the 
consensus regions were obtained.  
 
Figure 6. 20:Consensus region obtained for Isolate B isolated from the bark B. dalzielii  
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Figure 6. 21: Consensus sequence obtained for Isolate B isolated from the bark of B. dalzielii 
with 1087 bases 
 
Figure 6. 22: Consensus region obtained for Isolate D isolated from the bark B. dalzielii  
 
 Consensus Isolate B 
CAAGACCAAAGGGGGGACCTTCGGGCCTCAAGCCTTAAGATGGCCCAGATGGGATTAGCTTGTAGGTG
GGGTAACGGCTTACCTGGGCGACGATCCCTAGCTGGTTTGAGAGGATGACCAGCCACACTGGAAATGA
GACACGGTCCAGATTCTTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGATGCA
GCCATGCCGCGTGTGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTCAGCGGGGAGGAAGGCGTTAAG
GTTAATAACCTCATCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGG
TAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCAGGCGGTCTGTCAAGT
CGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTCGAAACTGGCAGGCTAGAGTCTTGTAGAGG
GGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGG
CCCCCTGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTA
GTCCACGCCGTAAACGATGTCGATTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTT
AAATCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAG
CGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCCACAGAACTTT
CCAGAGATGGATTGGTGCCTTCGGGAACTGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGT
GAAATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTTAGGCCGGGAAC
TCAAAGGAGACTGCCAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACG
ACCAGGGCTACACACGTGCTACAATGGCATATACAAAGAGAAGCGACCTC 
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Figure 6. 23:Consensus sequence obtained for Isolate D isolated from the bark B. dalzielii with 
501 bases 
 
 
Figure 6. 24: Consensus region obtained for Isolate E obtained from bark of B. dalzielii  
 
 
 
 
> Consensus Isolate D 
GGATGAACCCAGATGGGATTAGCTTGTTGGCGGGGTAATGGCCCACCTTGGCGACGATCCCTAGCTGGTTT
GAGAGGATGACCAGCCACACTGGAAATGAGACACGGTCCAGATTCCTACGGGAGGCAGCAGTGGGGAAT
ATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCCGCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTAC
TTTCAGCGGGGAGGAAGGCGGTGAGGTTAATAACCTTGCCGATTGACGTTACCCGCAGAAGAAGCACCGG
CTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGC
GCACGCAGGCGGTCTGTTAAGTCAGATGTGAAATCCCCGGGCTTAACCTGGGAACTGCATTTGAAACTGGC
AGGCTTGAGTCTCGTAGAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAAT
ACCGGTGGC 
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Figure 6. 25: Consensus sequence obtained for Isolate E isolated from bark of B. dalzielii with 
1023 bases 
The consensus regions obtained for isolated colonies (Isolate B, D and E) from the bark 
of B. dalzielii were used for NCBI Blast Search. The blast search for Isolate B consensus 
return with 100 hits and all having 100% query cover, suggesting that Isolate B is 
Klebsiella species, with 99% similarity to Klebsiella pneumonia (Figure 6.26).  
 
 
 
 Consensus Isolate E 
GGATTAGCTTGTAGGTGGGTAACGGCTTACCTTGGGGACGATCCCTAGCTGGTTTGAGAGGATGACCAGCC
ACACGGGAAATGAGACACGGTCCAGATTCCTACGGGAGGCAGCAGTGGGAATATTGCACAATGGGCGCAA
GCCTGATGCAGCCATGCCGCGTGTTTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTCAGCGGGGAGGAAG
GCGGTGAGGTTAATAACCTCATCGATTGACGTTACCCGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAG
CCGCGGTAATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCCGGCGGTCTGTC
AAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTCGAAACTGGCAGGCTAGAGTCTTGTAGA
GGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGG
CCCCCTGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGT
CCACGCCGTAAACGATGTCGATTTGGAGGTTGTGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAAT
CGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGG
AGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGTCTTGACATCCACAGAACTTTCCAGAGAT
GGATTGGTGCCTTCGGGAACTGTGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGG
GTTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTCCGGCCGGGAACTCAAAGGAGACT
GCCAGTGATAAACTGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACA
CGTGCTACAATGGCATATACAAAGAGAAGCGACCTC 
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Figure 6. 26: NCBI Blast Search for Isolate B obtained from B. dalzielii bark 
Taxonomy and lineage report generated showed that Isolate B belongs to the genus 
Klebsiella (Table 6.1) with a hit of 101 across 12 microorganisms. Taxonomy report 
showed that the 16S RNA sequence used to generate the taxonomy table is similar to 
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that of Klebsiella pneumonia with a hit of 73 across 4 microorganisms. However, all the 
73 hits belong description details of Klebsiella pneumonia, thus, Isolate B is suggested to 
be a Klebsiella pneumonia. Thus, the sequence was deposited in the GenBank database 
under the accession number MH762022 
(https://www.ncbi.nlm.nih.gov/nuccore/MH762022). 
Table 6. 1: Taxonomy and lineage report generated for Isolate B suggesting that Isolate B could 
be Klebsiella pneumonia  
The consensus sequence of Isolate D was used for nucleotide blast search and result 
obtained provided 100 blast hits on 100 subject sequences (Figure 6.27). 78 of the blast 
hit have 99% identity with Isolate D query, while 21 blast hits have 893 score for both 
maximum and total scores, most of which are described as Pantoea species. From the 
NCBI result, taxonomy and lineage report generated suggested that Isolate D could be 
Pantoea agglomerans (Table 6.2). Thus, the sequence was deposited in the GenBank 
 Taxonomy Number of hits 
Number of 
Organisms Score 
Kingdom Bacteria  106 16  
Genus Klebsiella 101 12  
Organisms 
Klebsiella pneumonia  72 4 1923 
Uncultured Klebsiella sp. 12 1 1917 
Klebsiella pneumonia subsp. 
Pneumonia 7 1 1912 
Klebsiella sp. 80MoSuero 1 1 1923 
Klebsiella sp. 50MoSuero 1 1 1923 
Klebsiella sp. 29MoSuero 1 1 1917 
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database under the accession number MH762024 
(https://www.ncbi.nlm.nih.gov/nuccore/MH762024). 
 
Figure 6. 27: NCBI Blast Search for Isolate D obtained from B. dalzielii 
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 Taxonomy Number of hits 
Number of 
Organisms Score 
Kingdom Bacteria  111  23  
Class Gammaproteobacteria 78 22  
Order Enterobacterales 71 20  
Genus Pantoea 69 18  
Organisms 
Pantoea agglomerans 14 1 893 
Pantoea sp. 14 1 893 
Uncultured Pantoea sp. 7 1 893 
Pantoea anthophila 16 1 893 
Pantoea sp. ND12 1 1 889 
Table 6. 2: Taxonomy and lineage report of Isolate D obtained from B. dalzielii 
The blast search for Isolate E consensus return with 100 hits and all having 100% query 
cover with 99% similarity to Klebsiella pneumonia suggesting that Isolate E is Klebsiella 
species (Figure 6.28). Taxonomy and lineage report was generated, the result obtained 
indicated that Isolate B belongs to the genus Klebsiella and all listed micro-organisms 
with similar 16S RNA sequences to that of Isolate E are Klebsiella pneumonia (Table 6.3). 
Thus, the sequence was deposited in the GenBank database under the accession 
number MH762023 (https://www.ncbi.nlm.nih.gov/nuccore/MH762023). 
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Figure 6. 28: NCBI Blast Search for Isolate E obtained from B. dalzielii 
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 Taxonomy Number of hits 
Number of 
Organisms Score 
Genus Klebsiella 100 8  
Organisms 
Klebsiella pneumonia  84 7 1825 
Klebsiella pneumonia UHKPC33 1 1 1825 
Klebsiella pneumonia UHKPC07 1 1 1825 
Klebsiella pneumonia DMC1097 1 1 1825 
Klebsiella pneumonia 500 1420 1 1 1825 
Klebsiella pneumonia subsp. 
Pneumonia 10 2 1825 
 Klebsiella pneumonia subsp. 
Pneumoniae KPRO928 1 1 1825 
Table 6. 3: Taxonomy and lineage report of Isolate E obtained from B. dalzielii 
Both Isolate B and Isolate E were suggested to be Klebsiella pneumonia, thus, pairwise 
alignment was conducted using EMBOSS Needle, an online sequence alignment tool. 
The consensus regions of both isolated microorganisms were used for this analysis. The 
pairwise alignment result returned for both identity and similarity between the two 
isolated microorganisms was 94.1%, suggesting that although they are similar but not 
100% identical (Figure 6.29). Thus, the isolated microorganisms are labelled as Klebsiella 
pneumonia B and Klebsiella pneumonia E.  
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Figure 6. 29: Pairwise alignment result obtained for K. pneumonia B and K. pneumonia E 
 
 
B                  1 CAAGACCAAAGGGGGGACCTTCGGGCCTCAAGCCTTAAGATGGCCCAGAT     50 
                                                                        
E                  1 --------------------------------------------------      0 
 
B                 51 GGGATTAGCTTGTAGGTGGGGTAACGGCTTACCTGGGCGACGATCCCTAG    100 
                      |||||||||||||||| ||||||||||||||||.||.|||||||||||| 
E                  1 -GGATTAGCTTGTAGGT-GGGTAACGGCTTACCTTGGGGACGATCCCTAG     48 
 
B                101 CTGGTTTGAGAGGATGACCAGCCACACTGGAAATGAGACACGGTCCAGAT    150 
                     |||||||||||||||||||||||||||.|||||||||||||||||||||| 
E                 49 CTGGTTTGAGAGGATGACCAGCCACACGGGAAATGAGACACGGTCCAGAT     98 
 
B                151 TCTTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGCAAGCCTGA    200 
                     ||.|||||||||||||||| |||||||||||||||||||||||||||||| 
E                 99 TCCTACGGGAGGCAGCAGT-GGGAATATTGCACAATGGGCGCAAGCCTGA    147 
 
B                201 TGCAGCCATGCCGCGTGTGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTT    250 
                     ||||||||||||||||||.||||||||||||||||||||||||||||||| 
E                148 TGCAGCCATGCCGCGTGTTTGAAGAAGGCCTTCGGGTTGTAAAGCACTTT    197 
 
B                251 CAGCGGGGAGGAAGGCGTTAAGGTTAATAACCTCATCGATTGACGTTACC    300 
                     |||||||||||||||||.|.|||||||||||||||||||||||||||||| 
E                198 CAGCGGGGAGGAAGGCGGTGAGGTTAATAACCTCATCGATTGACGTTACC    247 
 
B                301 CGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGA    350 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                248 CGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGA    297 
 
B                351 GGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCAGGCGGT    400 
                     |||||||||||||||||||||||||||||||||||||||||||.|||||| 
E                298 GGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCACGCCGGCGGT    347 
 
B                401 CTGTCAAGTCGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTCG    450 
                     |||||||||.|||||||||||||||||||||||||||||||||||||||| 
E                348 CTGTCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATTCG    397 
 
B                451 AAACTGGCAGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGC    500 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                398 AAACTGGCAGGCTAGAGTCTTGTAGAGGGGGGTAGAATTCCAGGTGTAGC    447 
 
B                501 GGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCC    550 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                448 GGTGAAATGCGTAGAGATCTGGAGGAATACCGGTGGCGAAGGCGGCCCCC    497 
 
B                551 TGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATT    600 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                498 TGGACAAAGACTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATT    547 
 
B                601 AGATACCCTGGTAGTCCACGCCGTAAACGATGTCGATTTGGAGGTTGTGC    650 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                548 AGATACCCTGGTAGTCCACGCCGTAAACGATGTCGATTTGGAGGTTGTGC    597 
 
B                651 CCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAATCGACCGCCTGGGGA    700 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                598 CCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAATCGACCGCCTGGGGA    647 
 
B                701 GTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAG    750 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                648 GTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCCGCACAAG    697 
 
B                751 CGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGT    800 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                698 CGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGT    747 
 
B                801 CTTGACATCCACAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTG    850 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                748 CTTGACATCCACAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTG    797 
 
B                851 TGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGG    900 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                798 TGAGACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTTGTGAAATGTTGGG    847 
 
B                901 TTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTTAGG    950 
                     ||||||||||||||||||||||||||||||||||||||||||||||..|| 
E                848 TTAAGTCCCGCAACGAGCGCAACCCTTATCCTTTGTTGCCAGCGGTCCGG    897 
 
B                951 CCGGGAACTCAAAGGAGACTGCCAGTGATAAACTGGAGGAAGGTGGGGAT   1000 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
E                898 CCGGGAACTCAAAGGAGACTGCCAGTGATAAACTGGAGGAAGGTGGGGAT    947 
 
B               1001 GACGTCAAGTCATCATGGCCCTTACGACCAGGGCTACACACGTGCTACAA   1050 
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 CONVERSION OF GALLIC ACID TO PYROGALLOL   
Calibration curve of gallic acid (Figure 6.30) and pyrogallol (Figure 6.31) were used to 
calculate the amount of compound used and produced in bioconversion. HPLC analysis 
showed the presence of gallic acid with a retention time of 4.3 in 0.1% gallic acid in MHB 
(Figure 6.33) and its absence in Mueller Hinton broth (MHB) (Figure 6.32). And pyrogallol 
was seen in samples inoculated with isolated microorganisms (Figure 6.34). 
 
Figure 6. 30: Calibration curve of gallic acid. Data represents mean ± standard error 
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Figure 6. 31: Calibration curve of pyrogallol. Data represents mean ± standard error 
 
 
Figure 6. 32: HPLC chromatogram of sterile Mueller Hinton broth 
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Figure 6. 33: HPLC chromatogram of gallic acid (retention time of 4.3) in sterile Mueller Hinton 
broth 
 
 
Figure 6. 34: HPLC chromatogram of 24hours sample inoculated with isolated K. pneumonia B 
HPLC analysis was conducted on all samples and the amount of pyrogallol produced and 
that of gallic acid spent was calculated. Samples inoculated with K. pneumonia B with 
the absorbance of 0.108 and 0.125 were seen to produce 0.16mg/mL (Figure 6.35) and 
0.27mg/mL (Figure 6.36), respectively, after 24hours. 
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Figure 6. 35: HPLC analysis of the bioconversion of gallic acid to pyrogallol from samples 
inoculated with K. pneumonia B having 0.108 turbidity. Data are presented as mean ± standard 
error for both compound. 
 
 
Figure 6. 36: HPLC analysis of the bioconversion of gallic acid to pyrogallol from samples 
inoculated with K. pneumonia B having 0.125 turbidity. Data are presented as mean ± standard 
error for both compound. 
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Figure 6. 37: HPLC analysis of the bioconversion of gallic acid to pyrogallol from samples 
inoculated with K. pneumonia E with 0.098 turbidity. Data are presented as mean ± standard 
error for both compound. 
 
Figure 6. 38: HPLC analysis of the bioconversion of gallic acid to pyrogallol from samples 
inoculated with K. pneumonia E with 0.108 turbidity. Data are presented as mean ± standard 
error for both compound. 
Whilst, samples inoculated with K. pneumonia E with 0.098 and 0.108 turbidity were 
seen to produce 0.25mg/mL (Figure 6.37) and 0.30mg/mL (Figure 6.38), respectively 
after 24hours. Thus, both isolated K. pneumonia were seen to convert gallic acid to 
pyrogallol. 
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 CONVERSION OF PROTOCHACEUIC ACID TO CATECHOL 
Calibration curve of protochaceuic acid (Figure 6.39) and catechol (Figure 6.40) were 
used to calculate the amount of compound used and produced in bioconversion. HPLC 
analysis showed the presence of protocatechuic acid with a retention time of 8.0 in 0.1% 
protocatechuic acid in MHB (Figure 6.41) and its absence in Mueller Hinton broth (MHB). 
And catechol was seen in samples inoculated with isolated microorganisms (Figure 
6.42). In chapter four, E. cloacae was isolated and shown to convert gallic acid to 
pyrogallol, thus it was tested for converting protocatechuic acid. 
 
Figure 6. 39: Calibration curve of protocatechuic acid. Data represents mean ± standard error 
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Figure 6. 40: Calibration curve of catechol. Data represents mean ± standard error 
 
Figure 6. 41: HPLC chromatogram of protocatechuic acid (retention time of 8.0) in sterile 
Mueller Hinton broth 
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Figure 6. 42: HPLC chromatogram of 24hours sample inoculated with isolated K. pneumonia B, 
showing the presence of protocatechuic acid and catechol. 
 
 
Figure 6. 43: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with K. pneumonia B with 0.091 turbidity. Data are presented as mean ± 
standard error for both compound. 
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Figure 6. 44: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with K. pneumonia B with 0.083 turbidity. Data are presented as mean ± 
standard error for both compound. 
 
 
Figure 6. 45: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with K. pneumonia E with 0.093 turbidity. Data are presented as mean ± 
standard error for both compound. 
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Figure 6. 46: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with K. pneumonia E with 0.118 turbidity. Data are presented as mean ± 
standard error for both compound. 
 
 
Figure 6. 47: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with E. cloacae E with 0.104 turbidity. Data are presented as mean ± 
standard error for both compound. 
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Figure 6. 48: HPLC analysis of the bioconversion of protocatechuic acid to catechol from 
samples inoculated with E. cloacae with 0.096 turbidity. Data are presented as mean ± 
standard error for both compound. 
HPLC analysis was conducted on all samples and the amount of catechol produced and 
that of protocatechuic acid spent was calculated. Samples inoculated with K. pneumonia 
B with the absorbance of 0.091 and 0.083 were seen to produce highest concentrations 
of 0.91mg/mL (Figure 6.43) and 0.88mg/mL (Figure 6.44) catechol after 12 and 24hours, 
respectively. However, samples inoculated with K. pneumonia E with 0.093 and 0.118 
turbidities were seen to produce highest concentrations of 0.89mg/mL (Figure 6.45) and 
0.93mg/mL (Figure 6.46) catechol after 12hours, respectively. Whilst, samples 
inoculated with E. cloacae with 0.104 and 0.096 turbidity were seen to produce 
0.94mg/mL (Figure 6.47) and 0.99mg/mL (Figure 6.48) after 12hours, respectively. Thus, 
all three isolated microorganisms from B. dalzielii bark are seen to successfully convert 
protocatechuic acid to catechol. 
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 CONCLUSION 
In this chapter of the thesis, gallic acid and protocatechuic acid present in the aqueous 
extract of B. dalzielii bark were seen to be converted to pyrogallol and catechol, 
respectively, by isolated K. pneumonia B and K. pneumonia E. The study on the 
conversion of gallic acid to pyrogallol by E. cloacae was shown in chapter four of this 
thesis, and chapter six exploited the conversion of protocatechuic acid to catechol by E. 
cloacae. This further confirms the role of microorganisms in aqueous extract of natural 
products with ethnopharmacological claims.   
Although, most strains of K. pneumonia are characterised as opportunistic human 
pathogens causing infections such as pneumonias and bacteremias, and rise in 
antibiotics resistance strains of K. pneumonia and the spread of virulent strains have 
been reported (Paczosa and Mecsas, 2016). K. pneumonia strains also play a role in plant 
growth, thus are characterised as endophyte (Dong, Chelius, et al., 2003). In a recent 
study, Enterobacteriaceae including K. pneumonia. E. cloacae and pantoea spp were 
shown to be present on fresh iceberg lettuce pre and post-harvest (Osaili et al., 2018). 
Another study showed that K. pneumonia as capable of infecting both plant and animal 
using maize and mice as test samples (HUANG et al., 2016). All identified isolates (K. 
pneumonia spp and pantoea spp) in this chapter are endophytes and studies showed 
that endophytes play major roles in plant growth and survival (Kandel, Joubert and Doty, 
2017). K. pneumonia was shown to enhance growth, increase chlorophyll content and 
contribute to nitrogen fixing in plants such as Alfalfa and maize (Dong, Iniguez, et al., 
2003; Iniguez, Dong and Triplett, 2004; Kifle and Laing, 2016). Also, Pantoea spp were 
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reported to partake in plant growth enhancement (Verma, Ladha and Tripathi, 2001; 
Verma et al., 2004; Kifle and Laing, 2016). In terms of bioconversion, literature reported 
the production of 1,3-propanediol, 2,3-butanediol and 3-hydroxypropionic acid from 
glycerol using k. pneumonia (Li, Zhang and Dang, 2016; Y. Li et al., 2016; Lee, Jung and 
Oh, 2018; Wang et al., 2018). In addition, research showed that K. pneumonia strains 
are capable of degrading amino acids such as histidine, lysine and arginine and produce 
biogenic amines such as tyramine, spermidine and cadaverine (Pugin et al., 2017). 
In conclusion, the biotransformation of gallic acid to pyrogallol and protocatechuic acid 
to catechol was studied first in aqueous plant extract via inoculating sterile aqueous 
extract of B. dalzielii obtained from six hours maceration. This was further confirmed by 
using purchased gallic acid and protocatechuic acid (0.1%) in Mueller Hinton broth then 
observing their biotransformation by isolated microorganisms at time interval with the 
aid of HPLC analysis. To the best of the author`s knowledge, this is the first work 
reporting the bioconversion of these phytochemicals present in aqueous B. dalzielii bark 
by isolated E. cloacae and K. pneumonia strains B and E. 
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7  
GENERAL DISCUSSION 
 
In the introduction (chapter 1) the role of ethnopharmacology in the provision of health 
care and in modern drug development was highlighted. Of the non-western health care 
systems, Ayurveda or Traditional Chinese Medicine have attracted particular interest 
since they have a historical and written record of applications and efficacy. African 
Traditional Medicine is part of an oral tradition. As fewer records of use are available for 
study, this field of medicine and health care has remained relatively unexplored. The 
Hausa in the Northern part of Nigeria macerate the bark of Boswellia dalzielii in cold 
water, and the resulting extract is used in the treatment of infections and tumours. The 
aims and objectives of this thesis were to validate the traditional use of aqueous bark 
extracts of B. dalzielli by performing the extraction under carefully controlled conditions 
followed by chemical analysis and bioactivity screening of the aqueous extract. 
The technical details of the extractions, analyses, and screening methods used in the 
present study are described in chapter 2.  
The antibacterial screening of Boswellia dalzielii (chapter 3) initially resulted in the 
isolation and identification of gallic acid, a compound with poor antibacterial activity 
against both S. aureus and its methicillin-resistant strain (see Figure 7.1), this finding 
corroborated previous observations (Sanhueza et al., 2017). However, our results 
showed that aqueous maceration conducted for a longer period (24 hours) resulted in 
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better antibacterial activity. Thus, the length of maceration affects the composition and 
the efficacy of a plant extract, and this finding was correlated with a paper that reported 
that longer maceration of herbal material results in an increased number of phenolics in 
the extract (Kocabey, Yilmaztekin and Hayaloglu 2016). In the Boswellia extract, the 
increase in the amount of pyrogallol was particularly notable. Using the checkerboard 
method, no synergistic interaction between gallic acid and pyrogallol could be observed. 
Possibly, other synergy screening methods using both genomic and statistic based 
approach (Chen et al., 2015; Roell, Reif and Motsinger-Reif, 2017), may still show 
synergistic interaction.  
 
Figure 7. 1: Bioactivity guided fractionation of B. dalzielii using different extraction solvents for 
maceration (50% aqueous methanol (×), water (6 hours) (+) and water (24 hours) (*)) resulted 
in the isolation of gallic acid and pyrogallol, however, pyrogallol was only present in the 24 
hours aqueous macerated sample. Pyrogallol has better antibacterial activity (↑) when 
compared to gallic acid (↓).  
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Chapter 4 of this thesis provides comprehensive data to understand the source of 
pyrogallol in the aqueous B. dalzielii extracts obtained after 24 hours maceration. The 
data collected showed that time and temperature affect the presence and 
concentration of phytochemicals in aqueous maceration as shown in figure 4.5, 4.15 and 
4.18. Consequently, resulting in exploring the possibility of the involvement of 
microorganisms and their effect on the phytochemicals present in an aqueous plant 
extract. The results obtained showed that the bacterium Enterobacter cloacae acts as a 
biocatalyst in the conversion of gallic acid to pyrogallol (see Figure 7.2). This novel 
finding contributes to the growing notion that some phytochemicals believed to be 
plant-derived could actually be a product of the interaction of endophytic microbes with 
the plant as reported in other studies (e.g. El-Elimat et al., 2014; Gutiérrez-García et al., 
2017; McMullin et al., 2017). Thus, the possible explanation regarding the 
ethnopharmacological claims, i.e. the antibacterial activity of the plant bark of B. dalzielii 
in the Northern part of Nigeria, could be due to the temperature favouring the growth 
of the microorganisms capable of producing active compounds via bio-converting 
phytochemicals present in aqueous extracts. Also, Pantoea sp. is another bacterium 
isolated from the plant bark of B. dalzielii, but this bacterium cannot bio-convert gallic 
acid to pyrogallol.  The 16S rRNA sequences of both isolated E. cloacae and Pantoea 
species are deposited in the GenBank database under the accession numbers MH764584 
and MH764583, respectively. 
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Figure 7. 2: Bioconversion of gallic acid to pyrogallol. 
 
Chapter 5 of this thesis provides experimental data to support the ethnopharmacology 
claim of using B. dalzielii for cancer treatment alone and in combination. The in-vitro 
MTT assay was used to assess the cytotoxic property of aqueous extract of B. dalzielii 
plant bark against human breast cancer cell line MCF7, although this assay is 
recommended to be conducted with any of the in-vivo screening models as mentioned 
in section 1.9.2 of this thesis. However, only the MTT in-vitro assay was conducted in 
this thesis, thus is recommended that an in-vivo screening assay should be performed 
to corroborate the MTT assay results in the future. Two extraction methods were 
explored which include acid-based extraction and acid hydrolysis to test the cytotoxicity 
activity of the aqueous extract of B. dalzielii. The acid-based extraction was conducted 
because most literature on the cytotoxicity assay of Boswellia species pointed to the 
organic acids as being responsible, especially the boswellic acids as mentioned in section 
1.9.1.1 of this thesis. However, the results obtained in this thesis showed that the 
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extracts obtained via the acid-based extraction method have no cytotoxic effect on 
MCF7 cells, therefore acid hydrolysis was used. The MTT cytotoxicity assay was 
conducted on MCF7 cells using MCF 1OA as control, and 10µg/mL extract sample was 
used. The cytotoxicity effect of aqueous extract of B. dalzielii plant bark obtained via 
acid hydrolysis was seen to have reduced MCF7 cell viability to 85%, however, when 
combined with extracts of other plants traditionally used in tumour treatment, i.e. 
Spondias mombin, Detarium microcarpum, Sclerocarya birrea and Vitellaria paradoxa 
the viability decreased to 68%. Thus, it is recommended to study the synergistic effect 
of the combination used for future study. Interestingly, the aqueous extract of B. dalzielii 
obtained after 24 hours maceration was seen to reduce the viability of MCF7 cells to 
62%. In this study, only one combination was used to compare cytotoxicity activity of 
plant extract alone and in conjunction and the results obtained showed better 
cytotoxicity activity when plants are combined (see Figure 5.6 and 5.7). However, the 
aim of this thesis was on the cytotoxicity effect of B. dalzielii. Moreover, a better result 
was obtained for the aqueous extract of B. dalzielii obtained via 24 hours maceration 
(see Figure 5.9) thus, the used of five combined plants for treatment might not 
necessarily be required.  
The bioactivity guided fractionation of the aqueous extract of B. dalzielii plant bark 
obtained via 24 hours maceration resulted in the extraction, isolation and identification 
of catechol as the main compound responsible for the cytotoxic effect. The 
concentration of catechol causing 50% maximum effect (EC50) was calculated to be 
9.46µg/mL (86µM) after 48 hours treatment (Figure 5. 20) and 5.33 µg/mL (48.45 µM) 
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after 72 hours (Figure 5. 21). The highest concentration of catechol 12.5ug/mL (114µM) 
used in the present study showed cytotoxicity against MCF 7, reducing cell viability to 
82%, 43% and 24% after treatment for 24 hours (Figure 5.17), 48 hours (Figure 5.18) and 
72 hours (Figure 5.19), respectively, while no cytotoxicity effect was observed against 
MCF10A. Thus, the cytotoxicity activity of catechol was observed to be time and 
concentration dependent, corroborating the findings reported by Choi et al., (2018). This 
chapter also contributes to the growing literature on the effect of time and temperature 
on the phytochemicals present in aqueous plant extract. Also, it contributes to the use 
of natural products with ethnopharmacological claims by providing scientific data as 
seen in the case of the cytotoxic effect of B. dalzielii on breast cancer cells (See Figure 
7.3).  
 
Figure 7. 3: Illustration of the cytotoxicity assay conducted on the 24 hours extract of B. dalzielii 
plant bark obtained via maceration. 
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Furthermore, it is important to mention that a new batch B. dalzielii was procured due 
to a shortage in the first batch used at the beginning of the study presented in this thesis. 
Although some variability was observed using TLC analysis (Figure 5. 10), for future 
research it is recommended to explore in detail the variability in terms of 
microorganisms, phytochemicals and bioactivity of B. dalzielii plant parts collected 
throughout a year. This will contribute to tackling the issues regarding the variability in 
plant samples for therapeutic applications. 
Finally, chapter 6 of the study presented in this thesis discusses the involvement of 
microorganisms in the production of catechol. Protochaceuic acid was identified as the 
compound that is bio-converted to catechol and the bacteria responsible for this bio-
conversion are Klebsiella pneumonia B and Klebsiella pneumonia E. These two strains of 
Klebsiella pneumonia where also shown to bio-convert gallic acid to pyrogallol.  
Furthermore, E. cloacae was also shown to be capable of bio-converting protochaceuic 
acid to catechol. Another microorganism isolated from the plant bark of B. dalzielii, 
Pantoea agglomerans, cannot bio-convert protochaceuic acid to catechol (See Figure 
7.4). The 16S rRNA sequences of Klebsiella pneumonia B, Klebsiella pneumonia E and 
Pantoea agglomerans are deposited in the GenBank nucleotide database under the 
accession number MH762022, MH762023 and MH762024, respectively.  
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Figure 7. 4: Bioconversion of gallic acid to pyrogallol and protocatechuic acid to catechol 
 
In conclusion, the study presented in this thesis contributes to the growing notion that 
some phytochemicals believed to be plant-derived could be a product of the interaction 
of endophytic microbes with plant exudates. Also, this study also contributes to the 
growing emphasis on the use of ethnopharmacology in search of active compounds with 
bioactivity from traditional medicine. The traditional use of aqueous extract of the bark 
of B. dalzielli in the treatment of infections and tumours was validated in part. 
Antimicrobial activity of the extracts was sufficient to treat topical infections, some weak 
to moderate anticancer activity was found after in vitro screening. 
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ABSTRACT 
In phytochemistry, spray reagents are used for visualizing compounds present in natural 
products. In this chapter, m-anisaldehyde vanillin spray reagent was used to visualized 
compounds present in the aqueous extract of B. dalzielii bark. This was due to lack of p-
anisaldehyde reagent. Although, vanillin also produced good visualization, the 
combination of vanillin and m-anisaldehyde reagents produced better colouration for 
phenols and sterols. 
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 INTRODUCTION 
Thin-layer chromatography (TLC) is a microscale method which involve the use of a 
stationary phase made up of either glass slide or plastic sheet thin layer coated with a 
polar absorbent which could be either (Al2O3.xH2O)n or silica (SiO2.xH2O)n particles 
and a mobile phase which could be a single or combination of solvents (Gorman and 
Jiang, 2004). This technique has been evolved for use in the screening of bioactive 
compounds and regarded as an effective-directed analysis and regarded as 
bioautographic assays (Marston, 2011).  
Over the years, different TLC visualization reagents have been reported, some are used 
for the detection of specific phytochemicals such as aluminium chloride and 
ethanolamine diphenylborate for flavonoid, Emerson reagent, p-anisaldehyde-sulfuric 
acid and chloranil reagent for phenols and Dragendorff`s reagent for alkaloids (Jork et 
al., 1994; Wagner and Bladt, 1996). In these studies, non-specific vanillin-sulfuric and 
anisaldehyde reagents were used.  
 METHODS 
 Preparation of vanillin reagent  
2g of vanillin was measured and transferred into a 100mL Duran bottle. 98mL of ethanol 
was measured in a measuring cylinder then added to the vanillin and mixed with the aid 
of a magnetic stirrer. Duran bottle containing vanillin solution was transferred on ice 
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and 2mL of sulfuric acid was added dropwise. Vanillin reagent was wrapped with a foil 
paper and stored in the refrigerator.  
 Preparation of m-anisaldehyde reagent 
0.5mL of m-anisaldehyde was measured and transferred into a 100mL Duran bottle 
containing 85mL of methanol, then 10mL of acetic acid and 5mL of sulfuric acid was 
added on ice. The prepared reagent was wrapped with a foil paper and stored in the 
refrigerator. 
 Preparation of m-anisaldehyde vanillin reagent 
1g of vanillin was measured and transferred into a 100mL Duran bottle containing 49mL 
of ethanol, 42.5 of methanol, 0.25mL of m-anisaldehyde then 5mL of acetic acid, and 
2.5mL of sulfuric acid was added on ice. The prepared reagent was wrapped with a foil 
paper and stored in the refrigerator. 
 Preparation of p-anisaldehyde vanillin reagent 
0.5mL of p-anisaldehyde was measured and transferred into a 100mL Duran bottle 
containing 85mL of methanol, then 10mL of acetic acid and 5mL of sulfuric acid was 
added on ice. The prepared reagent was wrapped with a foil paper and stored in the 
refrigerator. 
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 TLC analysis of boiled plant bark  
10g of B. dalzielii plant bark was measured and added to a 250mL round bottom flask 
containing 100mL of distilled water. The sample was boiled for an hour and allowed to 
cool. 40µL of the aqueous sample was spotted on four TLC plates with an approximate 
dimension of 10cm×3cm. Four TLC tanks were cleaned and three of those tanks had a 
different ratio of hexane and ethyl acetate was added as follows: 90:10, 80:20 and 50:50 
plus a drop of acetic acid. The fourth tank contains ethyl acetate, acetic acid and water 
in the ratio of 100: 1.0: 1.0, respectively. TLC plates were allowed to run in the four 
prepared tanks, afterwards dried in the fume cupboard before viewing TLC plate under 
the short wavelength then spraying with vanillin reagent. The whole procedure was 
repeated and TLC plate was sprayed with m-anisaldehyde reagent and m-anisaldehyde 
vanillin reagent.  
 TLC analysis of known compounds  
1mg/mL of the following compounds gallic acid, pyrogallol, β-sitosterol, stigmasterol, 
kaempferol, nobiletin, farnesol and terpinene was prepared. 5µL of each was spotted 
on three TLC plate with an approximate dimension of 10cm×3cm and each of this plate 
was labelled vanillin, m-anisaldehyde and p-anisaldehyde. 
 RESULTS AND DISCUSSION 
 Vanillin sprayed cromatogram  
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Figure 9. 1: Analysed TLC plates viewed under short wavelength  
 
 
Figure 9. 2: Analysed TLC plates sprayed with vanillin reagent and heat source used was 2000W 
hot air gun set at position I (40-450°C). 
Compounds labelled A and B obtained after running with 5mL of hexane and 5mL of 
ethyl acetate plus a drop of acetic acid were visible under the short wavelength, 
however, their visibility was lost after spraying with vanillin reagent (see Figure 7.1 and 
7.2).  
 m-Anisaldehye sprayed chromatogram 
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Figure 9. 3: Analysed TLC plates sprayed with m-anisaldehyde reagent and heat source used 
was 2000W hot air gun set at position II (90-600°C). 
Compound labelled F was only visible after spraying with m-anisaldehyde (Figure 7.3) 
but wasn`t visible with vanillin reagent (Figure 7.2) nor under the short wavelength 
(Figure 7.1). m-Anisaldehyde was used due to lack of p-Anisaldehyde. Therefore, a 
different reagent containing both m-anisaldehyde and vanillin was made. 
 m-Anisaldehye vanillin sprayed chromatogram 
 
 
Figure 9. 4: Analysed TLC plates sprayed with m-anisaldehyde vanillin reagent and heat source 
used was 2000W hot air gun set at position I (40-450°C). 
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Figure 9. 5: Analysed TLC plates sprayed with m-anisaldehyde vanillin reagent and heat source 
used was 2000W hot air gun set at position II (90-600°C). 
TLC chromatogram analysed with m-anisaldehyde vanillin reagent (Figure 7.5) after 
running with the 80mL of hexane and 20mL of ethyl acetate provided better visibility 
when compared to TLC plate viewed under the short wavelength (Figure 7.1) and TLC 
chromatograms obtained after spraying with vanillin (Figure 7.2) and m-anisaldehyde 
reagent alone (Figure 7.4).  
 TLC analysis of known compounds 
TLC analysis of known compounds was conducted to show that where p-anisaldehyde 
reagent is available, the use of m-anisaldehyde vanillin is not necessary.  However, m-
anisaldehyde vanillin provided distinct colouration compared to the individual reagent 
sprays used (Figure 7.6) 
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Figure 9. 6: Analysed TLC plates sprayed with m-anisaldehyde vanillin, vanillin, p-anisaldehyde 
and m-anisaldehyde reagents and heat source used was 2000W hot air gun set at position II 
(90-600°C). Where GA = gallic acid, PY = pyrogallol, NO = nobiletin, KM = kaempferol, ST = 
stigmasterol, SI = sitosterol, FR = farnesol and TP = terpinene. 
From Figure 7.6, gallic acid and terpinene were seen to have a more intense colour when 
treated with m-anisaldehyde vanillin spray when compared to other reagents used. 
Also, the spots for stigmasterol and sitosterol are more prominent when compared to 
the other spray reagent used.  
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 CONCLUSION 
In the absence of p-anisaldehyde reagent, m-anisaldehyde was used. However, there 
was no distinct difference obtained between compounds because the colouration 
obtained after heating is between light brown to intense brown. Vanillin reagent was 
used and some compounds visible under the short wavelength were not reacting with 
the vanillin reagent. Thus, a reagent containing both vanillin and m-anisaldehyde was 
made and better visibility was obtained. To confirm the reactivity of m-anisaldehyde 
vanillin spray, known compounds purchased from Sigma Aldrich were used. These 
compounds belong to the class of phenol (gallic acid), flavonoids (kaempferol and 
nobiletin), terpenes (farnesol and terpinene) and sterols (stigmasterol and β-sitosterol). 
The TLC analysis of these compounds was conducted and all the four spray reagents 
were used. From the TLC chromatogram, m-anisaldehyde vanillin spray reagent 
produced better colouration especially for gallic acid, sitosterol and stigmasterol. 
